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Radioactive iodine (RAI) therapy using 131I can be used to treat patients with thyroid 
dysfunction such as hyperthyroidism and differentiated thyroid cancer (DTC). In the case 
of DTC, cells in the thyroid gland, mainly follicular cells, continue to grow irregularly, 
forming a mass in one or both lobes of the thyroid that appear microscopically similar to 
normal thyroid tissue. Hyperthyroidism refers to when the thyroid is overstimulated and 
produces excess thyroxine hormone (T4) that adversely accelerates the body’s metabolism 
causing many symptoms, including the worsening of a DTC prognosis. While much work 
has been conducted focused on adult patients and adult members of the public with respect 
to radiation protection standards and patient release criteria, little has been considered in 
regard to age-specific pediatric patient cases, both as patients and exposed public. An 
evaluation of patient bioretention of RAI resulting in estimated exposure rates and 
effective dose to all members of the public from adult and pediatric patients receiving RAI 
therapy has been conducted to better inform patient release radiation protection guidelines 
or patients and exposed family members. The improvements to public protection and 
patient release criteria account for age-dependent analysis (both patient and public) are 
proposed in harnessing radiation transport simulations of age-specific phantoms correlated 
with biokinetics post-administration of RAI therapy. Results demonstrated current patient 
release regulatory guidelines overestimated dose to patients and members of the public at 
minimum by a factor of 2 across age groups, indicating that time-dependent age-specific 
models more accurately determined the time at which release can occur to is potentially 
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1. INTRODUCTION  
1.1. Nuclear Regulatory Commission Regulatory Guide 8.39 (NRC Reg. Guide) 
Although a variety of radioactive materials are used in the medical community for 
diagnostic, imaging, and therapeutic purposes, radioactive iodine (RAI) poses one of the 
more significant sources of exposure to the common public. Though RAI is used for 
therapeutic procedures more frequently, 131I emits gammas with energies between 29.4 
and 723 keV that easily escape the patient’s body and can penetrate another person who 
is in close proximity.1 131I predominantly emits a 364 keV gamma photon and many of 
these emissions from the patient expose nearby people in a uniform manner to the whole 
body of members of the public. While 131I does also emit beta particles with a maximum 
energy of 606 keV, pure beta particle emitters have a lower tissue penetration and deposit 
all of their energy locally within the patient.1 From a radiation safety perspective, while a 
considerable amount of radiation is emitted, it is confined to the patient, their excreta and 
body fluids and there is no external irradiation exposure of the public or others. Because 
of the little concern for beta emission, radioactive material such as 131I regularly 
administered, limits the external radiation hazard risk to the emitted gamma particles. 
A patient who is administered RAI therapy in either inpatient or outpatient care is 
radiologically monitored until criteria is met for the patient to be released. Patients can be 
cleared by appropriate guidelines or recommendations listed in US NRC’s Reg. Guide 
8.39, International Atomic Energy Agency (IAEA) Publication 63, National Council on 
Radiation Protection and Measurements (NCRP) Report 155 or International Commission 




licensee, the radioactive material retained in patient’s body or patient’s actions are not 
further radiologically monitored by the licensee. Patients are counseled in behaviors to 
minimize exposure to others before leaving the medical care, but ultimately, the patient’s 
actions are at their own discretion.2 Until 131I is fully excreted from the body and 
physically decayed, the patient continues to emit 131I gamma-rays from their body, 
potentially exposing members of the public who come in proximity such as on public 
transit as well as immediate family members of the patient treated. 
In April 1997, the U.S. Nuclear Regulatory Commission released Regulatory 
Guide 8.39 (NRC RG 8.39) which calculated external dose to a member of the general 
public who was exposed to the patient by assuming them as a point target 1 meter away 





 34.6 Γ 𝑄0 𝑇𝑝  (1 −  𝑒
−0.693 𝑡 𝑇𝑝⁄ )                                 (Eq. 1) 
where: 
D(t)  = accumulated exposure at time t, in Roentgens (R) 
34.6   = Conversion factor of 24 hrs/day times the total integration of decay (1.44), 
Γ    = Specific gamma ray constant for a point source, R/mCi-hr at 1 cm, 
Q0   = Initial activity of the point source in millicuries, at the time of the release,  
Tp   = Physical half-life in days 
r   =  Distance from the point source to the point of interest in centimeters,  
T   = Exposure time in days 
 
The more detailed models described in appendices of NRC RG 8.39 provide more 




rule.2 The regulation released in 1997 was based on the maximum effective dose 
equivalent to an exposed individual to exceed 5 mSv. To facilitate ease of use and 
compliance with the dose limit, a default table for activity, dose rate, or by performing a 
dose calculation specific to the patient was given and ultimately allows patients with 
considerably higher levels of activity to be released. Using the NRC’s assumption of a 
point source and a point target neglects attenuation occurring as radiation exits the 
patient’s body and enters the body of the exposed person.2 Additionally, using NRC’s RG 
8.39 methods only accounts for removal by physical decay of iodine but does not factor 
in a major biological excretion process, urination, or contamination from body fluids such 
as respiration, saliva, and perspiration estimated.5-7 Using this method for calculation from 
NRC RG 8.39 have resulted in a limited estimation of patient release criteria exclusive of 
state-of the art capabilities in phantom dosimetry and biokinetic excretion. While NRC 
RG 8.39 provides more specific methods in appendices to partially account for patient-
specific data, the NRC acknowledges the approach uses simplified exponential excretion 
models.8 The revision of NRC RG 8.39 was released in April 2020 providing more 
extensive patient instructions and information for release, but no change was made to the 
method used to determine patient release dose limits, with the release limit continuing to 
be a potential total effective dose equivalent of 5 millisieverts to any individual.8 
Furthermore, consideration of age-specific patient body burden and age-specific public 
dosimetry continues to remain a deficiency in radiation protection patient release criteria. 
The adoption of patient-specific, time-dependent data is important in future development 




exposure between a patient and members of the public. Patient type plays an integral role 
since treatment for hyperthyroidism versus a patient being treated for differentiated 
thyroid cancer which can be further classified as papillary and follicular, that make up for 
95% of thyroid cancers, and several other tumor types that are less common, all have 
specific treatment plans that affect patient release criteria.9 Accounting for different 
patient types can potentially allow for shorter post 131I therapy monitoring periods. An 
ongoing objective of evaluating the effects of radiation has been to design more accurate 
models that consider age specificity and improving patient release guidance for pediatric 
patients and to inform on the risks of radiation dose to pediatric family/members of the 




2. LITERATURE REVIEW 
2.1. International Commission on Radiological Protection (ICRP) 1 
The ICRP defines a protection quantity to quantitatively determine the human body’s 
extent of internal and external exposure to ionizing of radiation.10 In the Annals of ICRP 
Publication 103, the adopted method to determine effective dose, a fundamental radiation 
protection quantity, begins by using absorbed dose, the basic physical quantity for 
radiological protection used for all types of ionizing radiation and any irradiation 
geometry.10 Although absorbed dose is a physical quantity and represents the mean of the 
distribution of energy deposited in a specific tissue volume in units Gray (Gy), it differs 
from values such as equivalent dose, HT, and effective dose, E , that include weighting 
factors which are based on radiobiological and epidemiological findings.10 Applying a 
radiation weighting factor, wR, to the averaged absorbed dose over specific organ volumes, 
DT,R , accounts for differences in the biological effectiveness of different types of 
radiations to give the quantity equivalent dose in (Gy), HT, as defined in Equation 2.  
 
  𝐻𝑇 =  ∑ 𝑤𝑅𝐷𝑇,𝑅𝑅                                                             (Eq. 2) 
Table 1 contains the weighting factors for different types of radiation, where in the case 
of 131I therapy, the focus is only on photons that the radionuclide emits and is capable of 
penetrating to the exterior of the body. 
 
1 Table 1 and 2 reprinted with permission from International Commission on Radiological Protection. The 





Table 1. Radiation weighting factor values for different radiation types.10 
Radiation Type Radiation weighting 
factor, wR 
Photons 1 
Electrons and muons 1 
Protons and charged pions 2 
Alpha particles, fission fragments, heavy ions 20 
*Neutrons are represented by a continuous function of neutron energy as opposed to a constant. 
 
Values of the equivalent dose to organs can be then weighted for age- and sex-independent 
radiosensitivity of tissues, wT, and summed to give the effective dose, in units Sieverts 
(Sv), as defined by Equation 3. The values of tissue weighting factors used for various 
organs throughout the human body are listed in Table 2. 
 
  𝐸 =  ∑ 𝑤𝑇𝐻𝑇𝑇                                                             (Eq. 3) 
 
Effective dose can be used to assess stochastic health effects from biological reactions and 
primary physical interactions that occur when human tissues are exposed to radiation. The 
summation of tissue weights is equal to 1 and uniforms the sex-averaged dose distribution 
of the whole body. Defining these protection quantities help to determine exposure limit 
recommendations for regulation where the risk and occurrence of stochastic health effects 





Table 2. List of the tissue weighting factors for various human organs.10 
Tissue wT ΣwT 
Bone-marrow (red), Colon, Lung, 
Stomach, Breast, Remainder tissues* 
0.12 0.72 
Gonads 0.08 0.08 
Bladder, Oesophagus, Liver, Thyroid 0.04 0.16 
Bone surface, Brain, Salivary glands, skin 0.01 0.04 
 Total 1.00 
* A weight of 0.00923 is applied to each of the 12 remainder tissues: adrenals, extrathoracic (ET) region, 
gall bladder, heart, kidneys, lymphatic nodes, muscle, oral mucosa, pancreas, small intestine, spleen, 
thymus; and a weight of 0.00462 is applied to each sex-specific tissue (prostate and uterus) 
 
The ICRP recommends constraints, not limits for patient release, with 1 mSv/y for 
members of the public, which children fall under this category for ICRP Publication 94 
since infants and young children are less likely to give informed consent, are not 
considered to be essentially involved in patient care or comforting, but are more 
susceptible to radiation-induced thyroid cancer.1 ICRP Publication 94 further states, if 
methods for calculating external dose use activity that is widely distributed in the patient, 
use of an unattenuated point-source model overestimates external dose to nearby people, 
compared to a line source where an attenuation correction model is more accurate and can 
be implemented routinely.1 The ICRP recommendations listed in Publication 94 for the 
public are related to effective dose alone and give multiple alternatives for release such as 




dose rate at 1 m from the patient was 0.05 mSv/h or less.1 Another alternative listed was 
to specify an effective dose limit of 5 mSv for people exposed to the patient.1 
Meaningful radiation dose reduction and contamination control is achieved by 
following appropriate procedures, and facility and room design, including shielding where 
appropriate, as well as education and training to promote awareness and engagement in 
radiological protection. ICRP Publication 94 recommends that accident prevention and 
review of safety procedures in radiopharmaceutical therapy are an integral part of the 
design of facilities, equipment, and administration procedures as well as post therapy.11 
ICRP Publication 94 states that the decision to hospitalize or release a patient after 
treatment is to be made based on current guidance and regulations, but also needs to 
account for the individual patient’s circumstances such as the residual activity in the 
patient, the patient’s wishes, and family considerations (particularly the presence of 
children or pregnant family members).1  
The emphasis of ICRP recommendations, in general, are on the specific needs of 
patients as well as information to guide radiological protection at home to patients and 
caregivers, avoiding accidental exposure.11 ICRP Publication 140 notes reasoning behind 
lack of biokinetic data is due to the medical community not having adequate resources for 
the collection of useful biokinetic or dosimetric data for such procedures.11 Instead, 
quantitative imaging and dosimetry are recommended for the basis of treatment planning 
for radiopharmaceutical therapy. For inclusion of biokinetics in regulatory guidance, ICRP 
Publication 140 indicates more details on the biokinetics of uptake and retention should 




application.11 Additionally, for adoption of newer methods to determine patient release 
criteria, it is beneficial to assess the integrity of data gathered from descriptions of the 
methods used to acquire the data, meaning that the ICRP is focused on giving regulatory 
guidance but also paves the path to introduce new guidance in the future and methods for 
inclusion. Therapeutic radiopharmaceuticals typically exhibit large differences in 
biokinetics from one patient to another making personalized dosimetry essential to 
ascertain individual radiopharmaceutical biokinetics to ensure that a therapy 
administration does not exceed organ or tissue tolerance levels but also helps with the 
evaluation of patient release criteria. 
  Guidance for hyperthyroid patients treatment and release should take into 
account patient-specific factors, along with detailed written guidance for reducing 
exposure from the patient and their family. Currently no standardized protocols for thyroid 
disease treatment exist, which reflects a lack of evidence for best practices causing the 
administration of higher activities than necessary for effective treatment of benign thyroid 
disease and thus belaboring patient release. Table 3 outlines standard activities at while 
patients are to be released.11 The ICRP acknowledges that a personalized approach based 
on patient-specific measurements can ensure the administration of minimal effective 
activity, thereby minimizing external exposure and protecting staff, family, and 
caregivers. 
Unlike in cases of hyperthyroid treatment, management guidelines have been 
published for adult patients with thyroid nodules and differentiated thyroid cancer (DTC) 




postpartum period. These patients undergoing treatment are recommended hospitalization 
following administration, but the decision to hospitalize or to release a patient are 
recommended to be determined on an individual basis according to calculations of 
potential radiation doses to family and members of the public which differs from Reg. 
Guide 8.39. 
 
Table 3. Activities in MBq for release of patients dependent on external dose to 
other people. 
Radionuclide Half-life MBq for 5 mSv MBq for 1 mSv 
131I 8 days 1200 240 
 
 
2.2. The National Council on Radiation Protection and Measurements (NCRP)  
The NCRP released guidance on the management of radionuclide therapy patients 
in 2006, which stressed the importance of maintaining as low as reasonably achievable 
(ALARA) doses to members of the public (receptor). For purposes of limiting radiation 
doses, members of a patient’s family were considered as distinct from members of the 
public that are limited to 5 mSv, with receptors limited to 1 mSv.4 Because radiation 
treatments are considered events not likely to occur more than a few times or once in the 
course of a lifetime, exposure of patients’ families from radionuclide therapy are labeled 
as “infrequent” exposure with an effective dose limit of 5 mSv. Table 4 gives reference 
values of activities and their medical use.4 If patients require hospitalization, they are still 
allowed to have visitors during the period that radiation precautions are in effect, with the 




the recommendation of the treating physician.4 In the event that this occurs, family 
members are recommended to receive training and individual monitoring as if they were 
to be occupationally exposed, that is recorded the treating physicians.   
The NCRP recommendations are focused on the prevention of the occurrence of 
clinically significant radiation-induced deterministic effects by adhering to dose limits 
below the threshold level of such effects, limiting the risk of stochastic effects, cancer and 
genetic effects, to a reasonable level in relation to societal needs, values, benefits gained, 
and economic factors.4 Any procedure that involves radiation exposure have to be justified 
based on the expected benefits to society exceeding the overall societal cost while 
maintaining ALARA principles, with economic and societal factors being taken into 
account and following individual dose limits to ensure people do not exceed levels of 
acceptable risk. Accordingly, the ALARA principles followed, denote that radiation 
protection standards for patients’ families are not to be as restrictive as those for the 
public.4 
Table 4. Activity ranges for types of RAI treatment.4 
Radionuclide Typical Activity Used Medical use 
131I 185-740 MBq Hyperthyroidism (sodium iodide) 
2.59-3.7 GBq Thyroid ablation (sodium iodide) 
1.11-14.8 GBq Thyroid cancer (sodium iodide) 
 
Additionally, NCRP specifically noted pediatric patients are a special concern in 
radiation protection because they have greater radiation sensitivity due to rapid cell 
division occurring and have a longer period of risk compared to adults for radiogenic 
sequelae following therapy.4 Despite the relatively rare use of radiopharmaceutical 




because the biological distribution, metabolism and excretion of radiopharmaceuticals 
vary widely with age with disparities being most pronounced in infancy and geriatric age. 
The recommendation made was to develop age-dependent dosimetry models to be used in 
radiopharmaceutical treatment planning and patient release criteria.4 
 
2.3.  International Atomic Energy Agency (IAEA) 
The IAEA published guidance on release of patients after radionuclide therapy 
with contributions from the ICRP in 2009. Dose limits similar to other guidance mentioned 
are for effective dose to not exceed 5 mSv for family member but gives specific limits of 
1mSv for children younger than 10 years of age with constraints for children over the age 
of 10 to 3 mSv per episode.3 The ICRP does not have recommendations that explicitly 
require patients to be hospitalized for radionuclide therapy, but guidance from the IAEA 
in 1992 indicated that in radioiodine therapy of cancer, patients are not recommended to 
be sent home immediately.3 Instead, the patient should be hospitalized and monitored for 
a period of time between hours to several days based on patient circumstances. The IAEA 
does however document EU members that require treatment of thyroid cancer using 
radioactive iodine only performed on inpatients. For example, in Germany, all patients 
who receive RAI therapy are hospitalized for at least 48 hours which highlights how some 
European countries practice differs from guidelines in ICRP and those described in US 
radiation protection recommendations.3 Additionally, Table 5 compares release activity 
thresholds in patients from different countries, followed by Table 6 which gives guidance 




on patient release are dose limits for the public and dose constraints for the family and 
caregivers. The ICRP, IAEA and EU propose dose constraints rather than dose limits be 
applied to comforters and caregivers with primary concern on external dose. For those in 
contact with a patient’s urine, there is concern for contamination, but several studies have 
shown that the risk of contamination with 131I is generally low but not negligible. Adult 
relatives, the internal dose due to contamination risk is less than 10% of the external dose.3 
In addition, in a study where skin and thyroid doses were measured, external exposures 
exceeded the internal thyroid dose equivalent by a factor of over 100.3 
Much like its counterparts and other regulatory guidance, the IAEA and ICRP 
draw notice to the shortcomings and many methodological issues that compromise 
external dose calculations in practice that include: the assumption that the activity in 
patients behaves as an unattenuated point source, the use of the inverse square law at short 
distances, issues connected with the uptake and pharmacokinetics of radioiodine, and a 
tendency to use conservative assumptions. 
 
Table 5. Maximum activity for patient release internationally.3 
Radionuclide 
Retained activity (MBq) 
US NRC Germany Sweden Finland Japan Australia 








Table 6. Recommended time restrictions for contact with others.3 
Activity 
(MBq) 




























200 Hyperthyroid 0 15 15 11 5 
400 Hyperthyroid 3 20 21 16 11 
600 Hyperthyroid 6 24 24 20 14 
800 Hyperthyroid 8 26 27 22 16 
1850 Cancer 1,3 3,16 4,16 3,13 2,10 
3700 Cancer 2,7 4,20 4,20 4,17 3,13 
5550 Cancer 2,10 4,22 5,22 4,19 3,16 
7400 Cancer 2,12 5,23 5,24 4,21 4,17 
*Under the assumption sleeping 1.0 apart for 8 hours, the first value is for cancer follow 
ups, the second is for ablation patients. 
 
 
2.4. Prior Studies 
Sparks et al. demonstrated overestimations from NRC Reg. Guide 8.39’s point 
source method by using Monte Carlo radiation transport simulations with 
anthropomorphic phantoms that measured dose rate at 1 m from an 131I administered 
patient to calculate the whole-body dose to an exposed individual.12 Comparing the 
calculations to 49 131I radioimmunotherapy patients who received 0.9 to 4.4 MBq and were 
measured one hour post-administration with a calibrated ionization chamber positioned 1 
m medially of the torso, it was concluded that the NRC overestimated about 61% of the 
actual value because attenuation was not considered in the exposed individual.12   
In another study, Siegel et. al. made comparisons between NRC point source 
method and calculations with a line source method to highlight the conservative nature of 




groups between 20 and 174 cm. Exposure rates were converted to dose rates per unit 
activity and results indicated  similarly to statements in IAEA Publication 63 where the 
inverse square law approximation was not reliable for shorter distances in point source or 
line source calculations. Line source estimations for dose rates, however, were within 10% 
of inverse square law results making the approximation more valid and realistic for certain 
distances.13 
King Faisal Hospital and Research Center took another approach at examining the 
validity of Eq. 1 from RG 8.39 by measuring dose rates at 30 cm and 1 m in patients 
immediately after RAI treatment with a calibrated Victoreen (Inovision Radiation 
Measurements, 6045 Cochran Road, Cleveland, OH) model 450P ionization chamber.14 
Mean observed dose rate was typically lower than the theoretical dose rate highlighting 
the conservative methods of dose calculation in regulatory guidelines such as NRC RG 
8.39. The study at  King Faisal Hospital and Research Center stated their sample 
population of patients were grouped based on age and gender, with the overall sample 
population consisting of 76% females between the age of 21-40.14 For the 311 patients 
considered, the computed point source model overestimated the measured dose rates with 
the average for all females being lower than males. 
  While the majority of studies described focused on adults, Al-Haj et. al. indicated 
that 11 children measured in the sample population were under the age of 16, and all had 
a mean dose rate of 0.034 μSv h−1 per MBq, higher than adults due to their smaller body 
structure. With children having a higher dose rate, this can imply that their parents or 




conducted by the European Union Member States. Jansen and Zoetelief reported of 
various dose constraints for exposure of individuals helping in the care of patients 
undergoing medical exposure, the highest reported dose was to parents who assisted their 
young children after 131I, and for children younger than 1 years old, with an average of 2.3 
mSv.15  
Han et al. presented pediatric phantoms calculations and later, additionally 
performed 131I source distribution Monte Carlo simulations for position-specific voxel 
phantoms that were separated by varying distances in two exposure scenarios (standing 
vs. lying face-to- face) with one scenario modeling a newborn being cared for by a mother 
that received 131I therapy.16,17 The Monte Carlo demonstrated effective dose for two facing 
adult phantoms at 1 m were a factor 1.6 lower than the NRC’s  point-source method for a 
hyperthyroid patient.17 The DTC patient was a factor of 2.2 lower at 1 m distance, but the 
study overall lacked accounting for time-dependent biological excretion.17 Similarly, 
Kochovska et al. estimated effective doses to relatives of 30 hyperthyroid and 30 thyroid 
cancer patients after providing patients and family members with distancing guidance.18 
The study was for 1 week and resulted with a 0.87 mSv mean value of the effective dose 
for the relatives of the hyperthyroid patients compared to 0.21 mSv for spouses of thyroid 
cancer patients which are both below the NRC’s dose limits.18 Family members of 
hyperthyroid patients who followed appropriate guidance had recorded minimal values 
with the 1 spouse who did not, receiving the highest measured dose of the study of 6.79 
mSv which was over the NRC’s limit of 5 mSv.18 The measured family members of 




cancer patient family members received below the recommended dose even for children 
(1 mSv). The protocol followed included 3 days of hospitalization and continued dose rate 
measurements using thermo luminescence dosimeters. Written recommendations were 
given to patients instructing them to sleep in separate rooms from spouses or family 
members for 7 days and keep a distance of 2 m away to improve radiation protection to 
family members, general public and environment.18  
Additionally, Dewji et al. independently verified that the point-source method 
overestimated the external dose rate of an exposed adult (from an adult patient) between 
10 cm to 300 cm of separation distance, regardless of time post 131I administration but the 
two different methods began to converge beyond 300 cm separation distance, particularly 
for hyperthyroid subjects.19 This study employed computational phantom modeling to 
simulate the body anatomy of an adult patient and member of the public using stylized 
Phantom with Moving Arms and Limbs (PIMAL). The study concluded that the point-
source method overestimates the dose rate for a standing exposed person to a standing 
hyperthyroid patient by a factor of 1.9 at 8 h post administration at a separation distance 
of 1 m and by a factor of 3.3 at 8 h for a DTC patient.19  
 
2.5. Biokinetic Modeling 
As there has been an increase in incidence and concern of thyroid cancer in people, 
especially younger children, around the world after the accident in Chernobyl, there has 
been an increase of 131I therapy administered to treat patients.1 With increasing numbers 




of specific organ targets becomes magnified to develop and be included in patient release 
criteria that accounts for patient-specific factors such as age and time-dependent excretion 
patterns. While strides have been taken in absorbed dose estimations due to advancements 
in developing realistic phantom models, the same cannot be said for biokinetic models to 
determine real activity distribution retained by patients which can be variable due to 
prescribed doses, patient weight and other metabolic factors, thus potentially prolonging 
meeting release criteria by a licensee.  
With realistic and adaptive metabolic models becoming a powerful tool to 
determining dose across different patient age ranges and the retained activity, integrating 
biokinetics in patient release criteria can help better improve regulation guidelines for 
radiation protection with patient release. ICRP Publication 53 presented a simplified 
biokinetic pathway of 131I but lacked enough anatomical compartments which led to 
greater imprecisions.20 Though years later in ICRP 128, a new model proposed an 
expansion in detail to compartments, the complexity of the model was deemed difficult 
by some in adapting to patient specific data.21 Current ICRP biokinetic models also are 
not individualized and only consider an “average” metabolism, for example 26% iodine 
uptake for healthy thyroids, but lack consideration of metabolism due to thyroid 
dysfunction or illness, e.g. 5% uptake for differentiated thyroid carcinoma (DTC) or 80% 
uptake for hyperthyroidism.19,22-24 Furthermore, dose coefficients present in ICRP 
Publications 106, 128, 53 and 80 – are intended for diagnostic nuclear medicine and not 





Leggett proposed an adaptable biokinetic model for iodine that restructured physiological 
system models by describing three subsystems of the iodine cycle in a human adult: (1) 
circulating inorganic iodide; (2) thyroidal iodine, and (3) extrathyroidal organic iodine.24 
The model provided a detailed description of the early biokinetics of absorbed iodine to 
improve radiation dose estimates for short-lived isotopes of iodine compared to the model 
listed in ICRP Publications 54 and 67.27,28 By modifying baseline transfer coefficients, 
Leggett’s model becomes applicable to a number of different scenarios in radiation 
protection. Dewji et al. work highlights the adaptability by using modified transfer 
coefficients for the thyroid compartment to model hyperthyroid and differentiated thyroid 
cancer uptake.19,22  Leggett later expanded his model with more anatomical compartments 
in the alimentary tract and age-specific transfer coefficients for pediatric patients including 
excretion rates from ICRP Publication 67 and 100.23,27,29 A comparison of thyroidal dose 
coefficients suggested there is little effect on the changes with age in dose coefficients for 
iodine isotopes, except for short-lived radioiodine which is predicted to have a higher 
absolute thyroidal dose coefficient.  
Guiu-Souto et. al. presented an abbreviated model compared to Leggett’s that also 
expanded alimentary tract compartments to emulate oral administration of 131I in DTC 
patients.30 While citing the lack of well-established models and methods for quantifying 
absorbed doses to specific organs and tumors, Guiu-Souto acknowledged that a certain 
level of complexity beyond his model is necessary, otherwise there is far too significant 
degeneration in the validity of their model. Models adopted by the ICRP present for age 




since reference transfer coefficients were based on typical worldwide dietary intake of 
stable iodine.31 ICRP reference thyroidal biokinetics based on Leggett’s model showed 
even further adaptability being modified to use regional data which indicated differences 
from the global average due to low or high dietary intake of stable.31 The South Korean 
population, who generally have a higher dietary iodine intake than the global mean 
displayed these modifications.31 In the study, transfer coefficients that were altered for 
Korean-specific values in thyroidal uptake rate and leakage rate of thyroidal organic iodine 
as inorganic iodide. The Korean-specific values for these transfers were determined to be 
4.48 and 0.0171 d-1 compared to 7.26 and 0.0077 d-1 typically used.31 The changes were 
measured for thyroidal iodine and physiological status of Korean adults. The Korean 
model using Korean-specific transfer coefficients, predicted lower thyroidal uptake and 
faster decrease of thyroidal iodine. The predicted cumulative activities of 131I in the thyroid 
were 40 to 80% lower than those of the ICRP model.31 Developing a regional-specific 
model demonstrated how the iodine biokinetics for Koreans (i.e. high-iodine-consuming 
population) differ from ICRP model predictions and can serve to improve the accuracy of 
thyroid dose estimation for Koreans and improvements made to radiation protection 
standards. 
 
2.6. Detector Response 
NCRP Report 155 specifically mentioned that for patient release, instrumentation 
typically used was a scintillation well counter system which has the ability to measure 




biokinetic correlations or determining when to release a patient.4 While previous studies 
are discussed below, it is important to note several of the studies utilized in-vivo 
measurement instrumentation estimations for radiological emergency response scenarios, 
but the detectors used are also commonly used for nuclear medical procedures.32-34 
Among instrumentation used, the thyroid uptake system is of particular interest. 
Measurements for thyroid uptake are determined by the ratio of the radioactive material 
concentrated in the thyroid gland to the amount administered to the patient. Thyroid uptake 
measurements are typically used for overactive thyroid dysfunction conditions such as 
hyperthyroidism, Graves’ disease, toxic nodular goiter, and stimulator secreting tumors. 
Decreased or lower uptake can result from numerous conditions such as with thyroid 
hormone secretion in ectopic tumors, hormonal release in thyroid injury, after intake of 
thyroid hormone, or in Jod-Basedow disease. 131I ablation is commonly used during 
treatment for thyroid cancer, and uptake measurements are used to monitor thyroid 
activity.  
A detector such as the CAPTUS 3000 system has several useful medical 
applications and functions for thyroid uptake measurements such as storing patient 
identifiers like demographic and dosage information, count data for both the administered 
dosage and the patient, decay correcting count data, and calculating thyroid uptake 
results.35 One of the predefined regions of interest for library of radionuclides in the system 
is 131I where a set of “normal” values have been entered and results exceeding these values 
are flagged. The thyroid uptake software for Captus detectors have been designed for 




or x-ray from a radioactive source reaches the NaI crystal inside the Captus 3000 detector, 
energy is transferred after collision between electrons in the crystal matrix, primarily 
through Compton interaction. Excited electrons release energy in the form of visible light 
directly proportional to the absorbed energy of the electron. A single light pulse is 
measured by the system from every light emission for each incident ray generated by a 
Compton scattering event. Pulse intensity is directly proportional to the energy of the 
incident gamma or x-ray. Light is then directed toward the photomultiplier tube by 
reflection from the interior side of the aluminum housing. The photomultiplier tube then 
converts the visible light pulses into amplified electrical energy signals through a series of 
dynodes that is directly proportional to the intensity of the incident light pulse. In 
summary, the pulse height generated is directly proportional to the incident gamma or x-
ray energy detected. 
Several studies have proposed relationships between count rates and radionuclide 
distributions in the human body to assess dose to patients after an uptake of radioactive 
materials by using radiation detecting measurement instruments. Kramer et al. constructed 
a high-purity germanium detector in MCNP to simulate counting efficiencies in two 
children-aged phantoms.36 The development of a predictive analytical expression based 
on a function of photon energy and weight/height ration of an individual assuming a 
uniform distribution in the whole body, coupled with biokinetic models, estimated intakes 
and dose of radionuclides to people. 
Calibrations factors present another use of measurements made by detectors post 




Measurements from the detectors were coupled with biokinetic models from Oak Ridge 
National Laboratory’s (ORNL) Dose and Risk Calculation Software (DCAL) to determine 
the fraction retained of 131I in specific organs and distribution as a function of time.37 The 
results of the calibration factors provide estimation of quantities that are used in patient 
release criteria by a licensee such as committed effective dose and cumulative effective 
dose as a function of time. 
A study conducted by S. Cohen and Associates (SC&A) evaluated many common 
hospital radiation detectors used for nuclear medical procedures to assess internal 
contamination from radionuclides following nuclear security events (e.g. dirty bomb 
involving inhalation of 131I).32 The SC&A study concluded that the thyroid uptake system, 
among other detectors, were capable to detect low levels of radiation.32  In a similar dirty 
bomb scenario, Scarboro, S. B. also used a thyroid uptake system for the measurements 
made of various isotopes and concluded one minute to be the minimum necessary counting 
time for the threshold of one clinical decision level (approximately 0.4 Sv).34 For 
measurements of 131I, the probe was placed on the neck where the thyroid was located for 
the counting time. Analyzing various phantoms showed the count rates to be more similar 
between various phantom types for the case of 131I, with children showing the lowest count 
rate per becquerel. Because a child has a smaller thyroid gland than an adult, 131I rapidly 
saturates a child’s thyroid gland before an adult’s thyroid gland.  
Recently, a study by Li et al. states that there is a deficiency in child thyroidal 
monitoring with current techniques and instruments being designed and calibrated for 




The study proposed derived age specific calibration factors for thyroid monitoring using 
four selected detectors, one being the Captus 3000. An example scenario was presented 
for 131I thyroid uptake in a child. Measuring a count rate with a detector like the Captus 
3000 within a post-exposure timeframe, the intake, 30 d thyroid absorbed dose, committed 
thyroid equivalent dose, and committed effective dose could be estimated directly using 






The flow chart in Figure 1 below summarizes the methodology performed in this study. 
Computational phantoms were used to model members of the public and patients in 
newborn, 01-year-old (yo), 05yo, 10yo, 15yo and adult age groups. Biokinetics were 
calculated for each of the age groups by altering age-specific transfer coefficients. The 
exposure rates, external dose rates, and detector response functions were coupled with 
biokinetics to estimate radiation protection quantities with time-dependent biological 
clearance in each age group. Values are integrated to compare with RG 8.39 methods for 
patient release. 
 




Model the patient and 
member of the public
Model bioretention of 131I 
in the patient's body as a 
function of time
Calculate the external dose 
rate and exposure rates to 
the member of the public 
as a function of time
Integrate external dose 
rates and exposure rates to 
calculate total dose and 
exposure to compare to RG 
8.39 method
Model detector response 
for count rates per Bq
Compare external dose 






3.1. Biokinetics 2 
The predicted distribution of RAI activity in a patient following therapy for up to 
90 days post-administrations was based on the continuous, first-order systemic iodine 
biokinetic model proposed by Leggett in Figure 2.23 Modeling was conducted for 
newborn, 01 year old (yo), 05yo, 10yo, 15yo, and adult age groups. The body was 
simplified by dividing systemic iodine into three regions: thyroid contents, urinary bladder 
contents, and soft tissue contents. The soft tissue section represented all other systemic 
iodide combined where the expanded alimentary tract, liver, kidneys, and other remainder 
compartments were summed.  Three different levels of thyroid uptake of non-decay 
corrected 131I were considered: a peak thyroid content of 5% for DTC patients, where the 
5% represents the remnants of the thyroid following ablation therapy and thyroidectomy; 
a peak of ~27%, represented normal thyroid activity; and a peak of 80%, represented the 
overactive hyperthyroid uptake. Leggett defined age specific normal thyroid uptake with 
baseline parameter values. Peak thyroid uptakes of 5% and 80% were targeted by adjusting 
the age specific transfer coefficient from iodine in blood to the thyroid iodide compartment 
on Figure 2, denoted by a red box. The removal of activity from the urinary bladder 
contents in urine modeled voiding at a constant rate. Voiding and excretory transfer 
coefficients were adjusted for the alimentary tract based on values listed in ICRP 
Publications 53 and 100 for age specific parameters.27,29  
 






Figure 2. The adult iodine biokinetic model from Leggett used as the starting point for the age-specific 
model. The numbers correspond to baseline transfer coefficients (d-1). Values shown for urinary 
bladder and alimentary tract contents are reference values for an adult male (ICRP 1993, 2006); RC 
= right colon, LC= left colon, RS= rectosigmoid.23 
 
To execute the method of multiple compartments in Figure 2, a Python script was created 
to solve for a first order differential equation matrix system where each element of the 
matrix represented a positive transfer from one compartment going into another. The 
diagonal of the matrix system represented the loss of transfer leaving one compartment to 
another. The first order equations were solved to model continuous excretion. A cubic 
spline function was used to adjust the discretization of time and corresponding fraction 
retained of 131I and export Excel file. From the excel file, thyroid, bladder, and soft tissue 
components of biokinetics were computed. The adult values were compared to values 
obtained from DCAL comprehensive software system. DCAL calculates the retention of 




regions as a function of time following intake of radionuclides which implemented 
Leggett’s model. The age-specific biokinetics produced by the python script was validated 
against the DCAL software outputted data. Table 7 contains values age-specific transfer 
coefficients employed in the matrix system. 
Table 7. Age-specific transfer coefficients(d-1) altered from Figure 1 
compartments.23 
Pathway Newborn 01yo 05yo 10yo 15yo adult 
Thyroid 2 to blood organic 6.93E-2 4.62E-2 2.31E-2 1.39E-2 1.07E-2 7.70E-3 
Blood organic to Other 3 2.63E1 2.33E1 2.10E1 1.91E1 1.75E1 1.5E1 
Other 3 to blood organic 3.68E1 3.27E1 2.94E1 2.67E1 2.45E1 2.10E1 
Other 3 to Other 4 2.10E0 1.87E0 1.68E0 1.52E0 1.40E0 1.20E0 
Other 4 to Other 3 1.09E0 9.64E-1 8.68E-1 7.89E-1 7.23E-1 6.20E-1 
Other 4 to blood iodide 2.45E-1 2.18E-1 1.96E-1 1.78E-1 1.63E-1 1.40E-1 
Blood organic to kidneys 2 6.30E0 5.60E0 5.04E0 4.58E0 4.20E0 3.60E0 
Kidneys 2 to blood organic 3.68E1 3.27E1 2.94E1 2.67E1 2.45E1 2.10E1 
Kidneys 2 to blood iodide 2.45E-1 2.18E-1 1.96E-1 1.78E-1 1.63E-1 1.40E-1 
Blood organic to liver 2 3.68E1 3.27E1 2.94E1 2.67E1 2.45E1 2.10E1 
Liver 2 to blood organic 3.68E1 3.27E1 2.94E1 2.67E1 2.45E1 2.10E1 
Liver 2 to blood iodide 2.45E-1 2.18E-1 1.96E-1 1.78E-1 1.63E-1 1.40E-1 
Liver 2 to right colon contents 1.40E-1 1.24E-1 1.12E-1 1.02E-1 9.33E-2 8.00E-2 
Other 1 and other 2 represent inorganic iodide in ‘other tissue’. Other 3 and other 4 represent organic iodine 
compartments 1 and 2, respectively. Thyroid 1, kidneys 1, and liver 1 refers to inorganic iodide and thyroid 
2, kidneys 2, and liver 2 refers organic iodine pools in the thyroid, kidneys, and liver, respectively. 
 
 
3.2. Computational Models 
Stylized computational hermaphroditic pediatric phantom models were used with 
the Monte Carlo radiation transport code (MCNP) version 6.2 to estimate time dependent 
external dose rates at varying distances from each major pediatric milestone temporal 
phase: newborn, 01yo, 05yo, 10yo, 15yo, and adult for normal (27%) , DTC (5%), 
hyperthyroid (80%) biokinetics.38 The pediatric stylized phantoms employed in this study 
were originally developed at ORNL by Cristy and Eckerman which was later modified by 




89.10,16,39 The modified organs included the head, brain, salivary glands, respiratory tract, 
extra-pulmonary airways, alimentary tract, rectosigmoid colon, urinary bladder mucosa 
wall, and kidneys. Additionally, Han et. al. revised radiation transport parameters in the 
stylized phantoms to include updates to the assigned organ volumes.39-41 These stylized 
phantoms contain all organs used for effective dose calculations listed in ICRP Publication 
103 except for the extrathoracic region and the lymphatic system which the thymus acts a 
surrogate.10 The pediatric stylized phantoms have over 100 mathematical volumes which 
represent anatomical tissues and organs with 22 distinct material compositions defining 
the phantom. The tissue masses, compositions, and densities were consistent with ICRP 
Publication 89 and International Commission on Radiation Units and Measurements 
Report 46.42,43 The stylized phantom was determined to be appropriate per the conclusion 
comparing pediatric external dose coefficients from external gamma-ray exposures with 
voxel phantoms in Dewji et al.44 The study compared organ dose rate coefficients at 100, 
500, 1000 and 5000 keV energies for all pediatric phantoms, voxel and stylized, for photon 
assessments. The study concluded that the majority of the sex-averaged organ dose rate 
coefficients were within 15% of each other over all phantoms, ages and energies. For 
energies above 500 keV, effective dose rates between the voxel and stylized phantoms 
were within 5% of each other and for energies above 70 keV the dose rates were within 
10% of each other. The primary gamma energy for 131I is 364 keV, making the stylized 
phantom within 10% of the voxel phantom results. Figure 3 demonstrates a computational 








Figure 3. Computational adult phantom visually generated in Visual Editor 
software and colored for different materials.45 
 
3.3. Dose Rates 
3.3.1. Exposure Rates 
The external dose rate calculations were simplified by dividing the body into three 
sources: a soft tissue, thyroid and urinary bladder regions. The 131I contents of the thyroid 
and urinary bladder in patients generally represent the primary contributing organ sources 
of external dose rates to members of the public (receptors).24 An example of a soft tissue 
exposure source generated in Visual Editor software can be seen in Figure 4.45 For each 
Monte Carlo calculation in newborn, 01yo, 05yo, 10yo, 15yo, and adult hermaphroditic 




three separate Monte Carlo F5 tally calculations. The F5 tally was used to calculate a flux 
at a point and coupled with age-specific biokinetics at the three different uptakes: Normal 
(27%), DTC (5%), and  hyperthyroidism (80%), to calculate an exposure rate at varying 
distances from a unit activity distributed throughout the whole body. Exposure rates from 
the flux tally at a point were estimated by using the air kerma approximation. This 
approximation is known to be accurate to ~2% for 131I due to the primary photon energy 
of 364 keV.17 The results are to be compared to NRC Reg. Guide 8.39 exposure as a point 
method where the phantom burden with the unit activity of 131I is exposing a receptor at a 
point. 
 
Figure 4. Adult hermaphroditic phantom with soft tissue distributed source in the presence of air 







3.3.2. Phantom effective dose rates 
A phantom with 131I body burden was positioned directly in front, facing towards 
a second phantom that was the receptor. Permutations of different aged phantom patients 
and receptors were simulated at various distances between 10 cm to 300cm. Organ dose 
concentrations and absorbed dose were estimated in the receptor individual using F6 
MCNP tally. Dose rates for active marrow and the bone surface were estimated using 
skeletal response functions reported as cell-averaged flux (particles cm-2) in MCNP (F4 
tally) in the skeletal regions specific to the ORNL stylized phantoms. Tallies for receptors 
were over effective dose organs listed in ICRP Publication 103 except for the extrathoracic 
region and the lymphatic system which the thymus acts a surrogate.10 Although the 
skeletal response functions published in ICRP Publication 116 are specific to the adult 
voxel reference phantom, these were transposed here due to lack of recent ICRP 
publication of pediatric skeletal response models at the time of this work.46 The skeletal 
response functions employed in the pediatric stylized phantoms were derived from the 
approximations of the adult phantom from Cristy and Eckerman, which represented the 
best available data for application in the pediatric phantoms.39 Anterior dose rates were 
determined at the surface 1 m from the patient at the level of the patient's umbilicus.4 
Equivalent dose was calculated from absorbed dose results and using tissue weighting 
factors from Table 2, an effective dose was computed for each of the three sources 
simulated: thyroid, bladder, and soft tissue. A time dependent effective dose rate was 




effective dose for 5%, 27% and 80% thyroid uptake. Area under the curve was calculated 
for the effective dose as a function of time and compared to the point source method in 
NRC RG 8.39.  
Additionally, occupancy factor, is typically set to 0.25, where occupancy factor is 
the fraction of the time that a patient may be assumed to be close to the exposed member 
of the public, usually a family member at home. Because occupancy factor can vary 
depending on practices of patients once released, to build in conservative estimations, this 
was set to 1. Realistically, as an example, a DTC patient with no family or caregivers once 
released from the hospital by a licensee after 131I treatment, could have an occupancy 
factor much lower than the default 0.25, or conservative case of 1. In the US, because 
there is no standard activity used when treating patients, in some cases, activity is greater 
than the default 1.11 GBq (30 mCi), while still meeting the primary dose limit of 5 mSv 
(500 mrem). Adjusting occupancy factor can allow scenarios where the activity at which 
patients were released, or the activity that was administered on an outpatient basis was 
greater than 1.11 GBq to be within the 5 mSv dose limit. Figure 5 illustrates an example 







Figure 5. Adult phantom with bladder source at 30 cm away from a 10 year-old hermaphroditic 
phantom in the presence of air graphically generated by Visual Editor computer software.45 
 
 
3.4. Detector Response 
Detector responses for the age-specific phantom sources was assessed to propose 
a relationship between the count rates and radionuclide distributions from pediatric 
patients using a validated Captus 3000 Monte Carlo simulation that was used by Li et. al. 
which  accounts for different thyroid uptakes associated with normal thyroid function, 
DTC, and hyperthyroidism.33 The validated detector model was applied for simulations 




detector is seen in Figure 6. As a common nuclear medicine apparatus, the thyroid uptake 
system is readily available in hospital nuclear medicine departments and is a functional 
tool for use in patient release. 
A pulse height tally (MCNP F8 tally) was performed over the NaI crystal volume 
for the photons emitted by the source in the patient and energy deposited in crystal for a 
count rate. The Captus 3000 Thyroid Uptake System is manufactured by Capintec, Inc, 
and is a fully automated, PC-based system which is typically used to perform thyroid 
uptake tests, bioassay tests, and other lab tests. The system includes a 2” Sodium-Iodide 
(NaI) detector. The detector was collimated with a lead-antimony composite material. The 
thyroid uptake collimator extends approximately 16 centimeters from the detector face 
and the bioassay collimator extends only approximately six centimeters from the detector. 
All Captus 3000 thyroid uptake systems include the thyroid uptake collimator but the 
bioassay collimator is an optional feature.34 The focus of this work is on the standard 
thyroid uptake collimator. The system stores patient information and demographics as well 
as all collected spectral or counting data. These features are very useful for generating 
detailed thyroid uptake reports and staff bioassays; reports can be saved and printed as 
individual reports or as a cumulative history. Specifications from Capintec were used to 
model the critical components of the detector and collimator.35 The NaI detector crystal 
was surrounded by 0.508 mm of Aluminum. The photomultiplier tube is mounted directly 
against the back of the crystal and was represented by an enclosed cylindrical vacuum in 
the model. A detector side shield (3.175 mm thick lead) wraps around the detector and 




in a lead and antimony collimator that extends approximately 16 cm from the face of the 
crystal. The entire collimator is housed inside an outer steel layer. 
 
Figure 6. 15year-old hermaphroditic phantom with thyroid source at 10 cm away patient’s throat 







To summarize, biokinetic data is reported for different age groups to demonstrate which 
organs and age groups retain or clear activity fastest or slowest. The bladder was 
responsible for clearing activity in DTC patient, while hyperthyroid patients primarily 
cleared activity via thyroid. The biokinetics are then coupled with external dose rates, 
exposure rates and count rates from MCNP for time-dependent and age-specific trends 
that help with patient release criteria. Results shown are for 10yo, 15yo, and adult patient 
cases that reflect applicable patients being treated with newborn, 01yo, 05yo, 10yo, 15yo 
and adult receptors. External dose rates, exposure rates, and count rates per unit of activity 
indicated typically 10yo patients trended higher than adults. 
 
4.1. Biokinetics 
Implementing the method outlined by Leggett and in Figure 2, age-specific 
biokinetic models were generated using organ-specific transfer coefficients.23 Altering the 
transfer between different organs such as blood to thyroid created different uptake 
schemes that modeled patient’s excretion patterns after RAI therapy in normal, DTC, and 
hyperthyroid patient cases. Table 8 summarizes the numerically derived transfer 
coefficients altered to reflect 27% uptake for normal thyroid patients, 5% uptake for DTC 
patients, and 80% for hyperthyroid patients undergoing RAI treatment. The trend for 
altered thyroid uptakes in pediatric patients results in a higher uptake the younger the 






Table 8. Age-specific transfer coefficients altered for different patient uptakes (d-1). 
Age 00yo 01yo 05yo 10yo 15yo adult 
Normal Thyroid 7.26 7.26 7.26 7.26 7.26 7.26 
DTC 1.105 1.080 1.055 1.045 1.042 1.040 
Hyperthyroid 95.7 92.1 88.7 87.0 86.5 86.0 
 
The plots generated in Figures 7-9 demonstrated the totaled iodide fraction retained of 
activity over time throughout the entire body post administration of RAI for the three 
different types of uptakes. Calculating the total iodide fraction refers to the sum of iodide 
from each compartment in Figure 2 as a function of time. Differences or distinctions in 
the trends for specific age groups are attributed to the altering of certain organ transfer 
coefficients to develop age specificity, where 10yo, 15yo, and adult patients trend 
similarly to each other but differently than newborn, 01yo, and 05yo patients. Newborn 
models were based on 100-day old infant, but for practical purposes it was denoted as 
newborn or 00yo, and adult was denoted as 25yo.23  Transfer coefficients listed in methods 
were determined to have less influence on trends, however, alimentary tract, voiding, and 
thyroid transfer coefficients were the cause of change in uptake trends. The importance of 
groupings ages is based on growth milestones achieved by a person throughout their 


















Figure 9. Total biokinetics for hyperthyroid (80%) patients in different age groups. 
 
While trends in age groups compared among the same uptake pattern do not vary 
drastically and carry generally the same curve shape, Figure 10 makes the comparison in 
a 10yo patient between the three uptake schemes that highlights the distinctions between 
patients. Hyperthyroid patients retained activity for a longer period of time while DTC 
patients removed activity at a much more rapid rate comparatively among the three 





Figure 10. Total biokinetics for different uptakes in 10yo patient. 
 
Because a DTC patient typically undergoes a thyroidectomy, the partial or total removal 
of the thyroid, RAI redistributes throughout the body differently because a smaller amount 
of RAI is absorbed into the leftover remnants of the thyroid. Figure 11 illustrates the main 
driving mechanism of clearing RAI in a DTC patient is voiding with the bladder peaking 
higher and helps further explain why in Figures 8 and 10 the total DTC trend depresses 
much more rapidly than hyperthyroid and normal patients across age groups shown in 
Figures 7-9. Bladder transfer coefficients are adjusted based on age groups to reflect the 




The younger a patient, because the volume of the bladder is smaller than an adult, they 
have a higher rate of clearance due to voiding more frequently. 
 
Figure 11. Voiding comparison of uptakes in 10yo patient as function of percentage 
(%) retention over time. 
 
Figures 12-14 divide the total biokinetics into three main compartments, thyroid, soft 
tissue, and the urinary bladder to help depict why hyperthyroid patients require more time 
to clear RAI. Comparing the trends between each uptake scheme, Figure 14 demonstrates 
that the thyroid retains a higher fraction of RAI for a longer period of time because of the 
higher uptake by the thyroid due to hyperthyroidism, reflective of an overactive thyroid 
and the higher transfer coefficient defined in Table 8. Because less RAI is being cleared 




clearance compared in DTC patients who are more bladder dependent. In other words, 
DTC patients, clearance was driven by voiding while thyroid metabolism drives 
hyperthyroid patients. 
 












Figure 14. Hyperthyroid uptake (80%) 10yo patient’s organ contributions. 
 
4.2. Exposure Rates  
Previously outlining the different biokinetic uptakes was to further explain the role 
in calculations in determining radiation protection quantities and their limits placed by 
entities such as the NRC RG 8.39. An F5 tally was used to simulate a flux at a point and 
using the air kerma approximation, an exposure rate in μR/(Bq-hr) was calculated for 
10yo, 15yo, and adult patients at each of the three different uptakes. Figures 15-17 
demonstrate similar trends as those in Figures 7-9 while Figures 10 and 18 also share 
similarities due to the underlying role that biokinetics play with clearance of RAI. Of the 




faster than in adults. Exposure rate scenarios were calculated for 10yo, 15yo, and adult 
patients representing the patient demographics.47 The increased incidence of pediatric 
patients with thyroid dysfunction, and thus need for RAI treatment, occurs parallel to the 
onset of puberty which on average starts at the age of ten. Because the body is not yet fully 
developed, establishing radiation protection quantities for pediatric patients because more 
imperative as complications have a longer lifespan to arise than in adults.  
Exposure in μR can be determined mathematically after integrating exposure rate 
over time and defining the activity used for RAI treatment that can be then compared to 
the method defined by Equation 1 from NRC RG 8.39. Distances of 1m were used as 
comparison to the approximation established by NRC RG 8.39. Additionally, a 
comparison between the method established here and NRC’s point source method in 
Equation 1 will be further examined in discussion for determining whether current 
regulation defines a conservative estimation that is not applicable to children. Monte Carlo 
calculations converged with a standard error of less than 5% in all results of exposure rates 

























Figure 18. Comparison of exposure rates in 10yo for three different uptakes. 
 
 
4.3. Effective Dose 
Permutations of different aged pediatric patients with different aged targets were 
simulated in MCNP with an F4 and F6 tally over the major organs in the body to determine 
an absorbed dose, then an effective dose rate in units of mSv/(MBq-hour) was calculated 
using tissue weighting factors and iodide biokinetics. Figures 19-21 demonstrate the 




section, where 10yo patients have effective dose rates that peak higher than older age 
group counterparts. A 10yo target was used which is more reflective to occur in real life 
with RAI treatment more likely to occur in older patients who may come into contact with 
younger targets. 
 












Figure 21. Hyperthyroid patient comparison at 1 m distance for effective dose rates 
to 10yo target. 
 
Table 9 and 10 were calculated from the effective dose rate by integration and using a 
7400 MBq source of RAI for DTC patients and 1100 MBq source of RAI for hyperthyroid 
patients similarly to examples done in the appendix of RG 8.39.2 The results for effective 
doses indicated that younger targets exceeded the 1mSv dose limits set by NRC RG 8.39 
than older targets when a 10yo patient was treated for thyroid dysfunction with RAI. 
Monte Carlo calculations performed had a standard error of less than 10% in all data 
presented for effective dose rates estimated, different target age groups can be referred to 




Table 9. The time at which dose limits are exceeded for 10yo DTC patient. 
Time to exceed dose at 1 m 
Target 1 mSv 5 mSv 
10yo < 5 hours < 186 hours 
15yo < 6 hours < 222 hours 
25yo < 6 hours <234 hours 
 
Table 10.  The time at which it takes to exceed dose limits for hyperthyroid 10yo 
patient 
Time to exceed dose at 1 m 
Target 1 mSv 5 mSv 
10yo < 27 hours < 180 hours 
15yo < 28 hours < 192 hours 
25yo <28 hours < 192 hours 
 
Across distances in Figure 22, the further away a target was from the patient, the lower 
the effective dose rate and more applicable the point source method. Additionally, the 
further away a target was from the patient, the more applicable the inverse square law 








Figure 22. Comparison of effective dose rate at varying distances.  
 
 
4.4. Detector Response 
Using a validated Captus 3000 detector in a Monte Carlo simulation produced Figures 23-
25 that display count rates per Bq of administered activity over a period of time. In DTC 
patients, with little thyroid remnants, the whole body contributed to the higher count rate 
where the smaller 10yo patient peaks highest among the three age groups because the 
distribution of activity is spread throughout a shorter body. Unlike DTC patients, 
hyperthyroid and normal patients had adult patients with the highest count rates. Among 
the three uptakes per unit Bq, hyperthyroid adult patients had the highest count rates per 




adult age group and 20% distributed in the rest of the body. Count rates per Bq for all age 
groups compared together can be viewed in Appendix H. 
 
 





















5.1. Exposure Rates 
Calculated exposure rates in Figures 15-17 for the three different uptake schemes 
in 10yo, 15yo, and adult hermaphroditic phantoms were integrated to obtain exposure for 
each age group. Using Eq. 1, exposure was calculated with the point source method 
outlined under current NRC regulations in RG 8.39. Tables 12-14 below represents the 
ratio between the point source method outlined in NRC current regulation and exposures 
calculated using MCNP modeled 10yo, 15yo, and adult phantoms that account for 
biokinetic movement of iodine from compartments in Figure 2. The emphasis on 1 meter 
quantities is due to that clinically and under radiation protection recommendations, 
patients in hospitals base measurements or estimations 1 m from the surface of the patient 
and 1 m above the ground While calculations were done for 10 cm, they serve as the 
maximum overestimation possible compared to the point source method. 
Across different age groups, the ratios greater than 1 in Tables 11-13 indicate that 
there is overestimation using the point source method. Contributing factors that lead to the 
overestimation from point source method include that it does not consider attenuation by 
a patient’s tissues such as skin or the time-dependent fluctuations of the distribution of 
systemic 131I in a patient’s body.19 Values calculated for Table 11-13 are normalized to 1 
GBq for normal patients, with DTC patients administered 7.4 GBq and hyperthyroid 
patients administered 1.11 GBq, similarly done in examples in Appendix B of RG 8.39.2  
Typically, therapeutic radiopharmaceuticals are administered at standard fixed 




kg –1) or standard fixed activities per unit body surface area (MBq m-2 or mCi m–2) as 
determined empirically from clinical trials to yield an acceptable maximal frequency or 
severity of toxicity and an acceptable minimal frequency or extent of therapeutic 
response.4 
For hyperthyroid patients, the point-source method overestimated to exposure to a 
member of the public by a factor of ~1.2 from 8 hour post administration to 48 hours at a 
separation distance of 1 m, with no appreciable difference between age groups. As time 
progresses there is little significant change between ratios due to hyperthyroid patients 
reliance on physical decay of 131I and less clearance from voiding. Results from pediatric 
hyperthyroid patients show less overestimation with de Carvalho et. al. similarly using 
voxel phantoms and asserting that because most of the activity is distributed to a patients 
thyroid in these patients, at distance at 1 m and farther the point source approximation 
becomes more reasonable resulting in a ratio close to 1.48 Carvalho et. al.  further states 
that the difference between patients with hyperthyroidism in a realistic phantom model 
versus simplified point or line source models appear to be conservative by a factor of 2 to 
4 in their non-time-dependent scenarios.48 While a point source model may be more 
appropriate in further distances, expressing systemic activity of 131I in the body as a point 
in closer distances than 1 m is not as realistic since several structures in the body would 
be further away from the thyroid than the separation distance of an exposed person leading 
to over approximation for estimating exposure from therapy patients. Color legends in 




A-F and I-T. Orange denotes normal uptake, blue denotes DTC, and green denotes 
hyperthyroid. 
 
Table 11.  Ratio of RG 8.39 point source exposure to MCNP phantom exposure for 
10yo at separation distances for different 131I uptake modes. Exposure was 
normalized to 1 GBq for normal patients, with DTC patients administered 7.4 GBq 
and hyperthyroid patients administered 1.11 GBq. 
 Separation Distance 
Time post-
administration 
Uptake mode 10 cm 100 cm 
8 h Normal 5.89 1.91 
DTC 13.88 2.31 
Hyperthyroid 2.01 1.21 
24 h Normal 5.19 2.90 
DTC 21.82 6.93 
Hyperthyroid 2.04 1.26 
48 h Normal 5.39 3.31 
DTC 26.85 14.62 












Table 12. Ratio of Reg. Guide. 8.39 point source exposure to MCNP phantom 
exposure for 15yo at separation distances for 131I uptake modes. Exposure was 
normalized to 1 GBq for normal patients, with DTC patients administered 7.4 GBq 
and hyperthyroid patients administered 1.11 GBq. 
 Separation Distance 
Time post-
administration 
Uptake mode 10 cm 100 cm 
8 h Normal 5.79 2.04 
DTC 16.74 2.57 
Hyperthyroid 1.81 1.20 
24 h Normal 4.72 2.90 
DTC 21.61 7.39 
Hyperthyroid 1.84 1.25 
48 h Normal 4.84 3.26 
DTC 24.50 14.69 















Table 13. Ratio of Reg. Guide. 8.39 point source exposure to MCNP phantom 
exposure for adult at separation distances for 131I uptake modes. Exposure was 
normalized to 1 GBq for normal patients, with DTC patients administered 7.4 GBq 
and hyperthyroid patients administered 1.11 GBq. 
 Separation Distance 
Time post-
administration 
Uptake mode 10 cm 100 cm 
8 h Normal 5.30 2.10 
DTC 17.48 2.70 
Hyperthyroid 1.59 1.21 
24 h Normal 4.15 2.92 
DTC 19.86 7.63 
Hyperthyroid 1.61 1.25 
48 h Normal 4.23 3.26 
DTC 21.56 14.76 
Hyperthyroid 1.69 1.32 
 
However, for a standing 10yo DTC patient at 1 m, analysis indicated that the point-source 
method overestimated exposure to the public by a minimum factor of 2.31 at 8 h post 
administration for a separation distance of 1 m and the overestimation continued to widen 
as time progressed to 48 h, with the maximum overestimation by a factor of 14. A 
difference in the patient types and overestimations is a direct result of the inclusion of 
time-dependence and biokinetic modeling that demonstrated the bladder-driven excretion 
in DTC patients. The findings from Tables 11-13 are similar to those of others who have 
also indicated a significant overestimation of exposure rates modeled with the use of an 
unshielded point source.48,49 For a cancer patient for whom nearly all thyroid tissue is 




of a day or less, leading to a much smaller integrated dose for the exposed person 
compared to using the 8-day radiological half-life in the screening calculation.4 Yi et. al. 
reported that for 131I cancer patients with remnants of their thyroid, activity administered 
absorbed is generally distributed uniformly throughout the patient’s body and the exposure 
rates are concluded to be overestimations by a factor about 2 at 1 m after taking 
measurements with a regularly calibrated sodium iodide scintillation survey meter.49 The 
minimum reported by the study of all patients measured was ~0.8, with a maximum factor 
of ~9. While data analyzed for pubescent pediatric patients to adulthood were higher using 
realistic phantoms than the data Yi reported, the difference came from the inclusion of 
biokinetics and time-dependence of 131I systemic distribution as more is removed.49 The 
same author further assessed that the unshielded line source method resulted in less 
overapproximated factors to the measurements taken with exposure being overestimated 
by factors of about 1.3 to 1.5 at 1 m. 
While patient release NRC guidelines using the point source method were 
originally released in 1997, many studies, not limited to the ones listed, were quick to 
report the differences between measurements made for adult family members of patients 
exposed to radiation after release and the point source model estimates where removal of 
activity from the body only accounts for radioactive decay. Most of studies, however, 
lacked in pediatric guidance or recommendations as there has been an increase in use of 
131I therapy and with greater risk posed to younger patients who are developing and will 
live for longer periods. Use of more realistic modeling techniques demonstrated here, 




be used to develop future recommendations for the release of patients after radionuclides 
therapy to more accurately estimated quantities. Inclusion of patient specific data is of 
great importance because revised guidelines are likely to reduce patient monitoring times 
and hospital stays which are a larger factor in pediatric patients cases since they typically 
are accompanied by caregivers or parents. The benefit of new calculation methods greatly 
reduces any unnecessary burden to families in reduction hospitalization. 
 
5.2. Effective Dose 
Figures 19-21 display the results of pubescent pediatric patients and adult patients 
effective dose rates in a 10yo target. The results indicated similarly to those of Figures 26-
28 where the younger patient and the younger targets such as a 10yo have higher effective 
dose rates. A comparison was made to Dewji et. al. in adult patients with an adult target 
as reference towards the pediatric models and methods used where the adult stylized 
phantom produced little difference between the results from their study, but both the adult 
patient and Dewji’s study result in a lower effective dose rate than a 10yo patient with an 
adult target.19,22 Tables 14-16 generate ratios between point-source method and effective 
dose calculations with adult targets that indicate the point source method overestimates 
dose received in 10yo patients with adult targets less than 15yo and adult patients but 
nevertheless are over approximations by at least a factor of ~2 in all uptake modes. The 
inclusion of time-dependence and biological excretion in calculations further increases the 






Figure 26. Effective dose rate comparison for normal uptake mode between 






Figure 27. Effective dose rate comparison for DTC uptake mode between different 






Figure 28. Effective dose rate comparison for normal uptake mode between 
different age groups and Dewji.19 
 
The Monte Carlo simulations with realistic phantoms such as the ones used here 
provide more accurate dose rate estimates near patients treated with radionuclides such as 
131I, including the distribution to specific organs in different irradiation geometries.           
De Carvalho et al. presented a comparison of point, line, and phantom dose rate estimates 
around patients treated with radionuclides.48 The study evaluated hyperthyroid, thyroid 
cancer, and non-Hodgkin’s lymphoma patient therapy types. In the point source model, 
results were overestimated compared to the phantom dose rate source model by factors of 
1.45 to 2.10 at 1 m which are similar to the lower end results to the methods outlined for 




20 to 70% overestimated dose rates at 1 m. Another comparison to Han et al. can be made 
where the study reported that the point-source method overestimated the dose rate by a 
factor of ~1.6 for 1 m separation distance based on Monte Carlo simulations using a 
stylized phantom in hyperthyroid patients. 17 Han et al. also estimated that the point-source 
method overestimates by a factor of 2.2 at 100 cm for a DTC patient. While factors in 
Han’s study, she found similar results among the pediatric ages groups and cited the need 
for implementation of biokinetic modeling that improves approximations.17 
 
Table 14. Ratio of RG 8.39 point source to MCNP phantom dose for 10yo at 1 m 
separation distances for 131I uptake modes. 
Time post-administration Uptake mode 100 cm 
8 h Normal 2.68 
DTC 3.06 
Hyperthyroid 1.92 
24 h Normal 4.44 
DTC 9.68 
Hyperthyroid 2.02 











Table 15. Ratio of RG. 8.39 point source to MCNP phantom dose for 15yo at    1 m 
separation distances for 131I uptake modes. 
Time post-administration Uptake mode 100 cm 
8 h Normal 2.87 
DTC 3.28 
Hyperthyroid 2.05 
24 h Normal 4.78 
DTC 10.39 
Hyperthyroid 2.16 





Table 16. Ratio of RG 8.39 point source to MCNP phantom dose for adult at    1 m 
separation distances for 131I uptake modes. 
Time post-administration Uptake mode 100 cm 
8 h Normal 2.87 
DTC 3.22 
Hyperthyroid 2.10 
24 h Normal 4.86 
DTC 10.35 
Hyperthyroid 2.21 








Despite offering more specific examples in which decay is included from the initial 8 
hours post administration and inclusion of an extrathyroidal component, the NRC does 
not account for biological voiding in guidelines released in 1997 and lacked guidance or 
discussion in release criteria for pediatric patients.2 
While most patients receiving radiopharmaceuticals are compared with simplified 
line or point sources, other studies try to compare volume sources as alternative to 
phantom methods under the assumption the activities administered to patients are 
dispersed quickly in the blood and there is no loss occurred through excretion. Similarly, 
to the effective dose rates obtained by stylized pediatric phantoms, Liu et. al. stated 
MCNP-calculated results for organ-dependent activity distributions had the most realistic 
values that were selected for reference due to the accuracy comparatively with simplified 
models evaluated. Liu indicated that the activity distribution in the patient had limited 
impact on the external dose estimations unlike previous studies.48,50 Three simplified 
source models (i.e., point, line, and cylinder) were reported alongside the phantom models 
for radioactive patients that all overestimated the dose rates to varying degrees when 
compared to the phantom results. The dose rates calculated using the unshielded point 
source model however were reported to have exceeded the reference values by 
approximately 30–40% at 1m from the patient, far less than the dose rates calculated for 
pediatric patients. The unshielded line source model was the closest model with dose rates 
approximately 9 to 18% overestimated at 1 m distances.50 While results varied drastically 
compared to the dose rates from pediatric patient results, Liu indicated that inclusion of 




to 23 h50. Biological half-lives are another area that has lacked guidance of inclusion in 
NRC recommendations because calculations are patient dependent and impacted by 
numerous factors such as the patient’s gender and the administration of thyroid-
stimulating hormones. When taking measurements for comparison, Liu additionally 
discussed that the scattered radiation monitored room decreased 27.5% of the total dose 
rate at a distance of 1 m which can cause systematic underestimation of the simplified 
models but does not improve with lead shielding due to photoelectric absorption.50 
 
5.3. Detector Response  
Following analysis of the various phantom age groups, results indicated that in general, 
the highest count rate is found in the adults, likely due to the difference in size among 
different age groups from 10yo to adult. Children are expected to have the least amount 
of tissue, or attenuating material, between the radionuclide and the detector resulting in 
potentially higher count rates, from less absorption of the gamma ray photons before they 
reach the detector crystal, but the specific radionuclide used has equal impact on the count 
rates detected. 
Results from Figures 23-25 are of comparable magnitude to those of Scarboro 
where she used a similar validated Captus 3000 detector model positioned at the neck in 
Monte Carlo simulations with 131I in different phantom types.34 The count rates trend 
similarly between the phantom types, with the child showing the lowest count rate per 
becquerel. Because 131I gets rapidly absorbed systemically by the thyroid gland, a child 




count rates from phantom models can be coupled with exposure rates and kinetics for 
validation purposes of measurements in patient release criteria. An evaluation of a patient 
being monitored that results in similar count rates can be likely equated to have the 
correlating exposure rate listed in Figures 13, 14, and 15.  The exposure rate data was 
tabulated for calibration of any instrument that provides exposure rate which allows for 
flexibility in the medical setting. Studies monitoring members of the public outside the 
immediate family for radiation exposure poses considerable logistical, ethical and legal 
issues that in most situations would be overtly difficult as well as expensive, and 
potentially unethical, which has led to a limited number of studies done on this matter. 
5.4. Significance  
Extended hospitalization reduces exposure to the public and relatives, but often 
unnecessarily increases overall cost to the family which can be more burdening than the 
actual treatment and thus also may increase exposure to hospital staff. The decision to 
hospitalize patients is weighed heavily in several of the regulatory guides reviewed earlier 
because hospitalization often involves a significant psychological burden for patients and 
families due to isolation, as well as monetary and other costs that should be analyzed and 
justified. Cost should be considered in terms of both justification and optimization of any 
radiation practice because it tends to be a threshold for patients being treated early versus 
late staged. Few studies have attempted to determine the costs associated with the various 
methodologies related to release of patients after therapy with unsealed radionuclides. To 
be realistic, ‘costs’ should include both the immediate monetary considerations and the 




performed, but, while there was general interest, its applicability in many countries is 
limited due to different circumstances in each country.3,51  The study indicated that a single 
day of being hospitalized in 1990 was $687 and based on an 8% per year increase by 1993 
the estimate was $800, then factoring in each patient being treated with 
radiopharmaceuticals must be contained in a private room, the cost was $1000 per day.51 
Extrapolating this estimate to the current year 2021, at the 8% increase per year, 28 years 
later the estimate for one day of being hospitalized is $8,700. Considering the cost of this 
estimate that may be mandatory due to current guidelines provides a significant reason to 
have more accurate guidelines, especially if hospitalization is weighed against lost wages 
from work in the process. Lack of available data to inform recommendations for pediatric 
patients, under current criteria, may result in utilization of adult data and in increased 
hospital stays and unnecessary family burden.  
 
5.5. Future Work 
With the ever-evolving world of science, there continues to be a need for updating 
regulation that is current to matters being researched. Because Monte Carlo calculations 
tend to be computationally intensive depending on the simulation complexity with realistic 
phantoms, they are not as practical using this method for an individual per patient release 
basis. However, much like in the current NRC RG 8.39, a number of precalculated values 
could be provided from simulations previously executed to make more realistic guidelines 
that could be easily looked up or have a simple software algorithm developed that contains 




for example, after completion of the work, ICRP released Publication 143 which contains 
reference pediatric voxel phantoms and can be implemented in future computational 
phantom studies.52 Using instruments like the Captus 3000 provides the foundation for 
measurements and data to be benchmarked and capable of producing individualized 
biokinetics included in said library from patient monitoring. Using sophisticated imaging 
enables better biokinetics modeling of a radiopharmaceutical, but the benefits should be 
weighed against what is practically achievable. Multiple SPECT/computed tomography 
(CT) or PET/CT sessions for example, can be helpful for determining the biokinetics of 
novel therapeutic radiopharmaceuticals.4 The type and number of imaging sessions needed 
for a particular patient undergoing radiopharmaceutical therapy should be optimized. 
Considerations should include the availability of personnel, equipment, financial and 
logistical costs, as well as expected validity.4 The Captus 3000 count rates can also 
similarly be used to develop calibration factors much like those presented in Li.33 Planar 
imaging with a gamma camera for dosimetric purposes also can be useful for determining 
organ uptake and clearance biokinetics, and individual organ overlap to accurately assess, 
taking into account attenuation, scatter, and background correction.53 The number of data 
points needed depends on the biokinetics in the respective organ or tissue. Biokinetics can 
be further improved to solved in a non-continuous pattern by coupling excretion with 
multiple organs. The non-continuous voiding pattern would be to represent a patient 
periodic excretion rather than continuous. The versatility of biokinetics allows for 
different metabolic considerations to account for flushing of the thyroid with non-




comorbidities that present unique challenges such as a patient with end stage renal disease 
because clearance and buildup occurs with hemodialysis causing an increase dose to bone 
marrow. Applications of these patients types can be benchmarked through personal 
monitoring devices such as wearable devices or home monitoring systems that are 
provided upon release with instructions much like those of Gallicchio.54 
Additionally, NRC published new revisions and updates in April 2020 to RG 8.39 that 
expanded patient instructions given during discharge.8 The NRC further announced that it 
had plans to review the point source method as they became aware of the conservative 
estimations and aims to review alternative methods with an intent to have a second 
revision published within the next 2-3 years. With the results presented, it is concluded 
that current guidelines are too conservative in pediatric cases who have different 
considerations and should be specifically included in future iterations of guidelines. Future 
work analysis of resources and how overtly conservative protocols in 8.39 propagate in 







Monte Carlo methods simulating realistic phantoms to calculate exposure and 
external dose rates provide more realistic approximations that account for physical 
processes of scattering and attenuation. Because RG 8.39 lacks patient-specific guidance 
and the inclusion of pediatric patient release recommendations, an assessment to 
determine the relevance of RG 8.29 to pediatric patients undergoing RAI therapy was 
necessary to be performed. Using computational phantoms, time-dependent biokinetic 
data, and Monte Carlo simulations, it was determined that RG 8.39 was overtly 
conservative in pediatric patient and that specific guidance should be included in any 
upcoming revision. Phantom models allow flexibility for simulations at varied separation 
distances, age groups, and even in different geometries such as standing or sitting 
situations that occur scenarios involving buses or airlines, and others. The differences 
between the various methods published and studied can significantly impact the time 
before patients are released, as well as the time for them to be monitored, as current 
guidelines exercise conservatism. Use of more realistic calculations, with phantoms, 
Monte Carlo methods, and time-dependent excretion, should be used to develop new 
criteria for patient release as they provide more accurate results that are necessary for 
pediatric patients being treated and monitored. Considerations of these models avoids 
unnecessary hospital confinement of pediatric patients and the development of more 
accurate can lead to more meaningful instructions for patients with likely shorter 
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EXPOSURE RATES FOR NEWBORN 
 Normal DTC Hyper 
Time (h) 10cm 100cm 300cm 10cm 100cm 300cm 10cm 100cm 300cm 
0.00 1.78E-04 4.91E-06 5.77E-07 1.78E-04 4.91E-06 5.77E-07 1.78E-04 4.91E-06 5.77E-07 
0.25 1.78E-04 4.92E-06 5.78E-07 1.74E-04 4.89E-06 5.75E-07 2.25E-04 5.23E-06 6.12E-07 
0.50 1.76E-04 4.86E-06 5.70E-07 1.70E-04 4.81E-06 5.66E-07 2.42E-04 5.30E-06 6.19E-07 
1.00 1.73E-04 4.69E-06 5.50E-07 1.63E-04 4.62E-06 5.43E-07 2.63E-04 5.33E-06 6.21E-07 
2.00 1.65E-04 4.34E-06 5.09E-07 1.50E-04 4.21E-06 4.95E-07 2.88E-04 5.32E-06 6.18E-07 
3.00 1.59E-04 4.03E-06 4.72E-07 1.38E-04 3.85E-06 4.52E-07 3.01E-04 5.29E-06 6.14E-07 
4.00 1.53E-04 3.76E-06 4.40E-07 1.27E-04 3.52E-06 4.13E-07 3.08E-04 5.26E-06 6.10E-07 
5.00 1.49E-04 3.53E-06 4.13E-07 1.17E-04 3.23E-06 3.79E-07 3.12E-04 5.23E-06 6.06E-07 
6.00 1.44E-04 3.32E-06 3.89E-07 1.08E-04 2.96E-06 3.48E-07 3.14E-04 5.20E-06 6.03E-07 
7.00 1.40E-04 3.14E-06 3.67E-07 1.01E-04 2.72E-06 3.20E-07 3.14E-04 5.17E-06 5.99E-07 
8.00 1.37E-04 2.98E-06 3.48E-07 9.34E-05 2.51E-06 2.94E-07 3.13E-04 5.14E-06 5.95E-07 
9.00 1.33E-04 2.84E-06 3.31E-07 8.68E-05 2.31E-06 2.71E-07 3.12E-04 5.11E-06 5.91E-07 
10.00 1.30E-04 2.71E-06 3.16E-07 8.09E-05 2.13E-06 2.50E-07 3.11E-04 5.08E-06 5.88E-07 
11.00 1.28E-04 2.60E-06 3.03E-07 7.55E-05 1.97E-06 2.31E-07 3.09E-04 5.05E-06 5.84E-07 
12.00 1.25E-04 2.50E-06 2.91E-07 7.06E-05 1.82E-06 2.13E-07 3.07E-04 5.02E-06 5.80E-07 
13.00 1.23E-04 2.41E-06 2.80E-07 6.62E-05 1.69E-06 1.98E-07 3.06E-04 4.98E-06 5.77E-07 
14.00 1.21E-04 2.33E-06 2.71E-07 6.21E-05 1.56E-06 1.83E-07 3.04E-04 4.95E-06 5.73E-07 
15.00 1.19E-04 2.26E-06 2.62E-07 5.84E-05 1.45E-06 1.70E-07 3.02E-04 4.92E-06 5.69E-07 
16.00 1.18E-04 2.19E-06 2.55E-07 5.50E-05 1.35E-06 1.59E-07 3.00E-04 4.89E-06 5.66E-07 
17.00 1.16E-04 2.13E-06 2.48E-07 5.20E-05 1.26E-06 1.48E-07 2.98E-04 4.86E-06 5.62E-07 
18.00 1.14E-04 2.08E-06 2.42E-07 4.92E-05 1.18E-06 1.38E-07 2.96E-04 4.83E-06 5.59E-07 
19.00 1.13E-04 2.03E-06 2.36E-07 4.66E-05 1.10E-06 1.29E-07 2.94E-04 4.80E-06 5.55E-07 
20.00 1.12E-04 1.99E-06 2.31E-07 4.43E-05 1.03E-06 1.21E-07 2.93E-04 4.77E-06 5.52E-07 
21.00 1.11E-04 1.95E-06 2.26E-07 4.22E-05 9.72E-07 1.14E-07 2.91E-04 4.74E-06 5.48E-07 
22.00 1.09E-04 1.91E-06 2.22E-07 4.02E-05 9.14E-07 1.07E-07 2.89E-04 4.71E-06 5.45E-07 
23.00 1.08E-04 1.88E-06 2.18E-07 3.84E-05 8.62E-07 1.01E-07 2.87E-04 4.68E-06 5.42E-07 
24.00 1.07E-04 1.85E-06 2.15E-07 3.68E-05 8.15E-07 9.52E-08 2.85E-04 4.65E-06 5.38E-07 
25.00 1.06E-04 1.82E-06 2.11E-07 3.53E-05 7.71E-07 9.01E-08 2.84E-04 4.62E-06 5.35E-07 
26.00 1.05E-04 1.80E-06 2.08E-07 3.40E-05 7.31E-07 8.54E-08 2.82E-04 4.59E-06 5.32E-07 
27.00 1.04E-04 1.77E-06 2.05E-07 3.27E-05 6.95E-07 8.11E-08 2.80E-04 4.57E-06 5.28E-07 
28.00 1.03E-04 1.75E-06 2.03E-07 3.15E-05 6.62E-07 7.72E-08 2.78E-04 4.54E-06 5.25E-07 
29.00 1.03E-04 1.73E-06 2.00E-07 3.05E-05 6.31E-07 7.36E-08 2.77E-04 4.51E-06 5.22E-07 




 Normal DTC Hyper 
Time (h) 10cm 100cm 300cm 10cm 100cm 300cm 10cm 100cm 300cm 
31.00 1.01E-04 1.69E-06 1.96E-07 2.86E-05 5.78E-07 6.74E-08 2.73E-04 4.46E-06 5.15E-07 
32.00 1.00E-04 1.67E-06 1.94E-07 2.78E-05 5.55E-07 6.46E-08 2.72E-04 4.43E-06 5.12E-07 
33.00 9.94E-05 1.66E-06 1.92E-07 2.70E-05 5.33E-07 6.21E-08 2.70E-04 4.40E-06 5.09E-07 
34.00 9.86E-05 1.64E-06 1.90E-07 2.63E-05 5.13E-07 5.98E-08 2.68E-04 4.38E-06 5.06E-07 
35.00 9.79E-05 1.63E-06 1.88E-07 2.56E-05 4.95E-07 5.76E-08 2.67E-04 4.35E-06 5.03E-07 






EXPOSURE RATES FOR 01YO 
 Normal DTC Hyper 
Time (h) 10 cm 100cm 300cm 10 cm 100cm 300cm 10cm  100cm 300cm 
0.00 1.30E-04 4.63E-06 5.59E-07 1.30E-04 4.63E-06 5.59E-07 1.30E-04 4.63E-06 5.59E-07 
0.25 1.31E-04 4.66E-06 5.62E-07 1.27E-04 4.63E-06 5.59E-07 1.87E-04 5.02E-06 5.99E-07 
0.50 1.31E-04 4.63E-06 5.57E-07 1.24E-04 4.58E-06 5.52E-07 2.08E-04 5.13E-06 6.09E-07 
1.00 1.31E-04 4.50E-06 5.41E-07 1.19E-04 4.42E-06 5.33E-07 2.36E-04 5.22E-06 6.15E-07 
2.00 1.29E-04 4.19E-06 5.03E-07 1.10E-04 4.05E-06 4.88E-07 2.70E-04 5.26E-06 6.15E-07 
3.00 1.27E-04 3.90E-06 4.68E-07 1.02E-04 3.70E-06 4.46E-07 2.89E-04 5.26E-06 6.12E-07 
4.00 1.25E-04 3.65E-06 4.37E-07 9.41E-05 3.39E-06 4.08E-07 3.00E-04 5.24E-06 6.09E-07 
5.00 1.24E-04 3.43E-06 4.09E-07 8.74E-05 3.11E-06 3.74E-07 3.06E-04 5.22E-06 6.06E-07 
6.00 1.22E-04 3.24E-06 3.85E-07 8.13E-05 2.85E-06 3.43E-07 3.09E-04 5.20E-06 6.03E-07 
7.00 1.21E-04 3.07E-06 3.64E-07 7.58E-05 2.62E-06 3.15E-07 3.10E-04 5.18E-06 5.99E-07 
8.00 1.20E-04 2.92E-06 3.46E-07 7.08E-05 2.41E-06 2.90E-07 3.11E-04 5.15E-06 5.96E-07 
9.00 1.18E-04 2.78E-06 3.29E-07 6.63E-05 2.22E-06 2.67E-07 3.10E-04 5.12E-06 5.93E-07 
10.00 1.17E-04 2.66E-06 3.15E-07 6.22E-05 2.05E-06 2.46E-07 3.09E-04 5.10E-06 5.90E-07 
11.00 1.16E-04 2.56E-06 3.02E-07 5.85E-05 1.89E-06 2.27E-07 3.08E-04 5.07E-06 5.87E-07 
12.00 1.15E-04 2.46E-06 2.90E-07 5.51E-05 1.75E-06 2.10E-07 3.07E-04 5.04E-06 5.83E-07 
13.00 1.14E-04 2.38E-06 2.80E-07 5.20E-05 1.62E-06 1.94E-07 3.05E-04 5.02E-06 5.80E-07 
14.00 1.13E-04 2.31E-06 2.71E-07 4.92E-05 1.50E-06 1.80E-07 3.04E-04 4.99E-06 5.77E-07 
15.00 1.13E-04 2.24E-06 2.62E-07 4.66E-05 1.40E-06 1.67E-07 3.02E-04 4.96E-06 5.74E-07 
16.00 1.12E-04 2.18E-06 2.55E-07 4.43E-05 1.30E-06 1.56E-07 3.01E-04 4.93E-06 5.71E-07 
17.00 1.11E-04 2.13E-06 2.49E-07 4.22E-05 1.21E-06 1.45E-07 2.99E-04 4.91E-06 5.68E-07 
18.00 1.10E-04 2.08E-06 2.43E-07 4.02E-05 1.13E-06 1.35E-07 2.97E-04 4.88E-06 5.65E-07 
19.00 1.09E-04 2.03E-06 2.37E-07 3.85E-05 1.06E-06 1.27E-07 2.96E-04 4.86E-06 5.62E-07 
20.00 1.09E-04 1.99E-06 2.33E-07 3.68E-05 9.97E-07 1.19E-07 2.94E-04 4.83E-06 5.59E-07 
21.00 1.08E-04 1.96E-06 2.28E-07 3.54E-05 9.37E-07 1.12E-07 2.93E-04 4.80E-06 5.56E-07 
22.00 1.07E-04 1.93E-06 2.24E-07 3.40E-05 8.83E-07 1.05E-07 2.91E-04 4.78E-06 5.53E-07 
23.00 1.07E-04 1.90E-06 2.21E-07 3.28E-05 8.34E-07 9.90E-08 2.89E-04 4.75E-06 5.50E-07 
24.00 1.06E-04 1.87E-06 2.17E-07 3.17E-05 7.89E-07 9.36E-08 2.88E-04 4.73E-06 5.47E-07 
25.00 1.05E-04 1.84E-06 2.14E-07 3.06E-05 7.47E-07 8.86E-08 2.86E-04 4.70E-06 5.44E-07 
26.00 1.05E-04 1.82E-06 2.11E-07 2.97E-05 7.10E-07 8.41E-08 2.85E-04 4.68E-06 5.41E-07 
27.00 1.04E-04 1.80E-06 2.09E-07 2.88E-05 6.76E-07 8.00E-08 2.83E-04 4.65E-06 5.38E-07 
28.00 1.03E-04 1.78E-06 2.06E-07 2.80E-05 6.45E-07 7.62E-08 2.82E-04 4.63E-06 5.35E-07 
29.00 1.03E-04 1.76E-06 2.04E-07 2.72E-05 6.16E-07 7.27E-08 2.80E-04 4.60E-06 5.32E-07 




 Normal DTC Hyper 
Time (h) 10 cm 100cm 300cm 10 cm 100cm 300cm 10cm  100cm 300cm 
31.00 1.02E-04 1.72E-06 2.00E-07 2.59E-05 5.66E-07 6.67E-08 2.77E-04 4.55E-06 5.27E-07 
32.00 1.01E-04 1.71E-06 1.98E-07 2.53E-05 5.44E-07 6.41E-08 2.76E-04 4.53E-06 5.24E-07 
33.00 1.00E-04 1.69E-06 1.96E-07 2.48E-05 5.24E-07 6.16E-08 2.74E-04 4.50E-06 5.21E-07 
34.00 9.98E-05 1.68E-06 1.95E-07 2.43E-05 5.06E-07 5.94E-08 2.73E-04 4.48E-06 5.18E-07 
35.00 9.92E-05 1.67E-06 1.93E-07 2.38E-05 4.89E-07 5.74E-08 2.71E-04 4.46E-06 5.16E-07 







EXPOSURE RATES FOR 05YO 
 Normal DTC Hyper 
Time (h) 10 cm 100cm 300cm 10 cm 100cm 300cm 10cm  100cm 300cm 
0.00 8.98E-05 4.33E-06 5.52E-07 8.98E-05 4.33E-06 5.52E-07 8.98E-05 4.33E-06 5.52E-07 
0.25 9.26E-05 4.40E-06 5.59E-07 8.74E-05 4.36E-06 5.56E-07 1.49E-04 4.78E-06 5.94E-07 
0.50 9.36E-05 4.41E-06 5.60E-07 8.57E-05 4.36E-06 5.55E-07 1.72E-04 4.95E-06 6.08E-07 
1.00 9.50E-05 4.39E-06 5.55E-07 8.27E-05 4.30E-06 5.47E-07 2.03E-04 5.12E-06 6.22E-07 
2.00 9.70E-05 4.24E-06 5.34E-07 7.73E-05 4.10E-06 5.21E-07 2.41E-04 5.26E-06 6.29E-07 
3.00 9.85E-05 4.04E-06 5.07E-07 7.22E-05 3.85E-06 4.89E-07 2.62E-04 5.29E-06 6.26E-07 
4.00 9.96E-05 3.83E-06 4.78E-07 6.76E-05 3.58E-06 4.54E-07 2.75E-04 5.27E-06 6.20E-07 
5.00 1.00E-04 3.62E-06 4.50E-07 6.33E-05 3.31E-06 4.20E-07 2.82E-04 5.23E-06 6.13E-07 
6.00 1.01E-04 3.42E-06 4.24E-07 5.94E-05 3.06E-06 3.87E-07 2.86E-04 5.19E-06 6.06E-07 
7.00 1.01E-04 3.24E-06 3.99E-07 5.58E-05 2.82E-06 3.57E-07 2.88E-04 5.15E-06 6.01E-07 
8.00 1.02E-04 3.07E-06 3.77E-07 5.25E-05 2.60E-06 3.28E-07 2.89E-04 5.11E-06 5.96E-07 
9.00 1.02E-04 2.92E-06 3.57E-07 4.96E-05 2.39E-06 3.02E-07 2.89E-04 5.08E-06 5.91E-07 
10.00 1.02E-04 2.79E-06 3.39E-07 4.69E-05 2.21E-06 2.78E-07 2.89E-04 5.05E-06 5.87E-07 
11.00 1.02E-04 2.67E-06 3.24E-07 4.44E-05 2.04E-06 2.56E-07 2.88E-04 5.02E-06 5.84E-07 
12.00 1.02E-04 2.56E-06 3.09E-07 4.21E-05 1.88E-06 2.36E-07 2.87E-04 4.99E-06 5.81E-07 
13.00 1.02E-04 2.46E-06 2.97E-07 4.01E-05 1.74E-06 2.18E-07 2.86E-04 4.97E-06 5.78E-07 
14.00 1.02E-04 2.38E-06 2.86E-07 3.82E-05 1.61E-06 2.02E-07 2.85E-04 4.95E-06 5.75E-07 
15.00 1.02E-04 2.30E-06 2.76E-07 3.65E-05 1.49E-06 1.87E-07 2.84E-04 4.92E-06 5.72E-07 
16.00 1.02E-04 2.23E-06 2.67E-07 3.50E-05 1.39E-06 1.73E-07 2.83E-04 4.90E-06 5.69E-07 
17.00 1.01E-04 2.17E-06 2.59E-07 3.36E-05 1.29E-06 1.61E-07 2.81E-04 4.88E-06 5.67E-07 
18.00 1.01E-04 2.12E-06 2.52E-07 3.23E-05 1.20E-06 1.50E-07 2.80E-04 4.85E-06 5.64E-07 
19.00 1.01E-04 2.07E-06 2.46E-07 3.11E-05 1.13E-06 1.40E-07 2.79E-04 4.83E-06 5.61E-07 
20.00 1.01E-04 2.03E-06 2.40E-07 3.00E-05 1.05E-06 1.31E-07 2.78E-04 4.81E-06 5.59E-07 
21.00 1.00E-04 1.99E-06 2.35E-07 2.91E-05 9.88E-07 1.22E-07 2.77E-04 4.79E-06 5.56E-07 
22.00 9.98E-05 1.95E-06 2.30E-07 2.82E-05 9.28E-07 1.15E-07 2.75E-04 4.77E-06 5.54E-07 
23.00 9.95E-05 1.92E-06 2.26E-07 2.73E-05 8.74E-07 1.08E-07 2.74E-04 4.74E-06 5.51E-07 
24.00 9.91E-05 1.89E-06 2.23E-07 2.66E-05 8.24E-07 1.02E-07 2.73E-04 4.72E-06 5.49E-07 
25.00 9.87E-05 1.87E-06 2.19E-07 2.59E-05 7.80E-07 9.58E-08 2.72E-04 4.70E-06 5.46E-07 
26.00 9.83E-05 1.84E-06 2.16E-07 2.52E-05 7.39E-07 9.06E-08 2.70E-04 4.68E-06 5.44E-07 
27.00 9.80E-05 1.82E-06 2.13E-07 2.46E-05 7.01E-07 8.58E-08 2.69E-04 4.66E-06 5.41E-07 
28.00 9.75E-05 1.80E-06 2.11E-07 2.41E-05 6.67E-07 8.15E-08 2.68E-04 4.64E-06 5.39E-07 
29.00 9.71E-05 1.78E-06 2.08E-07 2.36E-05 6.36E-07 7.75E-08 2.67E-04 4.62E-06 5.36E-07 




 Normal DTC Hyper 
Time (h) 10 cm 100cm 300cm 10 cm 100cm 300cm 10cm  100cm 300cm 
31.00 9.63E-05 1.74E-06 2.04E-07 2.27E-05 5.82E-07 7.06E-08 2.64E-04 4.58E-06 5.32E-07 
32.00 9.59E-05 1.73E-06 2.02E-07 2.23E-05 5.59E-07 6.76E-08 2.63E-04 4.56E-06 5.29E-07 
33.00 9.55E-05 1.71E-06 2.00E-07 2.19E-05 5.37E-07 6.49E-08 2.62E-04 4.54E-06 5.27E-07 
34.00 9.51E-05 1.70E-06 1.98E-07 2.16E-05 5.17E-07 6.24E-08 2.61E-04 4.51E-06 5.25E-07 
35.00 9.46E-05 1.69E-06 1.97E-07 2.13E-05 4.99E-07 6.01E-08 2.60E-04 4.49E-06 5.22E-07 







EXPOSURE RATES FOR 10YO 
 Normal DTC Hyper 
Time (h) 10 cm 100cm 300cm 10 cm 100cm 300cm 10cm  100cm 300cm 
0.00 6.31E-05 3.98E-06 5.43E-07 6.31E-05 3.98E-06 5.43E-07 6.31E-05 3.98E-06 5.43E-07 
0.25 6.82E-05 4.07E-06 5.51E-07 6.17E-05 4.02E-06 5.47E-07 1.37E-04 4.57E-06 5.91E-07 
0.50 7.05E-05 4.09E-06 5.52E-07 6.07E-05 4.02E-06 5.46E-07 1.67E-04 4.78E-06 6.08E-07 
1.00 7.41E-05 4.08E-06 5.48E-07 5.88E-05 3.97E-06 5.39E-07 2.06E-04 5.04E-06 6.26E-07 
2.00 8.01E-05 3.98E-06 5.30E-07 5.56E-05 3.80E-06 5.14E-07 2.55E-04 5.28E-06 6.39E-07 
3.00 8.50E-05 3.82E-06 5.04E-07 5.26E-05 3.57E-06 4.83E-07 2.83E-04 5.37E-06 6.39E-07 
4.00 8.91E-05 3.64E-06 4.76E-07 4.99E-05 3.33E-06 4.49E-07 3.00E-04 5.39E-06 6.35E-07 
5.00 9.27E-05 3.46E-06 4.49E-07 4.74E-05 3.08E-06 4.15E-07 3.11E-04 5.38E-06 6.29E-07 
6.00 9.57E-05 3.29E-06 4.24E-07 4.52E-05 2.85E-06 3.83E-07 3.17E-04 5.35E-06 6.23E-07 
7.00 9.83E-05 3.13E-06 4.00E-07 4.31E-05 2.63E-06 3.53E-07 3.20E-04 5.33E-06 6.18E-07 
8.00 1.00E-04 2.98E-06 3.79E-07 4.12E-05 2.43E-06 3.25E-07 3.22E-04 5.30E-06 6.14E-07 
9.00 1.02E-04 2.85E-06 3.60E-07 3.95E-05 2.24E-06 2.99E-07 3.22E-04 5.27E-06 6.10E-07 
10.00 1.04E-04 2.74E-06 3.43E-07 3.79E-05 2.07E-06 2.76E-07 3.22E-04 5.24E-06 6.06E-07 
11.00 1.05E-04 2.63E-06 3.27E-07 3.64E-05 1.91E-06 2.54E-07 3.22E-04 5.22E-06 6.03E-07 
12.00 1.06E-04 2.54E-06 3.14E-07 3.51E-05 1.77E-06 2.35E-07 3.21E-04 5.19E-06 6.00E-07 
13.00 1.07E-04 2.45E-06 3.01E-07 3.39E-05 1.64E-06 2.17E-07 3.20E-04 5.17E-06 5.97E-07 
14.00 1.08E-04 2.38E-06 2.91E-07 3.28E-05 1.52E-06 2.01E-07 3.19E-04 5.15E-06 5.94E-07 
15.00 1.09E-04 2.31E-06 2.81E-07 3.18E-05 1.41E-06 1.86E-07 3.17E-04 5.12E-06 5.91E-07 
16.00 1.09E-04 2.25E-06 2.73E-07 3.09E-05 1.32E-06 1.73E-07 3.16E-04 5.10E-06 5.89E-07 
17.00 1.09E-04 2.20E-06 2.65E-07 3.01E-05 1.23E-06 1.61E-07 3.15E-04 5.08E-06 5.86E-07 
18.00 1.10E-04 2.15E-06 2.58E-07 2.93E-05 1.15E-06 1.50E-07 3.14E-04 5.06E-06 5.84E-07 
19.00 1.10E-04 2.11E-06 2.52E-07 2.86E-05 1.07E-06 1.40E-07 3.12E-04 5.04E-06 5.81E-07 
20.00 1.10E-04 2.07E-06 2.47E-07 2.80E-05 1.01E-06 1.31E-07 3.11E-04 5.02E-06 5.79E-07 
21.00 1.10E-04 2.04E-06 2.42E-07 2.74E-05 9.47E-07 1.22E-07 3.10E-04 5.00E-06 5.76E-07 
22.00 1.10E-04 2.00E-06 2.37E-07 2.68E-05 8.92E-07 1.15E-07 3.09E-04 4.98E-06 5.74E-07 
23.00 1.10E-04 1.98E-06 2.33E-07 2.63E-05 8.43E-07 1.08E-07 3.07E-04 4.95E-06 5.72E-07 
24.00 1.10E-04 1.95E-06 2.30E-07 2.58E-05 7.97E-07 1.02E-07 3.06E-04 4.93E-06 5.69E-07 
25.00 1.09E-04 1.93E-06 2.26E-07 2.54E-05 7.56E-07 9.61E-08 3.05E-04 4.91E-06 5.67E-07 
26.00 1.09E-04 1.90E-06 2.23E-07 2.50E-05 7.18E-07 9.10E-08 3.03E-04 4.89E-06 5.64E-07 
27.00 1.09E-04 1.88E-06 2.21E-07 2.46E-05 6.84E-07 8.63E-08 3.02E-04 4.87E-06 5.62E-07 
28.00 1.09E-04 1.86E-06 2.18E-07 2.43E-05 6.53E-07 8.20E-08 3.01E-04 4.85E-06 5.60E-07 
29.00 1.08E-04 1.85E-06 2.16E-07 2.39E-05 6.24E-07 7.82E-08 3.00E-04 4.83E-06 5.57E-07 




 Normal DTC Hyper 
Time (h) 10 cm 100cm 300cm 10 cm 100cm 300cm 10cm  100cm 300cm 
31.00 1.08E-04 1.82E-06 2.12E-07 2.33E-05 5.74E-07 7.14E-08 2.97E-04 4.79E-06 5.53E-07 
32.00 1.07E-04 1.80E-06 2.10E-07 2.31E-05 5.53E-07 6.84E-08 2.96E-04 4.77E-06 5.51E-07 
33.00 1.07E-04 1.79E-06 2.08E-07 2.28E-05 5.33E-07 6.57E-08 2.95E-04 4.75E-06 5.48E-07 
34.00 1.07E-04 1.78E-06 2.06E-07 2.26E-05 5.15E-07 6.32E-08 2.94E-04 4.73E-06 5.46E-07 
35.00 1.06E-04 1.76E-06 2.05E-07 2.24E-05 4.98E-07 6.10E-08 2.92E-04 4.71E-06 5.44E-07 







EXPOSURE RATES FOR 15YO 
 Normal DTC Hyper 
Time (h) 10 cm 100cm 300cm 10 cm 100cm 300cm 10cm  100cm 300cm 
0.00 4.57E-05 3.56E-06 5.18E-07 4.57E-05 3.56E-06 5.18E-07 4.57E-05 3.56E-06 5.18E-07 
0.25 5.27E-05 3.65E-06 5.27E-07 4.50E-05 3.60E-06 5.23E-07 1.34E-04 4.25E-06 5.73E-07 
0.50 5.60E-05 3.68E-06 5.29E-07 4.45E-05 3.59E-06 5.23E-07 1.69E-04 4.51E-06 5.92E-07 
1.00 6.14E-05 3.69E-06 5.27E-07 4.35E-05 3.56E-06 5.17E-07 2.16E-04 4.83E-06 6.14E-07 
2.00 7.05E-05 3.62E-06 5.10E-07 4.18E-05 3.40E-06 4.93E-07 2.74E-04 5.16E-06 6.31E-07 
3.00 7.81E-05 3.49E-06 4.87E-07 4.03E-05 3.20E-06 4.63E-07 3.09E-04 5.31E-06 6.34E-07 
4.00 8.46E-05 3.35E-06 4.61E-07 3.89E-05 2.98E-06 4.31E-07 3.29E-04 5.37E-06 6.32E-07 
5.00 9.02E-05 3.20E-06 4.36E-07 3.76E-05 2.77E-06 3.99E-07 3.42E-04 5.38E-06 6.28E-07 
6.00 9.51E-05 3.06E-06 4.12E-07 3.65E-05 2.56E-06 3.68E-07 3.49E-04 5.38E-06 6.23E-07 
7.00 9.92E-05 2.93E-06 3.90E-07 3.54E-05 2.37E-06 3.40E-07 3.54E-04 5.36E-06 6.18E-07 
8.00 1.03E-04 2.81E-06 3.70E-07 3.45E-05 2.19E-06 3.13E-07 3.56E-04 5.34E-06 6.14E-07 
9.00 1.06E-04 2.71E-06 3.52E-07 3.36E-05 2.02E-06 2.88E-07 3.57E-04 5.32E-06 6.10E-07 
10.00 1.09E-04 2.61E-06 3.36E-07 3.28E-05 1.87E-06 2.66E-07 3.57E-04 5.30E-06 6.07E-07 
11.00 1.11E-04 2.52E-06 3.21E-07 3.20E-05 1.73E-06 2.45E-07 3.56E-04 5.28E-06 6.04E-07 
12.00 1.13E-04 2.44E-06 3.08E-07 3.13E-05 1.61E-06 2.26E-07 3.56E-04 5.26E-06 6.01E-07 
13.00 1.14E-04 2.37E-06 2.97E-07 3.07E-05 1.49E-06 2.09E-07 3.54E-04 5.23E-06 5.98E-07 
14.00 1.16E-04 2.31E-06 2.87E-07 3.01E-05 1.39E-06 1.94E-07 3.53E-04 5.21E-06 5.95E-07 
15.00 1.17E-04 2.26E-06 2.78E-07 2.96E-05 1.29E-06 1.80E-07 3.52E-04 5.19E-06 5.93E-07 
16.00 1.18E-04 2.21E-06 2.70E-07 2.91E-05 1.21E-06 1.67E-07 3.51E-04 5.17E-06 5.90E-07 
17.00 1.19E-04 2.16E-06 2.63E-07 2.86E-05 1.13E-06 1.55E-07 3.49E-04 5.15E-06 5.88E-07 
18.00 1.19E-04 2.12E-06 2.56E-07 2.82E-05 1.06E-06 1.45E-07 3.48E-04 5.13E-06 5.85E-07 
19.00 1.20E-04 2.09E-06 2.50E-07 2.78E-05 9.94E-07 1.35E-07 3.47E-04 5.11E-06 5.83E-07 
20.00 1.20E-04 2.05E-06 2.45E-07 2.74E-05 9.35E-07 1.27E-07 3.45E-04 5.08E-06 5.81E-07 
21.00 1.20E-04 2.02E-06 2.41E-07 2.71E-05 8.82E-07 1.19E-07 3.44E-04 5.06E-06 5.78E-07 
22.00 1.20E-04 2.00E-06 2.36E-07 2.68E-05 8.33E-07 1.12E-07 3.43E-04 5.04E-06 5.76E-07 
23.00 1.20E-04 1.97E-06 2.33E-07 2.65E-05 7.89E-07 1.05E-07 3.41E-04 5.02E-06 5.74E-07 
24.00 1.20E-04 1.95E-06 2.29E-07 2.62E-05 7.49E-07 9.92E-08 3.40E-04 5.00E-06 5.71E-07 
25.00 1.20E-04 1.93E-06 2.26E-07 2.59E-05 7.13E-07 9.38E-08 3.38E-04 4.98E-06 5.69E-07 
26.00 1.20E-04 1.91E-06 2.23E-07 2.57E-05 6.79E-07 8.89E-08 3.37E-04 4.96E-06 5.67E-07 
27.00 1.20E-04 1.89E-06 2.21E-07 2.54E-05 6.49E-07 8.44E-08 3.36E-04 4.94E-06 5.64E-07 
28.00 1.20E-04 1.87E-06 2.18E-07 2.52E-05 6.21E-07 8.03E-08 3.34E-04 4.92E-06 5.62E-07 
29.00 1.20E-04 1.86E-06 2.16E-07 2.50E-05 5.96E-07 7.66E-08 3.33E-04 4.90E-06 5.60E-07 




 Normal DTC Hyper 
Time (h) 10 cm 100cm 300cm 10 cm 100cm 300cm 10cm  100cm 300cm 
31.00 1.19E-04 1.83E-06 2.12E-07 2.46E-05 5.51E-07 7.01E-08 3.30E-04 4.86E-06 5.55E-07 
32.00 1.19E-04 1.82E-06 2.10E-07 2.44E-05 5.32E-07 6.72E-08 3.29E-04 4.84E-06 5.53E-07 
33.00 1.18E-04 1.81E-06 2.08E-07 2.42E-05 5.14E-07 6.47E-08 3.28E-04 4.82E-06 5.51E-07 
34.00 1.18E-04 1.79E-06 2.07E-07 2.41E-05 4.98E-07 6.23E-08 3.26E-04 4.80E-06 5.49E-07 
35.00 1.18E-04 1.78E-06 2.05E-07 2.39E-05 4.83E-07 6.01E-08 3.25E-04 4.79E-06 5.46E-07 








EXPOSURE RATES FOR ADULT 
 Normal DTC Hyper 
Time (h) 10 cm 100cm 300cm 10 cm 100cm 300cm 10cm  100cm 300cm 
0.00 3.84E-05 3.39E-06 5.11E-07 3.84E-05 3.39E-06 5.11E-07 3.84E-05 3.39E-06 5.11E-07 
0.25 4.73E-05 3.48E-06 5.20E-07 3.83E-05 3.42E-06 5.16E-07 1.42E-04 4.11E-06 5.64E-07 
0.50 5.16E-05 3.50E-06 5.22E-07 3.81E-05 3.41E-06 5.16E-07 1.83E-04 4.38E-06 5.83E-07 
1.00 5.86E-05 3.52E-06 5.20E-07 3.76E-05 3.37E-06 5.10E-07 2.39E-04 4.71E-06 6.04E-07 
2.00 7.04E-05 3.45E-06 5.03E-07 3.68E-05 3.23E-06 4.87E-07 3.08E-04 5.07E-06 6.20E-07 
3.00 8.02E-05 3.34E-06 4.80E-07 3.61E-05 3.03E-06 4.57E-07 3.49E-04 5.24E-06 6.22E-07 
4.00 8.87E-05 3.21E-06 4.55E-07 3.54E-05 2.83E-06 4.26E-07 3.73E-04 5.32E-06 6.20E-07 
5.00 9.61E-05 3.08E-06 4.30E-07 3.48E-05 2.63E-06 3.94E-07 3.88E-04 5.34E-06 6.15E-07 
6.00 1.02E-04 2.96E-06 4.06E-07 3.42E-05 2.43E-06 3.64E-07 3.97E-04 5.35E-06 6.11E-07 
7.00 1.08E-04 2.84E-06 3.84E-07 3.37E-05 2.25E-06 3.35E-07 4.02E-04 5.34E-06 6.06E-07 
8.00 1.13E-04 2.73E-06 3.64E-07 3.32E-05 2.08E-06 3.09E-07 4.05E-04 5.32E-06 6.02E-07 
9.00 1.17E-04 2.63E-06 3.46E-07 3.28E-05 1.92E-06 2.84E-07 4.06E-04 5.30E-06 5.98E-07 
10.00 1.20E-04 2.54E-06 3.30E-07 3.23E-05 1.78E-06 2.62E-07 4.07E-04 5.28E-06 5.95E-07 
11.00 1.23E-04 2.46E-06 3.16E-07 3.19E-05 1.65E-06 2.42E-07 4.06E-04 5.26E-06 5.92E-07 
12.00 1.26E-04 2.39E-06 3.03E-07 3.16E-05 1.53E-06 2.23E-07 4.05E-04 5.24E-06 5.89E-07 
13.00 1.28E-04 2.33E-06 2.92E-07 3.12E-05 1.43E-06 2.06E-07 4.04E-04 5.22E-06 5.87E-07 
14.00 1.30E-04 2.27E-06 2.82E-07 3.09E-05 1.33E-06 1.91E-07 4.03E-04 5.20E-06 5.84E-07 
15.00 1.32E-04 2.22E-06 2.73E-07 3.06E-05 1.24E-06 1.77E-07 4.02E-04 5.18E-06 5.82E-07 
16.00 1.33E-04 2.18E-06 2.65E-07 3.03E-05 1.16E-06 1.65E-07 4.00E-04 5.16E-06 5.79E-07 
17.00 1.34E-04 2.13E-06 2.58E-07 3.01E-05 1.08E-06 1.53E-07 3.99E-04 5.14E-06 5.77E-07 
18.00 1.35E-04 2.10E-06 2.52E-07 2.98E-05 1.02E-06 1.43E-07 3.97E-04 5.12E-06 5.74E-07 
19.00 1.35E-04 2.06E-06 2.46E-07 2.96E-05 9.56E-07 1.33E-07 3.96E-04 5.10E-06 5.72E-07 
20.00 1.36E-04 2.03E-06 2.41E-07 2.93E-05 9.01E-07 1.25E-07 3.94E-04 5.08E-06 5.70E-07 
21.00 1.36E-04 2.01E-06 2.36E-07 2.91E-05 8.51E-07 1.17E-07 3.93E-04 5.06E-06 5.68E-07 
22.00 1.37E-04 1.98E-06 2.32E-07 2.89E-05 8.05E-07 1.10E-07 3.91E-04 5.04E-06 5.65E-07 
23.00 1.37E-04 1.96E-06 2.29E-07 2.87E-05 7.64E-07 1.04E-07 3.90E-04 5.02E-06 5.63E-07 
24.00 1.37E-04 1.94E-06 2.25E-07 2.85E-05 7.26E-07 9.78E-08 3.88E-04 5.00E-06 5.61E-07 
25.00 1.37E-04 1.92E-06 2.22E-07 2.83E-05 6.91E-07 9.24E-08 3.87E-04 4.98E-06 5.59E-07 
26.00 1.37E-04 1.90E-06 2.19E-07 2.82E-05 6.60E-07 8.76E-08 3.85E-04 4.96E-06 5.57E-07 
27.00 1.37E-04 1.88E-06 2.17E-07 2.80E-05 6.31E-07 8.32E-08 3.84E-04 4.94E-06 5.54E-07 
28.00 1.37E-04 1.87E-06 2.15E-07 2.78E-05 6.05E-07 7.92E-08 3.82E-04 4.92E-06 5.52E-07 
29.00 1.36E-04 1.85E-06 2.12E-07 2.77E-05 5.81E-07 7.55E-08 3.81E-04 4.90E-06 5.50E-07 




 Normal DTC Hyper 
Time (h) 10 cm 100cm 300cm 10 cm 100cm 300cm 10cm  100cm 300cm 
31.00 1.36E-04 1.83E-06 2.09E-07 2.74E-05 5.40E-07 6.91E-08 3.78E-04 4.86E-06 5.46E-07 
32.00 1.36E-04 1.81E-06 2.07E-07 2.72E-05 5.22E-07 6.63E-08 3.76E-04 4.84E-06 5.44E-07 
33.00 1.35E-04 1.80E-06 2.05E-07 2.71E-05 5.05E-07 6.38E-08 3.75E-04 4.82E-06 5.41E-07 
34.00 1.35E-04 1.79E-06 2.04E-07 2.69E-05 4.89E-07 6.14E-08 3.73E-04 4.81E-06 5.39E-07 
35.00 1.35E-04 1.78E-06 2.02E-07 2.68E-05 4.75E-07 5.93E-08 3.72E-04 4.79E-06 5.37E-07 








DETECTOR RESPONSE ALL AGE GROUPS 
 



















EFFECTIVE DOSE RATE 10 CM FOR ADULT PATIENT 
 Adult 15yo 10yo 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
0.00 1.82E-04 1.82E-04 1.82E-04 1.85E-04 1.85E-04 1.85E-04 2.18E-04 2.18E-04 2.18E-04 
0.25 1.86E-04 1.85E-04 2.00E-04 1.89E-04 1.89E-04 1.96E-04 2.23E-04 2.24E-04 2.12E-04 
0.50 1.87E-04 1.86E-04 2.06E-04 1.90E-04 1.89E-04 2.00E-04 2.25E-04 2.27E-04 2.09E-04 
1.00 1.87E-04 1.84E-04 2.12E-04 1.90E-04 1.89E-04 2.03E-04 2.24E-04 2.27E-04 2.02E-04 
2.00 1.82E-04 1.77E-04 2.17E-04 1.84E-04 1.82E-04 2.03E-04 2.16E-04 2.20E-04 1.87E-04 
3.00 1.74E-04 1.67E-04 2.16E-04 1.75E-04 1.71E-04 2.00E-04 2.03E-04 2.08E-04 1.74E-04 
4.00 1.64E-04 1.55E-04 2.14E-04 1.65E-04 1.59E-04 1.96E-04 1.88E-04 1.93E-04 1.64E-04 
5.00 1.55E-04 1.44E-04 2.12E-04 1.54E-04 1.48E-04 1.93E-04 1.74E-04 1.79E-04 1.56E-04 
6.00 1.46E-04 1.33E-04 2.10E-04 1.45E-04 1.36E-04 1.90E-04 1.60E-04 1.65E-04 1.50E-04 
7.00 1.38E-04 1.22E-04 2.08E-04 1.36E-04 1.25E-04 1.87E-04 1.47E-04 1.51E-04 1.45E-04 
8.00 1.30E-04 1.13E-04 2.06E-04 1.28E-04 1.15E-04 1.85E-04 1.36E-04 1.38E-04 1.42E-04 
9.00 1.23E-04 1.04E-04 2.05E-04 1.20E-04 1.06E-04 1.84E-04 1.26E-04 1.27E-04 1.40E-04 
10.00 1.17E-04 9.56E-05 2.04E-04 1.14E-04 9.73E-05 1.82E-04 1.17E-04 1.16E-04 1.38E-04 
11.00 1.12E-04 8.81E-05 2.03E-04 1.08E-04 8.96E-05 1.81E-04 1.08E-04 1.06E-04 1.37E-04 
12.00 1.07E-04 8.13E-05 2.02E-04 1.03E-04 8.25E-05 1.80E-04 1.01E-04 9.74E-05 1.36E-04 
13.00 1.03E-04 7.51E-05 2.01E-04 9.79E-05 7.60E-05 1.79E-04 9.49E-05 8.93E-05 1.35E-04 
14.00 9.91E-05 6.94E-05 2.00E-04 9.38E-05 7.02E-05 1.78E-04 8.92E-05 8.19E-05 1.34E-04 
15.00 9.57E-05 6.43E-05 1.99E-04 9.02E-05 6.48E-05 1.78E-04 8.42E-05 7.52E-05 1.33E-04 
16.00 9.27E-05 5.97E-05 1.98E-04 8.69E-05 6.00E-05 1.77E-04 7.98E-05 6.92E-05 1.32E-04 
17.00 9.01E-05 5.54E-05 1.97E-04 8.41E-05 5.56E-05 1.76E-04 7.59E-05 6.37E-05 1.32E-04 
18.00 8.77E-05 5.16E-05 1.96E-04 8.15E-05 5.16E-05 1.75E-04 7.24E-05 5.87E-05 1.31E-04 
19.00 8.56E-05 4.81E-05 1.96E-04 7.92E-05 4.80E-05 1.75E-04 6.94E-05 5.41E-05 1.31E-04 
20.00 8.36E-05 4.50E-05 1.95E-04 7.72E-05 4.47E-05 1.74E-04 6.67E-05 5.00E-05 1.30E-04 
21.00 8.19E-05 4.21E-05 1.94E-04 7.54E-05 4.18E-05 1.73E-04 6.43E-05 4.63E-05 1.30E-04 
22.00 8.04E-05 3.95E-05 1.93E-04 7.37E-05 3.91E-05 1.73E-04 6.21E-05 4.29E-05 1.29E-04 
23.00 7.90E-05 3.71E-05 1.93E-04 7.23E-05 3.66E-05 1.72E-04 6.02E-05 3.98E-05 1.29E-04 
24.00 7.78E-05 3.50E-05 1.92E-04 7.10E-05 3.44E-05 1.71E-04 5.85E-05 3.70E-05 1.28E-04 
25.00 7.66E-05 3.30E-05 1.91E-04 6.98E-05 3.23E-05 1.71E-04 5.70E-05 3.45E-05 1.28E-04 
26.00 7.56E-05 3.12E-05 1.90E-04 6.87E-05 3.05E-05 1.70E-04 5.57E-05 3.22E-05 1.27E-04 
27.00 7.47E-05 2.96E-05 1.90E-04 6.77E-05 2.88E-05 1.69E-04 5.45E-05 3.01E-05 1.27E-04 
28.00 7.38E-05 2.81E-05 1.89E-04 6.69E-05 2.73E-05 1.69E-04 5.34E-05 2.82E-05 1.26E-04 
29.00 7.30E-05 2.68E-05 1.88E-04 6.60E-05 2.59E-05 1.68E-04 5.24E-05 2.64E-05 1.26E-04 




 Adult 15yo 10yo 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
31.00 7.16E-05 2.44E-05 1.87E-04 6.46E-05 2.34E-05 1.67E-04 5.07E-05 2.34E-05 1.25E-04 
32.00 7.10E-05 2.34E-05 1.86E-04 6.40E-05 2.24E-05 1.66E-04 5.00E-05 2.21E-05 1.24E-04 
33.00 7.04E-05 2.24E-05 1.85E-04 6.34E-05 2.14E-05 1.65E-04 4.93E-05 2.09E-05 1.24E-04 
34.00 6.98E-05 2.16E-05 1.84E-04 6.28E-05 2.05E-05 1.65E-04 4.87E-05 1.98E-05 1.23E-04 
35.00 6.93E-05 2.08E-05 1.84E-04 6.23E-05 1.97E-05 1.64E-04 4.81E-05 1.88E-05 1.23E-04 
36.00 6.88E-05 2.01E-05 1.83E-04 6.19E-05 1.90E-05 1.63E-04 4.76E-05 1.79E-05 1.22E-04 
 
 
 05yo 01yo Newborn 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
0.00 2.22E-04 2.22E-04 2.22E-04 2.37E-04 2.37E-04 2.37E-04 2.67E-04 2.67E-04 2.67E-04 
0.25 2.29E-04 2.31E-04 2.04E-04 2.47E-04 2.51E-04 2.11E-04 2.86E-04 2.90E-04 2.37E-04 
0.50 2.31E-04 2.35E-04 1.96E-04 2.51E-04 2.57E-04 1.99E-04 2.94E-04 3.01E-04 2.24E-04 
1.00 2.31E-04 2.37E-04 1.81E-04 2.53E-04 2.61E-04 1.80E-04 3.00E-04 3.11E-04 2.01E-04 
2.00 2.22E-04 2.31E-04 1.56E-04 2.44E-04 2.58E-04 1.46E-04 2.93E-04 3.12E-04 1.59E-04 
3.00 2.07E-04 2.19E-04 1.37E-04 2.28E-04 2.45E-04 1.21E-04 2.74E-04 2.99E-04 1.25E-04 
4.00 1.91E-04 2.04E-04 1.22E-04 2.09E-04 2.30E-04 1.01E-04 2.52E-04 2.81E-04 9.98E-05 
5.00 1.74E-04 1.89E-04 1.11E-04 1.90E-04 2.12E-04 8.73E-05 2.28E-04 2.60E-04 8.11E-05 
6.00 1.59E-04 1.74E-04 1.03E-04 1.71E-04 1.95E-04 7.72E-05 2.05E-04 2.40E-04 6.77E-05 
7.00 1.44E-04 1.59E-04 9.78E-05 1.54E-04 1.79E-04 7.01E-05 1.84E-04 2.20E-04 5.82E-05 
8.00 1.31E-04 1.46E-04 9.38E-05 1.39E-04 1.63E-04 6.51E-05 1.64E-04 2.01E-04 5.16E-05 
9.00 1.19E-04 1.33E-04 9.10E-05 1.25E-04 1.49E-04 6.16E-05 1.47E-04 1.83E-04 4.69E-05 
10.00 1.09E-04 1.21E-04 8.89E-05 1.12E-04 1.36E-04 5.91E-05 1.31E-04 1.66E-04 4.37E-05 
11.00 9.95E-05 1.11E-04 8.74E-05 1.01E-04 1.24E-04 5.73E-05 1.17E-04 1.52E-04 4.15E-05 
12.00 9.13E-05 1.01E-04 8.63E-05 9.15E-05 1.13E-04 5.61E-05 1.05E-04 1.38E-04 3.99E-05 
13.00 8.40E-05 9.25E-05 8.54E-05 8.28E-05 1.03E-04 5.52E-05 9.38E-05 1.25E-04 3.88E-05 
14.00 7.75E-05 8.45E-05 8.47E-05 7.52E-05 9.35E-05 5.45E-05 8.41E-05 1.14E-04 3.80E-05 
15.00 7.18E-05 7.72E-05 8.41E-05 6.85E-05 8.53E-05 5.40E-05 7.56E-05 1.04E-04 3.74E-05 
16.00 6.68E-05 7.07E-05 8.36E-05 6.26E-05 7.78E-05 5.36E-05 6.82E-05 9.44E-05 3.70E-05 
17.00 6.24E-05 6.47E-05 8.32E-05 5.74E-05 7.10E-05 5.32E-05 6.16E-05 8.60E-05 3.67E-05 
18.00 5.85E-05 5.93E-05 8.28E-05 5.28E-05 6.48E-05 5.29E-05 5.58E-05 7.83E-05 3.64E-05 
19.00 5.50E-05 5.44E-05 8.24E-05 4.88E-05 5.92E-05 5.26E-05 5.07E-05 7.13E-05 3.62E-05 
20.00 5.20E-05 5.00E-05 8.21E-05 4.52E-05 5.41E-05 5.24E-05 4.62E-05 6.50E-05 3.60E-05 
21.00 4.93E-05 4.59E-05 8.17E-05 4.21E-05 4.95E-05 5.22E-05 4.23E-05 5.93E-05 3.58E-05 




 05yo 01yo Newborn 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
23.00 4.48E-05 3.89E-05 8.11E-05 3.69E-05 4.15E-05 5.17E-05 3.57E-05 4.94E-05 3.54E-05 
24.00 4.30E-05 3.59E-05 8.07E-05 3.48E-05 3.81E-05 5.15E-05 3.30E-05 4.51E-05 3.53E-05 
25.00 4.13E-05 3.32E-05 8.04E-05 3.29E-05 3.50E-05 5.13E-05 3.07E-05 4.13E-05 3.51E-05 
26.00 3.99E-05 3.07E-05 8.01E-05 3.12E-05 3.21E-05 5.11E-05 2.86E-05 3.78E-05 3.50E-05 
27.00 3.85E-05 2.84E-05 7.98E-05 2.97E-05 2.96E-05 5.09E-05 2.67E-05 3.46E-05 3.48E-05 
28.00 3.74E-05 2.64E-05 7.94E-05 2.84E-05 2.72E-05 5.07E-05 2.51E-05 3.17E-05 3.47E-05 
29.00 3.63E-05 2.45E-05 7.91E-05 2.72E-05 2.51E-05 5.05E-05 2.36E-05 2.90E-05 3.46E-05 
30.00 3.54E-05 2.28E-05 7.88E-05 2.61E-05 2.32E-05 5.02E-05 2.24E-05 2.67E-05 3.44E-05 
31.00 3.46E-05 2.13E-05 7.85E-05 2.52E-05 2.14E-05 5.00E-05 2.12E-05 2.45E-05 3.43E-05 
32.00 3.38E-05 1.99E-05 7.82E-05 2.44E-05 1.98E-05 4.98E-05 2.02E-05 2.25E-05 3.41E-05 
33.00 3.32E-05 1.86E-05 7.79E-05 2.37E-05 1.84E-05 4.96E-05 1.93E-05 2.07E-05 3.40E-05 
34.00 3.25E-05 1.74E-05 7.76E-05 2.30E-05 1.71E-05 4.94E-05 1.85E-05 1.91E-05 3.38E-05 
35.00 3.20E-05 1.64E-05 7.73E-05 2.24E-05 1.59E-05 4.92E-05 1.78E-05 1.76E-05 3.37E-05 














EFFECTIVE DOSE RATE 10 CM FOR 15YO PATIENT 
 Adult 15yo 10yo 
Time (hrs) Normal  DTC Hyper  Normal  DTC Hyper  Normal  DTC Hyper  
0.00 1.76E-04 1.76E-04 1.76E-04 2.01E-04 2.01E-04 2.01E-04 2.32E-04 2.32E-04 2.32E-04 
0.25 1.81E-04 1.79E-04 1.95E-04 2.05E-04 2.04E-04 2.15E-04 2.38E-04 2.38E-04 2.33E-04 
0.50 1.82E-04 1.80E-04 2.02E-04 2.06E-04 2.05E-04 2.19E-04 2.39E-04 2.40E-04 2.32E-04 
1.00 1.82E-04 1.79E-04 2.09E-04 2.06E-04 2.04E-04 2.23E-04 2.39E-04 2.40E-04 2.28E-04 
2.00 1.77E-04 1.72E-04 2.14E-04 1.99E-04 1.96E-04 2.24E-04 2.30E-04 2.32E-04 2.17E-04 
3.00 1.69E-04 1.62E-04 2.14E-04 1.89E-04 1.84E-04 2.21E-04 2.17E-04 2.19E-04 2.07E-04 
4.00 1.60E-04 1.51E-04 2.13E-04 1.78E-04 1.72E-04 2.18E-04 2.02E-04 2.04E-04 1.98E-04 
5.00 1.51E-04 1.40E-04 2.11E-04 1.67E-04 1.59E-04 2.14E-04 1.88E-04 1.88E-04 1.91E-04 
6.00 1.43E-04 1.29E-04 2.09E-04 1.57E-04 1.47E-04 2.12E-04 1.74E-04 1.73E-04 1.86E-04 
7.00 1.35E-04 1.19E-04 2.07E-04 1.48E-04 1.35E-04 2.09E-04 1.61E-04 1.59E-04 1.82E-04 
8.00 1.28E-04 1.10E-04 2.05E-04 1.39E-04 1.24E-04 2.07E-04 1.50E-04 1.46E-04 1.79E-04 
9.00 1.21E-04 1.01E-04 2.04E-04 1.31E-04 1.14E-04 2.05E-04 1.39E-04 1.34E-04 1.76E-04 
10.00 1.15E-04 9.29E-05 2.03E-04 1.24E-04 1.05E-04 2.04E-04 1.30E-04 1.23E-04 1.74E-04 
11.00 1.10E-04 8.57E-05 2.02E-04 1.18E-04 9.66E-05 2.03E-04 1.22E-04 1.13E-04 1.73E-04 
12.00 1.05E-04 7.91E-05 2.01E-04 1.12E-04 8.90E-05 2.01E-04 1.15E-04 1.03E-04 1.72E-04 
13.00 1.01E-04 7.31E-05 2.00E-04 1.07E-04 8.21E-05 2.00E-04 1.08E-04 9.50E-05 1.71E-04 
14.00 9.76E-05 6.76E-05 1.99E-04 1.03E-04 7.58E-05 1.99E-04 1.02E-04 8.73E-05 1.70E-04 
15.00 9.44E-05 6.26E-05 1.98E-04 9.92E-05 7.01E-05 1.99E-04 9.74E-05 8.04E-05 1.69E-04 
16.00 9.15E-05 5.81E-05 1.97E-04 9.58E-05 6.49E-05 1.98E-04 9.29E-05 7.40E-05 1.68E-04 
17.00 8.89E-05 5.40E-05 1.96E-04 9.27E-05 6.02E-05 1.97E-04 8.89E-05 6.83E-05 1.67E-04 
18.00 8.66E-05 5.03E-05 1.95E-04 9.00E-05 5.59E-05 1.96E-04 8.54E-05 6.31E-05 1.67E-04 
19.00 8.45E-05 4.70E-05 1.94E-04 8.76E-05 5.21E-05 1.95E-04 8.23E-05 5.84E-05 1.66E-04 
20.00 8.27E-05 4.39E-05 1.94E-04 8.54E-05 4.85E-05 1.94E-04 7.95E-05 5.41E-05 1.65E-04 
21.00 8.10E-05 4.11E-05 1.93E-04 8.34E-05 4.53E-05 1.94E-04 7.71E-05 5.02E-05 1.65E-04 
22.00 7.95E-05 3.86E-05 1.92E-04 8.17E-05 4.24E-05 1.93E-04 7.49E-05 4.67E-05 1.64E-04 
23.00 7.82E-05 3.63E-05 1.91E-04 8.01E-05 3.98E-05 1.92E-04 7.29E-05 4.35E-05 1.63E-04 
24.00 7.70E-05 3.42E-05 1.91E-04 7.87E-05 3.74E-05 1.91E-04 7.11E-05 4.05E-05 1.63E-04 
25.00 7.59E-05 3.23E-05 1.90E-04 7.74E-05 3.52E-05 1.90E-04 6.96E-05 3.79E-05 1.62E-04 
26.00 7.48E-05 3.06E-05 1.89E-04 7.63E-05 3.32E-05 1.90E-04 6.82E-05 3.55E-05 1.61E-04 
27.00 7.39E-05 2.90E-05 1.88E-04 7.52E-05 3.14E-05 1.89E-04 6.69E-05 3.33E-05 1.61E-04 
28.00 7.31E-05 2.75E-05 1.87E-04 7.43E-05 2.97E-05 1.88E-04 6.57E-05 3.13E-05 1.60E-04 
29.00 7.23E-05 2.62E-05 1.87E-04 7.34E-05 2.82E-05 1.87E-04 6.47E-05 2.95E-05 1.59E-04 




 Adult 15yo 10yo 
Time (hrs) Normal  DTC Hyper  Normal  DTC Hyper  Normal  DTC Hyper  
31.00 7.09E-05 2.39E-05 1.85E-04 7.18E-05 2.56E-05 1.86E-04 6.29E-05 2.63E-05 1.58E-04 
32.00 7.03E-05 2.29E-05 1.84E-04 7.11E-05 2.45E-05 1.85E-04 6.21E-05 2.50E-05 1.57E-04 
33.00 6.97E-05 2.20E-05 1.84E-04 7.05E-05 2.34E-05 1.84E-04 6.14E-05 2.37E-05 1.57E-04 
34.00 6.92E-05 2.12E-05 1.83E-04 6.99E-05 2.25E-05 1.84E-04 6.07E-05 2.26E-05 1.56E-04 
35.00 6.87E-05 2.04E-05 1.82E-04 6.93E-05 2.16E-05 1.83E-04 6.01E-05 2.15E-05 1.55E-04 
36.00 6.82E-05 1.97E-05 1.82E-04 6.88E-05 2.08E-05 1.82E-04 5.95E-05 2.06E-05 1.55E-04 
 
 
 05yo 01yo Newborn 
Time (hrs) Normal  DTC Hyper  Normal  DTC Hyper  Normal  DTC Hyper  
0.00 2.40E-04 2.40E-04 2.40E-04 2.47E-04 2.47E-04 2.47E-04 2.94E-04 2.94E-04 2.94E-04 
0.25 2.47E-04 2.49E-04 2.25E-04 2.56E-04 2.59E-04 2.22E-04 3.11E-04 3.16E-04 2.61E-04 
0.50 2.49E-04 2.52E-04 2.18E-04 2.59E-04 2.64E-04 2.11E-04 3.19E-04 3.26E-04 2.46E-04 
1.00 2.48E-04 2.53E-04 2.05E-04 2.60E-04 2.68E-04 1.93E-04 3.23E-04 3.35E-04 2.20E-04 
2.00 2.38E-04 2.46E-04 1.82E-04 2.50E-04 2.62E-04 1.61E-04 3.14E-04 3.34E-04 1.76E-04 
3.00 2.23E-04 2.33E-04 1.64E-04 2.33E-04 2.49E-04 1.37E-04 2.94E-04 3.19E-04 1.41E-04 
4.00 2.06E-04 2.17E-04 1.49E-04 2.14E-04 2.33E-04 1.19E-04 2.70E-04 2.99E-04 1.14E-04 
5.00 1.89E-04 2.00E-04 1.39E-04 1.95E-04 2.15E-04 1.05E-04 2.45E-04 2.77E-04 9.50E-05 
6.00 1.72E-04 1.84E-04 1.31E-04 1.77E-04 1.98E-04 9.57E-05 2.20E-04 2.55E-04 8.12E-05 
7.00 1.58E-04 1.69E-04 1.26E-04 1.60E-04 1.81E-04 8.89E-05 1.98E-04 2.34E-04 7.14E-05 
8.00 1.44E-04 1.55E-04 1.22E-04 1.44E-04 1.66E-04 8.41E-05 1.77E-04 2.13E-04 6.45E-05 
9.00 1.32E-04 1.41E-04 1.19E-04 1.31E-04 1.51E-04 8.07E-05 1.58E-04 1.95E-04 5.97E-05 
10.00 1.21E-04 1.29E-04 1.17E-04 1.18E-04 1.38E-04 7.83E-05 1.42E-04 1.77E-04 5.64E-05 
11.00 1.11E-04 1.18E-04 1.15E-04 1.07E-04 1.26E-04 7.65E-05 1.27E-04 1.61E-04 5.41E-05 
12.00 1.03E-04 1.08E-04 1.14E-04 9.77E-05 1.15E-04 7.53E-05 1.14E-04 1.47E-04 5.24E-05 
13.00 9.54E-05 9.88E-05 1.13E-04 8.91E-05 1.05E-04 7.43E-05 1.03E-04 1.34E-04 5.13E-05 
14.00 8.88E-05 9.04E-05 1.12E-04 8.16E-05 9.54E-05 7.36E-05 9.24E-05 1.22E-04 5.04E-05 
15.00 8.29E-05 8.28E-05 1.12E-04 7.49E-05 8.71E-05 7.30E-05 8.34E-05 1.11E-04 4.98E-05 
16.00 7.77E-05 7.59E-05 1.11E-04 6.90E-05 7.95E-05 7.25E-05 7.55E-05 1.01E-04 4.93E-05 
17.00 7.32E-05 6.96E-05 1.10E-04 6.39E-05 7.27E-05 7.21E-05 6.86E-05 9.19E-05 4.89E-05 
18.00 6.91E-05 6.39E-05 1.10E-04 5.93E-05 6.65E-05 7.17E-05 6.25E-05 8.37E-05 4.86E-05 
19.00 6.56E-05 5.88E-05 1.09E-04 5.53E-05 6.08E-05 7.14E-05 5.71E-05 7.64E-05 4.83E-05 
20.00 6.24E-05 5.41E-05 1.09E-04 5.18E-05 5.57E-05 7.10E-05 5.24E-05 6.97E-05 4.80E-05 
21.00 5.96E-05 4.98E-05 1.09E-04 4.86E-05 5.11E-05 7.07E-05 4.82E-05 6.36E-05 4.78E-05 




 05yo 01yo Newborn 
Time (hrs) Normal  DTC Hyper  Normal  DTC Hyper  Normal  DTC Hyper  
23.00 5.49E-05 4.25E-05 1.08E-04 4.34E-05 4.30E-05 7.01E-05 4.13E-05 5.31E-05 4.74E-05 
24.00 5.30E-05 3.93E-05 1.07E-04 4.13E-05 3.96E-05 6.98E-05 3.84E-05 4.86E-05 4.72E-05 
25.00 5.12E-05 3.64E-05 1.07E-04 3.94E-05 3.64E-05 6.95E-05 3.59E-05 4.44E-05 4.70E-05 
26.00 4.97E-05 3.38E-05 1.06E-04 3.77E-05 3.36E-05 6.92E-05 3.37E-05 4.07E-05 4.68E-05 
27.00 4.83E-05 3.14E-05 1.06E-04 3.62E-05 3.10E-05 6.90E-05 3.17E-05 3.73E-05 4.66E-05 
28.00 4.71E-05 2.93E-05 1.05E-04 3.48E-05 2.86E-05 6.87E-05 3.00E-05 3.43E-05 4.64E-05 
29.00 4.60E-05 2.73E-05 1.05E-04 3.36E-05 2.65E-05 6.84E-05 2.84E-05 3.15E-05 4.62E-05 
30.00 4.50E-05 2.55E-05 1.05E-04 3.26E-05 2.45E-05 6.81E-05 2.71E-05 2.89E-05 4.60E-05 
31.00 4.41E-05 2.39E-05 1.04E-04 3.16E-05 2.28E-05 6.78E-05 2.59E-05 2.66E-05 4.58E-05 
32.00 4.33E-05 2.24E-05 1.04E-04 3.08E-05 2.12E-05 6.76E-05 2.48E-05 2.45E-05 4.56E-05 
33.00 4.25E-05 2.10E-05 1.03E-04 3.00E-05 1.97E-05 6.73E-05 2.38E-05 2.26E-05 4.54E-05 
34.00 4.19E-05 1.98E-05 1.03E-04 2.93E-05 1.84E-05 6.70E-05 2.30E-05 2.09E-05 4.52E-05 
35.00 4.13E-05 1.87E-05 1.02E-04 2.87E-05 1.72E-05 6.67E-05 2.22E-05 1.93E-05 4.50E-05 






EFFECTIVE DOSE RATE 10 CM FOR 10YO PATIENT 
 Adult 15yo 10yo 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
0.00 1.85E-04 1.85E-04 1.85E-04 2.24E-04 2.24E-04 2.24E-04 2.68E-04 2.68E-04 2.68E-04 
0.25 1.85E-04 1.85E-04 1.85E-04 2.28E-04 2.26E-04 2.49E-04 2.73E-04 2.72E-04 2.82E-04 
0.50 1.85E-04 1.85E-04 1.84E-04 2.30E-04 2.27E-04 2.58E-04 2.75E-04 2.74E-04 2.87E-04 
1.00 1.82E-04 1.82E-04 1.81E-04 2.29E-04 2.25E-04 2.68E-04 2.74E-04 2.72E-04 2.90E-04 
2.00 1.73E-04 1.73E-04 1.74E-04 2.22E-04 2.15E-04 2.76E-04 2.65E-04 2.61E-04 2.88E-04 
3.00 1.62E-04 1.61E-04 1.68E-04 2.12E-04 2.02E-04 2.77E-04 2.51E-04 2.46E-04 2.83E-04 
4.00 1.51E-04 1.50E-04 1.63E-04 2.01E-04 1.88E-04 2.76E-04 2.36E-04 2.29E-04 2.77E-04 
5.00 1.40E-04 1.38E-04 1.59E-04 1.91E-04 1.74E-04 2.74E-04 2.21E-04 2.12E-04 2.72E-04 
6.00 1.31E-04 1.27E-04 1.56E-04 1.80E-04 1.61E-04 2.72E-04 2.07E-04 1.95E-04 2.68E-04 
7.00 1.22E-04 1.16E-04 1.53E-04 1.70E-04 1.48E-04 2.70E-04 1.94E-04 1.80E-04 2.64E-04 
8.00 1.14E-04 1.07E-04 1.51E-04 1.62E-04 1.37E-04 2.68E-04 1.82E-04 1.65E-04 2.61E-04 
9.00 1.06E-04 9.81E-05 1.50E-04 1.54E-04 1.26E-04 2.66E-04 1.71E-04 1.52E-04 2.59E-04 
10.00 1.00E-04 9.00E-05 1.49E-04 1.47E-04 1.16E-04 2.65E-04 1.62E-04 1.40E-04 2.57E-04 
11.00 9.44E-05 8.27E-05 1.47E-04 1.40E-04 1.07E-04 2.63E-04 1.53E-04 1.28E-04 2.55E-04 
12.00 8.93E-05 7.60E-05 1.47E-04 1.35E-04 9.90E-05 2.62E-04 1.46E-04 1.18E-04 2.54E-04 
13.00 8.48E-05 7.00E-05 1.46E-04 1.30E-04 9.16E-05 2.61E-04 1.39E-04 1.09E-04 2.52E-04 
14.00 8.08E-05 6.45E-05 1.45E-04 1.25E-04 8.48E-05 2.59E-04 1.33E-04 1.01E-04 2.51E-04 
15.00 7.73E-05 5.95E-05 1.44E-04 1.21E-04 7.86E-05 2.58E-04 1.28E-04 9.29E-05 2.50E-04 
16.00 7.42E-05 5.49E-05 1.44E-04 1.18E-04 7.30E-05 2.57E-04 1.23E-04 8.60E-05 2.49E-04 
17.00 7.14E-05 5.08E-05 1.43E-04 1.14E-04 6.80E-05 2.56E-04 1.19E-04 7.97E-05 2.48E-04 
18.00 6.90E-05 4.71E-05 1.42E-04 1.12E-04 6.34E-05 2.55E-04 1.15E-04 7.39E-05 2.47E-04 
19.00 6.68E-05 4.37E-05 1.42E-04 1.09E-04 5.92E-05 2.54E-04 1.12E-04 6.87E-05 2.46E-04 
20.00 6.48E-05 4.06E-05 1.41E-04 1.07E-04 5.54E-05 2.53E-04 1.09E-04 6.40E-05 2.45E-04 
21.00 6.31E-05 3.78E-05 1.41E-04 1.05E-04 5.19E-05 2.52E-04 1.06E-04 5.97E-05 2.44E-04 
22.00 6.15E-05 3.52E-05 1.40E-04 1.03E-04 4.88E-05 2.51E-04 1.04E-04 5.58E-05 2.43E-04 
23.00 6.01E-05 3.29E-05 1.39E-04 1.01E-04 4.59E-05 2.50E-04 1.02E-04 5.23E-05 2.42E-04 
24.00 5.89E-05 3.08E-05 1.39E-04 9.97E-05 4.33E-05 2.49E-04 9.99E-05 4.90E-05 2.41E-04 
25.00 5.78E-05 2.89E-05 1.38E-04 9.84E-05 4.10E-05 2.48E-04 9.82E-05 4.61E-05 2.40E-04 
26.00 5.67E-05 2.72E-05 1.38E-04 9.71E-05 3.88E-05 2.47E-04 9.66E-05 4.34E-05 2.39E-04 
27.00 5.58E-05 2.56E-05 1.37E-04 9.59E-05 3.68E-05 2.46E-04 9.52E-05 4.10E-05 2.38E-04 
28.00 5.50E-05 2.41E-05 1.37E-04 9.49E-05 3.51E-05 2.45E-04 9.39E-05 3.88E-05 2.37E-04 
29.00 5.42E-05 2.28E-05 1.36E-04 9.39E-05 3.34E-05 2.43E-04 9.27E-05 3.68E-05 2.36E-04 




 Adult 15yo 10yo 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
31.00 5.29E-05 2.05E-05 1.35E-04 9.22E-05 3.06E-05 2.41E-04 9.07E-05 3.33E-05 2.34E-04 
32.00 5.23E-05 1.96E-05 1.34E-04 9.14E-05 2.93E-05 2.40E-04 8.97E-05 3.18E-05 2.33E-04 
33.00 5.17E-05 1.86E-05 1.34E-04 9.06E-05 2.82E-05 2.39E-04 8.89E-05 3.04E-05 2.32E-04 
34.00 5.12E-05 1.78E-05 1.33E-04 8.99E-05 2.72E-05 2.38E-04 8.81E-05 2.91E-05 2.31E-04 
35.00 5.08E-05 1.71E-05 1.33E-04 8.93E-05 2.62E-05 2.38E-04 8.73E-05 2.79E-05 2.30E-04 
36.00 5.03E-05 1.64E-05 1.32E-04 8.86E-05 2.53E-05 2.37E-04 8.66E-05 2.69E-05 2.29E-04 
 
 05yo 01yo Newborn 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
0.00 3.36E-05 3.36E-05 3.36E-05 3.49E-05 3.49E-05 3.49E-05 3.72E-05 3.72E-05 3.72E-05 
0.25 3.41E-05 3.39E-05 3.54E-05 3.53E-05 3.53E-05 3.61E-05 3.77E-05 3.77E-05 3.79E-05 
0.50 3.41E-05 3.40E-05 3.59E-05 3.54E-05 3.53E-05 3.64E-05 3.78E-05 3.78E-05 3.81E-05 
1.00 3.39E-05 3.36E-05 3.64E-05 3.51E-05 3.49E-05 3.65E-05 3.75E-05 3.74E-05 3.79E-05 
2.00 3.26E-05 3.21E-05 3.62E-05 3.37E-05 3.34E-05 3.59E-05 3.59E-05 3.58E-05 3.69E-05 
3.00 3.09E-05 3.02E-05 3.57E-05 3.18E-05 3.14E-05 3.51E-05 3.38E-05 3.36E-05 3.57E-05 
4.00 2.91E-05 2.81E-05 3.51E-05 2.98E-05 2.91E-05 3.43E-05 3.17E-05 3.12E-05 3.47E-05 
5.00 2.72E-05 2.59E-05 3.45E-05 2.79E-05 2.69E-05 3.36E-05 2.95E-05 2.89E-05 3.38E-05 
6.00 2.55E-05 2.39E-05 3.40E-05 2.61E-05 2.48E-05 3.30E-05 2.75E-05 2.66E-05 3.32E-05 
7.00 2.40E-05 2.20E-05 3.36E-05 2.44E-05 2.28E-05 3.26E-05 2.57E-05 2.44E-05 3.26E-05 
8.00 2.25E-05 2.02E-05 3.33E-05 2.29E-05 2.10E-05 3.22E-05 2.40E-05 2.24E-05 3.22E-05 
9.00 2.12E-05 1.86E-05 3.30E-05 2.15E-05 1.93E-05 3.19E-05 2.25E-05 2.06E-05 3.19E-05 
10.00 2.01E-05 1.71E-05 3.28E-05 2.03E-05 1.77E-05 3.17E-05 2.11E-05 1.89E-05 3.16E-05 
11.00 1.91E-05 1.57E-05 3.26E-05 1.92E-05 1.63E-05 3.14E-05 1.99E-05 1.74E-05 3.14E-05 
12.00 1.82E-05 1.45E-05 3.24E-05 1.82E-05 1.50E-05 3.13E-05 1.89E-05 1.60E-05 3.12E-05 
13.00 1.74E-05 1.34E-05 3.22E-05 1.74E-05 1.38E-05 3.11E-05 1.79E-05 1.47E-05 3.10E-05 
14.00 1.67E-05 1.23E-05 3.20E-05 1.66E-05 1.27E-05 3.09E-05 1.71E-05 1.35E-05 3.09E-05 
15.00 1.60E-05 1.14E-05 3.19E-05 1.59E-05 1.17E-05 3.08E-05 1.64E-05 1.25E-05 3.07E-05 
16.00 1.55E-05 1.06E-05 3.18E-05 1.53E-05 1.09E-05 3.06E-05 1.57E-05 1.15E-05 3.06E-05 
17.00 1.50E-05 9.79E-06 3.16E-05 1.48E-05 1.01E-05 3.05E-05 1.51E-05 1.07E-05 3.04E-05 
18.00 1.45E-05 9.10E-06 3.15E-05 1.43E-05 9.33E-06 3.04E-05 1.46E-05 9.89E-06 3.03E-05 
19.00 1.41E-05 8.47E-06 3.13E-05 1.39E-05 8.67E-06 3.02E-05 1.42E-05 9.18E-06 3.02E-05 
20.00 1.38E-05 7.89E-06 3.12E-05 1.35E-05 8.07E-06 3.01E-05 1.37E-05 8.53E-06 3.01E-05 
21.00 1.34E-05 7.37E-06 3.11E-05 1.32E-05 7.53E-06 3.00E-05 1.34E-05 7.94E-06 2.99E-05 
22.00 1.31E-05 6.89E-06 3.09E-05 1.29E-05 7.03E-06 2.99E-05 1.31E-05 7.41E-06 2.98E-05 
23.00 1.29E-05 6.46E-06 3.08E-05 1.26E-05 6.58E-06 2.97E-05 1.28E-05 6.92E-06 2.97E-05 




 05yo 01yo Newborn 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
25.00 1.25E-05 5.71E-06 3.06E-05 1.21E-05 5.80E-06 2.95E-05 1.23E-05 6.08E-06 2.94E-05 
26.00 1.23E-05 5.39E-06 3.04E-05 1.20E-05 5.46E-06 2.94E-05 1.20E-05 5.72E-06 2.93E-05 
27.00 1.21E-05 5.09E-06 3.03E-05 1.18E-05 5.15E-06 2.92E-05 1.19E-05 5.39E-06 2.92E-05 
28.00 1.19E-05 4.82E-06 3.02E-05 1.16E-05 4.87E-06 2.91E-05 1.17E-05 5.08E-06 2.91E-05 
29.00 1.18E-05 4.58E-06 3.01E-05 1.15E-05 4.62E-06 2.90E-05 1.15E-05 4.81E-06 2.89E-05 
30.00 1.17E-05 4.36E-06 2.99E-05 1.13E-05 4.38E-06 2.89E-05 1.14E-05 4.56E-06 2.88E-05 
31.00 1.15E-05 4.15E-06 2.98E-05 1.12E-05 4.17E-06 2.88E-05 1.12E-05 4.33E-06 2.87E-05 
32.00 1.14E-05 3.97E-06 2.97E-05 1.11E-05 3.98E-06 2.86E-05 1.11E-05 4.12E-06 2.86E-05 
33.00 1.13E-05 3.80E-06 2.96E-05 1.10E-05 3.80E-06 2.85E-05 1.10E-05 3.93E-06 2.85E-05 
34.00 1.12E-05 3.64E-06 2.94E-05 1.09E-05 3.64E-06 2.84E-05 1.09E-05 3.76E-06 2.83E-05 
35.00 1.11E-05 3.50E-06 2.93E-05 1.08E-05 3.49E-06 2.83E-05 1.08E-05 3.60E-06 2.82E-05 







EFFECTIVE DOSE RATE 30 CM FOR ADULT PATIENT 
 Adult 15yo 10yo 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
0.00 1.02E-04 1.02E-04 1.02E-04 1.03E-04 1.03E-04 1.03E-04 1.18E-04 1.18E-04 1.18E-04 
0.25 1.04E-04 1.04E-04 1.12E-04 1.05E-04 1.05E-04 1.10E-04 1.21E-04 1.21E-04 1.19E-04 
0.50 1.05E-04 1.04E-04 1.15E-04 1.06E-04 1.05E-04 1.12E-04 1.21E-04 1.22E-04 1.18E-04 
1.00 1.05E-04 1.03E-04 1.19E-04 1.06E-04 1.05E-04 1.14E-04 1.21E-04 1.21E-04 1.16E-04 
2.00 1.02E-04 9.90E-05 1.22E-04 1.02E-04 1.01E-04 1.14E-04 1.16E-04 1.17E-04 1.11E-04 
3.00 9.71E-05 9.32E-05 1.21E-04 9.72E-05 9.48E-05 1.13E-04 1.10E-04 1.10E-04 1.06E-04 
4.00 9.19E-05 8.68E-05 1.20E-04 9.15E-05 8.83E-05 1.11E-04 1.02E-04 1.03E-04 1.02E-04 
5.00 8.66E-05 8.04E-05 1.19E-04 8.59E-05 8.17E-05 1.09E-04 9.50E-05 9.50E-05 9.85E-05 
6.00 8.17E-05 7.42E-05 1.18E-04 8.06E-05 7.54E-05 1.07E-04 8.81E-05 8.74E-05 9.58E-05 
7.00 7.71E-05 6.84E-05 1.17E-04 7.56E-05 6.94E-05 1.06E-04 8.17E-05 8.03E-05 9.38E-05 
8.00 7.29E-05 6.30E-05 1.16E-04 7.12E-05 6.38E-05 1.05E-04 7.60E-05 7.37E-05 9.23E-05 
9.00 6.91E-05 5.80E-05 1.15E-04 6.71E-05 5.87E-05 1.04E-04 7.08E-05 6.76E-05 9.11E-05 
10.00 6.58E-05 5.34E-05 1.15E-04 6.35E-05 5.39E-05 1.03E-04 6.62E-05 6.20E-05 9.02E-05 
11.00 6.28E-05 4.92E-05 1.14E-04 6.03E-05 4.96E-05 1.03E-04 6.21E-05 5.69E-05 8.95E-05 
12.00 6.01E-05 4.54E-05 1.13E-04 5.74E-05 4.57E-05 1.02E-04 5.84E-05 5.22E-05 8.88E-05 
13.00 5.77E-05 4.20E-05 1.13E-04 5.49E-05 4.22E-05 1.02E-04 5.52E-05 4.80E-05 8.83E-05 
14.00 5.56E-05 3.88E-05 1.12E-04 5.27E-05 3.89E-05 1.01E-04 5.23E-05 4.41E-05 8.79E-05 
15.00 5.37E-05 3.60E-05 1.12E-04 5.07E-05 3.60E-05 1.01E-04 4.98E-05 4.06E-05 8.74E-05 
16.00 5.20E-05 3.34E-05 1.11E-04 4.89E-05 3.33E-05 1.00E-04 4.76E-05 3.74E-05 8.70E-05 
17.00 5.06E-05 3.10E-05 1.11E-04 4.73E-05 3.09E-05 9.99E-05 4.56E-05 3.45E-05 8.66E-05 
18.00 4.92E-05 2.89E-05 1.10E-04 4.59E-05 2.87E-05 9.95E-05 4.38E-05 3.19E-05 8.63E-05 
19.00 4.80E-05 2.69E-05 1.10E-04 4.46E-05 2.67E-05 9.91E-05 4.23E-05 2.96E-05 8.59E-05 
20.00 4.70E-05 2.52E-05 1.10E-04 4.35E-05 2.49E-05 9.87E-05 4.09E-05 2.74E-05 8.56E-05 
21.00 4.60E-05 2.36E-05 1.09E-04 4.25E-05 2.33E-05 9.83E-05 3.96E-05 2.54E-05 8.52E-05 
22.00 4.52E-05 2.21E-05 1.09E-04 4.16E-05 2.18E-05 9.80E-05 3.85E-05 2.37E-05 8.49E-05 
23.00 4.44E-05 2.08E-05 1.08E-04 4.08E-05 2.04E-05 9.76E-05 3.76E-05 2.21E-05 8.46E-05 
24.00 4.37E-05 1.96E-05 1.08E-04 4.01E-05 1.92E-05 9.72E-05 3.67E-05 2.06E-05 8.42E-05 
25.00 4.31E-05 1.85E-05 1.07E-04 3.95E-05 1.80E-05 9.68E-05 3.59E-05 1.93E-05 8.39E-05 
26.00 4.25E-05 1.75E-05 1.07E-04 3.89E-05 1.70E-05 9.64E-05 3.52E-05 1.80E-05 8.36E-05 
27.00 4.20E-05 1.66E-05 1.07E-04 3.83E-05 1.61E-05 9.60E-05 3.45E-05 1.69E-05 8.32E-05 
28.00 4.15E-05 1.58E-05 1.06E-04 3.78E-05 1.52E-05 9.57E-05 3.40E-05 1.59E-05 8.29E-05 
29.00 4.10E-05 1.50E-05 1.06E-04 3.74E-05 1.45E-05 9.53E-05 3.34E-05 1.50E-05 8.26E-05 




 Adult 15yo 10yo 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
31.00 4.03E-05 1.37E-05 1.05E-04 3.66E-05 1.31E-05 9.45E-05 3.25E-05 1.34E-05 8.19E-05 
32.00 3.99E-05 1.31E-05 1.05E-04 3.62E-05 1.25E-05 9.42E-05 3.21E-05 1.28E-05 8.16E-05 
33.00 3.96E-05 1.26E-05 1.04E-04 3.59E-05 1.20E-05 9.38E-05 3.18E-05 1.21E-05 8.13E-05 
34.00 3.93E-05 1.21E-05 1.04E-04 3.56E-05 1.15E-05 9.34E-05 3.14E-05 1.15E-05 8.10E-05 
35.00 3.90E-05 1.17E-05 1.03E-04 3.53E-05 1.11E-05 9.31E-05 3.11E-05 1.10E-05 8.06E-05 
36.00 3.87E-05 1.13E-05 1.03E-04 3.51E-05 1.07E-05 9.27E-05 3.09E-05 1.05E-05 8.03E-05 
 
 05yo 01yo Newborn 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
0.00 1.21E-04 1.21E-04 1.21E-04 1.27E-04 1.27E-04 1.27E-04 1.41E-04 1.41E-04 1.41E-04 
0.25 1.24E-04 1.24E-04 1.16E-04 1.30E-04 1.31E-04 1.18E-04 1.45E-04 1.47E-04 1.27E-04 
0.50 1.24E-04 1.26E-04 1.14E-04 1.31E-04 1.33E-04 1.13E-04 1.47E-04 1.49E-04 1.21E-04 
1.00 1.24E-04 1.26E-04 1.09E-04 1.31E-04 1.34E-04 1.06E-04 1.47E-04 1.51E-04 1.11E-04 
2.00 1.19E-04 1.21E-04 9.94E-05 1.25E-04 1.30E-04 9.29E-05 1.40E-04 1.47E-04 9.38E-05 
3.00 1.11E-04 1.15E-04 9.17E-05 1.17E-04 1.23E-04 8.27E-05 1.31E-04 1.39E-04 8.05E-05 
4.00 1.03E-04 1.07E-04 8.57E-05 1.08E-04 1.14E-04 7.49E-05 1.20E-04 1.30E-04 7.05E-05 
5.00 9.49E-05 9.86E-05 8.12E-05 9.87E-05 1.06E-04 6.92E-05 1.10E-04 1.20E-04 6.33E-05 
6.00 8.73E-05 9.07E-05 7.78E-05 9.01E-05 9.72E-05 6.51E-05 9.94E-05 1.10E-04 5.81E-05 
7.00 8.02E-05 8.32E-05 7.54E-05 8.22E-05 8.91E-05 6.21E-05 9.01E-05 1.01E-04 5.44E-05 
8.00 7.38E-05 7.62E-05 7.36E-05 7.50E-05 8.15E-05 6.00E-05 8.16E-05 9.24E-05 5.18E-05 
9.00 6.81E-05 6.97E-05 7.22E-05 6.85E-05 7.45E-05 5.84E-05 7.40E-05 8.44E-05 4.99E-05 
10.00 6.30E-05 6.38E-05 7.12E-05 6.27E-05 6.80E-05 5.73E-05 6.72E-05 7.70E-05 4.86E-05 
11.00 5.84E-05 5.84E-05 7.05E-05 5.76E-05 6.22E-05 5.65E-05 6.11E-05 7.02E-05 4.76E-05 
12.00 5.44E-05 5.35E-05 6.98E-05 5.31E-05 5.68E-05 5.58E-05 5.58E-05 6.41E-05 4.69E-05 
13.00 5.08E-05 4.90E-05 6.93E-05 4.91E-05 5.19E-05 5.53E-05 5.11E-05 5.85E-05 4.64E-05 
14.00 4.77E-05 4.49E-05 6.89E-05 4.55E-05 4.75E-05 5.49E-05 4.69E-05 5.34E-05 4.60E-05 
15.00 4.49E-05 4.12E-05 6.85E-05 4.24E-05 4.35E-05 5.46E-05 4.33E-05 4.88E-05 4.57E-05 
16.00 4.25E-05 3.79E-05 6.82E-05 3.97E-05 3.98E-05 5.43E-05 4.00E-05 4.46E-05 4.54E-05 
17.00 4.03E-05 3.48E-05 6.79E-05 3.72E-05 3.65E-05 5.40E-05 3.72E-05 4.08E-05 4.51E-05 
18.00 3.84E-05 3.21E-05 6.76E-05 3.51E-05 3.35E-05 5.38E-05 3.47E-05 3.73E-05 4.49E-05 
19.00 3.67E-05 2.96E-05 6.73E-05 3.32E-05 3.08E-05 5.35E-05 3.24E-05 3.42E-05 4.47E-05 
20.00 3.52E-05 2.73E-05 6.70E-05 3.15E-05 2.83E-05 5.33E-05 3.05E-05 3.13E-05 4.45E-05 
21.00 3.38E-05 2.52E-05 6.68E-05 3.01E-05 2.61E-05 5.31E-05 2.88E-05 2.88E-05 4.43E-05 
22.00 3.26E-05 2.34E-05 6.65E-05 2.87E-05 2.40E-05 5.29E-05 2.72E-05 2.64E-05 4.41E-05 
23.00 3.16E-05 2.17E-05 6.62E-05 2.76E-05 2.22E-05 5.27E-05 2.59E-05 2.43E-05 4.39E-05 




 05yo 01yo Newborn 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
25.00 2.98E-05 1.87E-05 6.57E-05 2.56E-05 1.90E-05 5.22E-05 2.36E-05 2.06E-05 4.36E-05 
26.00 2.91E-05 1.74E-05 6.54E-05 2.48E-05 1.76E-05 5.20E-05 2.27E-05 1.90E-05 4.34E-05 
27.00 2.84E-05 1.63E-05 6.52E-05 2.41E-05 1.63E-05 5.18E-05 2.19E-05 1.76E-05 4.32E-05 
28.00 2.78E-05 1.52E-05 6.49E-05 2.34E-05 1.52E-05 5.16E-05 2.11E-05 1.63E-05 4.31E-05 
29.00 2.73E-05 1.43E-05 6.47E-05 2.29E-05 1.42E-05 5.14E-05 2.05E-05 1.51E-05 4.29E-05 
30.00 2.68E-05 1.34E-05 6.44E-05 2.23E-05 1.32E-05 5.12E-05 1.99E-05 1.40E-05 4.27E-05 
31.00 2.63E-05 1.26E-05 6.42E-05 2.19E-05 1.24E-05 5.10E-05 1.94E-05 1.30E-05 4.25E-05 
32.00 2.59E-05 1.19E-05 6.39E-05 2.15E-05 1.16E-05 5.08E-05 1.89E-05 1.22E-05 4.24E-05 
33.00 2.56E-05 1.12E-05 6.36E-05 2.11E-05 1.09E-05 5.06E-05 1.85E-05 1.13E-05 4.22E-05 
34.00 2.52E-05 1.06E-05 6.34E-05 2.07E-05 1.02E-05 5.04E-05 1.81E-05 1.06E-05 4.20E-05 
35.00 2.49E-05 1.01E-05 6.31E-05 2.04E-05 9.63E-06 5.02E-05 1.77E-05 9.93E-06 4.19E-05 





EFFECTIVE DOSE RATE 30 CM FOR 15YO PATIENT 
 Adult 15yo 10yo 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
0.00 9.96E-05 9.96E-05 9.96E-05 1.09E-04 1.09E-04 1.09E-04 1.23E-04 1.23E-04 1.23E-04 
0.25 1.02E-04 1.01E-04 1.10E-04 1.11E-04 1.11E-04 1.17E-04 1.26E-04 1.26E-04 1.25E-04 
0.50 1.03E-04 1.02E-04 1.14E-04 1.12E-04 1.11E-04 1.20E-04 1.26E-04 1.26E-04 1.26E-04 
1.00 1.03E-04 1.01E-04 1.18E-04 1.12E-04 1.10E-04 1.22E-04 1.26E-04 1.26E-04 1.25E-04 
2.00 9.97E-05 9.68E-05 1.21E-04 1.08E-04 1.06E-04 1.23E-04 1.21E-04 1.21E-04 1.21E-04 
3.00 9.52E-05 9.11E-05 1.21E-04 1.03E-04 9.99E-05 1.22E-04 1.14E-04 1.14E-04 1.17E-04 
4.00 9.02E-05 8.49E-05 1.20E-04 9.70E-05 9.30E-05 1.20E-04 1.07E-04 1.06E-04 1.13E-04 
5.00 8.51E-05 7.87E-05 1.19E-04 9.12E-05 8.61E-05 1.19E-04 9.95E-05 9.82E-05 1.09E-04 
6.00 8.04E-05 7.26E-05 1.18E-04 8.56E-05 7.94E-05 1.17E-04 9.26E-05 9.05E-05 1.07E-04 
7.00 7.59E-05 6.69E-05 1.17E-04 8.05E-05 7.31E-05 1.16E-04 8.62E-05 8.32E-05 1.05E-04 
8.00 7.19E-05 6.16E-05 1.16E-04 7.59E-05 6.73E-05 1.15E-04 8.04E-05 7.63E-05 1.04E-04 
9.00 6.82E-05 5.68E-05 1.15E-04 7.17E-05 6.19E-05 1.14E-04 7.51E-05 7.00E-05 1.02E-04 
10.00 6.49E-05 5.23E-05 1.15E-04 6.79E-05 5.69E-05 1.13E-04 7.05E-05 6.43E-05 1.01E-04 
11.00 6.20E-05 4.82E-05 1.14E-04 6.46E-05 5.24E-05 1.12E-04 6.63E-05 5.90E-05 1.01E-04 
12.00 5.94E-05 4.45E-05 1.13E-04 6.16E-05 4.83E-05 1.12E-04 6.26E-05 5.42E-05 1.00E-04 
13.00 5.71E-05 4.11E-05 1.13E-04 5.90E-05 4.46E-05 1.11E-04 5.94E-05 4.99E-05 9.94E-05 
14.00 5.51E-05 3.81E-05 1.12E-04 5.67E-05 4.12E-05 1.11E-04 5.65E-05 4.59E-05 9.89E-05 
15.00 5.32E-05 3.53E-05 1.12E-04 5.46E-05 3.81E-05 1.10E-04 5.39E-05 4.23E-05 9.84E-05 
16.00 5.16E-05 3.27E-05 1.11E-04 5.27E-05 3.53E-05 1.10E-04 5.16E-05 3.91E-05 9.80E-05 
17.00 5.02E-05 3.04E-05 1.11E-04 5.11E-05 3.27E-05 1.09E-04 4.96E-05 3.61E-05 9.76E-05 
18.00 4.89E-05 2.83E-05 1.10E-04 4.96E-05 3.04E-05 1.09E-04 4.78E-05 3.34E-05 9.71E-05 
19.00 4.77E-05 2.65E-05 1.10E-04 4.83E-05 2.83E-05 1.08E-04 4.63E-05 3.10E-05 9.67E-05 
20.00 4.67E-05 2.47E-05 1.09E-04 4.71E-05 2.64E-05 1.08E-04 4.48E-05 2.87E-05 9.63E-05 
21.00 4.57E-05 2.32E-05 1.09E-04 4.61E-05 2.47E-05 1.07E-04 4.36E-05 2.67E-05 9.59E-05 
22.00 4.49E-05 2.17E-05 1.09E-04 4.51E-05 2.31E-05 1.07E-04 4.25E-05 2.49E-05 9.55E-05 
23.00 4.42E-05 2.04E-05 1.08E-04 4.43E-05 2.17E-05 1.07E-04 4.15E-05 2.32E-05 9.51E-05 
24.00 4.35E-05 1.93E-05 1.08E-04 4.35E-05 2.04E-05 1.06E-04 4.05E-05 2.17E-05 9.48E-05 
25.00 4.28E-05 1.82E-05 1.07E-04 4.28E-05 1.92E-05 1.06E-04 3.97E-05 2.04E-05 9.44E-05 
26.00 4.23E-05 1.72E-05 1.07E-04 4.22E-05 1.81E-05 1.05E-04 3.90E-05 1.91E-05 9.40E-05 
27.00 4.18E-05 1.63E-05 1.06E-04 4.16E-05 1.72E-05 1.05E-04 3.83E-05 1.80E-05 9.36E-05 
28.00 4.13E-05 1.55E-05 1.06E-04 4.11E-05 1.63E-05 1.04E-04 3.77E-05 1.69E-05 9.32E-05 
29.00 4.08E-05 1.48E-05 1.06E-04 4.06E-05 1.55E-05 1.04E-04 3.72E-05 1.60E-05 9.29E-05 




 Adult 15yo 10yo 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
31.00 4.01E-05 1.35E-05 1.05E-04 3.98E-05 1.40E-05 1.03E-04 3.63E-05 1.44E-05 9.21E-05 
32.00 3.97E-05 1.29E-05 1.04E-04 3.94E-05 1.34E-05 1.03E-04 3.58E-05 1.36E-05 9.17E-05 
33.00 3.94E-05 1.24E-05 1.04E-04 3.91E-05 1.29E-05 1.02E-04 3.55E-05 1.30E-05 9.14E-05 
34.00 3.91E-05 1.20E-05 1.03E-04 3.87E-05 1.23E-05 1.02E-04 3.51E-05 1.24E-05 9.10E-05 
35.00 3.88E-05 1.15E-05 1.03E-04 3.84E-05 1.19E-05 1.02E-04 3.48E-05 1.19E-05 9.06E-05 
36.00 3.85E-05 1.11E-05 1.03E-04 3.81E-05 1.14E-05 1.01E-04 3.45E-05 1.14E-05 9.03E-05 
 
 05yo 01yo Newborn 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
0.00 1.26E-04 1.26E-04 1.26E-04 1.29E-04 1.29E-04 1.29E-04 1.48E-04 1.48E-04 1.48E-04 
0.25 1.29E-04 1.29E-04 1.22E-04 1.32E-04 1.33E-04 1.21E-04 1.52E-04 1.54E-04 1.35E-04 
0.50 1.29E-04 1.30E-04 1.20E-04 1.33E-04 1.34E-04 1.17E-04 1.53E-04 1.56E-04 1.29E-04 
1.00 1.29E-04 1.30E-04 1.16E-04 1.32E-04 1.35E-04 1.11E-04 1.53E-04 1.57E-04 1.18E-04 
2.00 1.23E-04 1.26E-04 1.08E-04 1.27E-04 1.31E-04 9.86E-05 1.46E-04 1.53E-04 1.01E-04 
3.00 1.16E-04 1.18E-04 1.01E-04 1.18E-04 1.23E-04 8.91E-05 1.37E-04 1.45E-04 8.79E-05 
4.00 1.07E-04 1.10E-04 9.51E-05 1.09E-04 1.15E-04 8.19E-05 1.26E-04 1.35E-04 7.80E-05 
5.00 9.92E-05 1.02E-04 9.07E-05 1.00E-04 1.06E-04 7.65E-05 1.15E-04 1.25E-04 7.08E-05 
6.00 9.15E-05 9.37E-05 8.75E-05 9.18E-05 9.75E-05 7.26E-05 1.04E-04 1.14E-04 6.56E-05 
7.00 8.43E-05 8.59E-05 8.51E-05 8.40E-05 8.94E-05 6.97E-05 9.45E-05 1.05E-04 6.19E-05 
8.00 7.79E-05 7.88E-05 8.33E-05 7.69E-05 8.18E-05 6.77E-05 8.58E-05 9.59E-05 5.93E-05 
9.00 7.21E-05 7.21E-05 8.19E-05 7.05E-05 7.48E-05 6.62E-05 7.80E-05 8.76E-05 5.74E-05 
10.00 6.69E-05 6.61E-05 8.09E-05 6.48E-05 6.84E-05 6.51E-05 7.10E-05 7.99E-05 5.61E-05 
11.00 6.23E-05 6.05E-05 8.01E-05 5.98E-05 6.25E-05 6.43E-05 6.49E-05 7.29E-05 5.51E-05 
12.00 5.82E-05 5.54E-05 7.95E-05 5.53E-05 5.72E-05 6.36E-05 5.94E-05 6.66E-05 5.44E-05 
13.00 5.46E-05 5.08E-05 7.90E-05 5.14E-05 5.23E-05 6.31E-05 5.46E-05 6.08E-05 5.38E-05 
14.00 5.14E-05 4.67E-05 7.85E-05 4.79E-05 4.79E-05 6.27E-05 5.03E-05 5.55E-05 5.34E-05 
15.00 4.86E-05 4.29E-05 7.81E-05 4.48E-05 4.39E-05 6.23E-05 4.65E-05 5.08E-05 5.30E-05 
16.00 4.61E-05 3.94E-05 7.77E-05 4.21E-05 4.03E-05 6.20E-05 4.32E-05 4.64E-05 5.27E-05 
17.00 4.39E-05 3.63E-05 7.73E-05 3.97E-05 3.70E-05 6.17E-05 4.03E-05 4.25E-05 5.24E-05 
18.00 4.19E-05 3.35E-05 7.70E-05 3.76E-05 3.40E-05 6.14E-05 3.77E-05 3.89E-05 5.21E-05 
19.00 4.02E-05 3.09E-05 7.67E-05 3.57E-05 3.12E-05 6.11E-05 3.54E-05 3.57E-05 5.19E-05 
20.00 3.87E-05 2.85E-05 7.63E-05 3.41E-05 2.88E-05 6.08E-05 3.34E-05 3.28E-05 5.17E-05 
21.00 3.73E-05 2.64E-05 7.60E-05 3.26E-05 2.65E-05 6.06E-05 3.17E-05 3.01E-05 5.14E-05 
22.00 3.61E-05 2.45E-05 7.57E-05 3.13E-05 2.45E-05 6.03E-05 3.01E-05 2.77E-05 5.12E-05 
23.00 3.50E-05 2.28E-05 7.54E-05 3.01E-05 2.27E-05 6.01E-05 2.87E-05 2.55E-05 5.10E-05 




 05yo 01yo Newborn 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
25.00 3.32E-05 1.97E-05 7.48E-05 2.82E-05 1.95E-05 5.96E-05 2.64E-05 2.17E-05 5.06E-05 
26.00 3.24E-05 1.84E-05 7.45E-05 2.74E-05 1.81E-05 5.93E-05 2.54E-05 2.01E-05 5.04E-05 
27.00 3.17E-05 1.72E-05 7.42E-05 2.66E-05 1.68E-05 5.91E-05 2.45E-05 1.86E-05 5.02E-05 
28.00 3.11E-05 1.61E-05 7.39E-05 2.60E-05 1.57E-05 5.89E-05 2.38E-05 1.72E-05 4.99E-05 
29.00 3.05E-05 1.51E-05 7.36E-05 2.54E-05 1.46E-05 5.86E-05 2.31E-05 1.60E-05 4.97E-05 
30.00 3.00E-05 1.42E-05 7.33E-05 2.49E-05 1.37E-05 5.84E-05 2.25E-05 1.49E-05 4.95E-05 
31.00 2.96E-05 1.34E-05 7.30E-05 2.44E-05 1.28E-05 5.81E-05 2.19E-05 1.38E-05 4.93E-05 
32.00 2.91E-05 1.27E-05 7.27E-05 2.40E-05 1.20E-05 5.79E-05 2.14E-05 1.29E-05 4.91E-05 
33.00 2.87E-05 1.20E-05 7.24E-05 2.36E-05 1.13E-05 5.77E-05 2.10E-05 1.21E-05 4.89E-05 
34.00 2.84E-05 1.14E-05 7.21E-05 2.32E-05 1.07E-05 5.74E-05 2.06E-05 1.13E-05 4.87E-05 
35.00 2.81E-05 1.08E-05 7.18E-05 2.29E-05 1.01E-05 5.72E-05 2.02E-05 1.06E-05 4.85E-05 







EFFECTIVE DOSE RATE 30 CM FOR 10YO PATIENT 
 Adult 15yo 10yo 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
0.00 1.13E-04 1.13E-04 1.13E-04 1.19E-04 1.19E-04 1.19E-04 1.36E-04 1.36E-04 1.36E-04 
0.25 1.15E-04 1.14E-04 1.26E-04 1.21E-04 1.20E-04 1.31E-04 1.39E-04 1.38E-04 1.45E-04 
0.50 1.16E-04 1.15E-04 1.31E-04 1.22E-04 1.21E-04 1.35E-04 1.39E-04 1.39E-04 1.48E-04 
1.00 1.16E-04 1.13E-04 1.36E-04 1.22E-04 1.20E-04 1.39E-04 1.39E-04 1.38E-04 1.50E-04 
2.00 1.12E-04 1.09E-04 1.40E-04 1.18E-04 1.14E-04 1.42E-04 1.34E-04 1.32E-04 1.51E-04 
3.00 1.07E-04 1.02E-04 1.41E-04 1.12E-04 1.08E-04 1.42E-04 1.28E-04 1.24E-04 1.49E-04 
4.00 1.02E-04 9.52E-05 1.40E-04 1.06E-04 1.00E-04 1.41E-04 1.20E-04 1.16E-04 1.46E-04 
5.00 9.64E-05 8.82E-05 1.39E-04 1.00E-04 9.27E-05 1.40E-04 1.13E-04 1.07E-04 1.44E-04 
6.00 9.12E-05 8.14E-05 1.38E-04 9.46E-05 8.56E-05 1.39E-04 1.06E-04 9.88E-05 1.42E-04 
7.00 8.63E-05 7.51E-05 1.37E-04 8.94E-05 7.89E-05 1.38E-04 9.94E-05 9.09E-05 1.40E-04 
8.00 8.19E-05 6.91E-05 1.36E-04 8.46E-05 7.26E-05 1.37E-04 9.35E-05 8.36E-05 1.39E-04 
9.00 7.79E-05 6.37E-05 1.35E-04 8.03E-05 6.69E-05 1.36E-04 8.82E-05 7.69E-05 1.38E-04 
10.00 7.43E-05 5.87E-05 1.35E-04 7.64E-05 6.16E-05 1.35E-04 8.35E-05 7.07E-05 1.37E-04 
11.00 7.12E-05 5.42E-05 1.34E-04 7.30E-05 5.68E-05 1.34E-04 7.93E-05 6.51E-05 1.36E-04 
12.00 6.83E-05 5.01E-05 1.33E-04 6.99E-05 5.24E-05 1.33E-04 7.55E-05 6.00E-05 1.35E-04 
13.00 6.58E-05 4.63E-05 1.33E-04 6.72E-05 4.84E-05 1.33E-04 7.22E-05 5.53E-05 1.34E-04 
14.00 6.35E-05 4.29E-05 1.32E-04 6.48E-05 4.48E-05 1.32E-04 6.93E-05 5.11E-05 1.34E-04 
15.00 6.15E-05 3.98E-05 1.31E-04 6.26E-05 4.15E-05 1.31E-04 6.66E-05 4.72E-05 1.33E-04 
16.00 5.97E-05 3.70E-05 1.31E-04 6.07E-05 3.86E-05 1.31E-04 6.43E-05 4.37E-05 1.33E-04 
17.00 5.81E-05 3.44E-05 1.30E-04 5.90E-05 3.59E-05 1.30E-04 6.22E-05 4.06E-05 1.32E-04 
18.00 5.67E-05 3.21E-05 1.30E-04 5.75E-05 3.34E-05 1.30E-04 6.04E-05 3.77E-05 1.31E-04 
19.00 5.54E-05 3.00E-05 1.29E-04 5.61E-05 3.12E-05 1.29E-04 5.88E-05 3.51E-05 1.31E-04 
20.00 5.43E-05 2.80E-05 1.29E-04 5.49E-05 2.91E-05 1.29E-04 5.73E-05 3.27E-05 1.30E-04 
21.00 5.33E-05 2.63E-05 1.28E-04 5.38E-05 2.73E-05 1.28E-04 5.60E-05 3.05E-05 1.30E-04 
22.00 5.23E-05 2.47E-05 1.28E-04 5.28E-05 2.56E-05 1.28E-04 5.48E-05 2.86E-05 1.29E-04 
23.00 5.15E-05 2.33E-05 1.27E-04 5.19E-05 2.41E-05 1.27E-04 5.37E-05 2.68E-05 1.29E-04 
24.00 5.07E-05 2.19E-05 1.27E-04 5.11E-05 2.27E-05 1.27E-04 5.28E-05 2.52E-05 1.28E-04 
25.00 5.00E-05 2.08E-05 1.26E-04 5.03E-05 2.14E-05 1.26E-04 5.19E-05 2.37E-05 1.28E-04 
26.00 4.94E-05 1.97E-05 1.25E-04 4.97E-05 2.03E-05 1.25E-04 5.11E-05 2.23E-05 1.27E-04 
27.00 4.88E-05 1.87E-05 1.25E-04 4.91E-05 1.92E-05 1.25E-04 5.04E-05 2.11E-05 1.27E-04 
28.00 4.83E-05 1.78E-05 1.24E-04 4.85E-05 1.83E-05 1.24E-04 4.97E-05 2.00E-05 1.26E-04 
29.00 4.78E-05 1.69E-05 1.24E-04 4.80E-05 1.74E-05 1.24E-04 4.91E-05 1.90E-05 1.25E-04 




 Adult 15yo 10yo 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
31.00 4.69E-05 1.55E-05 1.23E-04 4.70E-05 1.59E-05 1.23E-04 4.81E-05 1.72E-05 1.24E-04 
32.00 4.65E-05 1.49E-05 1.22E-04 4.66E-05 1.52E-05 1.22E-04 4.76E-05 1.65E-05 1.24E-04 
33.00 4.61E-05 1.43E-05 1.22E-04 4.62E-05 1.46E-05 1.22E-04 4.72E-05 1.58E-05 1.23E-04 
34.00 4.58E-05 1.38E-05 1.21E-04 4.59E-05 1.41E-05 1.21E-04 4.68E-05 1.51E-05 1.23E-04 
35.00 4.54E-05 1.33E-05 1.21E-04 4.55E-05 1.36E-05 1.21E-04 4.64E-05 1.45E-05 1.22E-04 
36.00 4.51E-05 1.29E-05 1.20E-04 4.52E-05 1.31E-05 1.20E-04 4.60E-05 1.40E-05 1.22E-04 
 
 05yo 01yo Newborn 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
0.00 1.42E-04 1.42E-04 1.42E-04 1.52E-04 1.52E-04 1.52E-04 1.70E-04 1.70E-04 1.70E-04 
0.25 1.45E-04 1.45E-04 1.45E-04 1.55E-04 1.56E-04 1.49E-04 1.74E-04 1.75E-04 1.60E-04 
0.50 1.45E-04 1.45E-04 1.46E-04 1.56E-04 1.57E-04 1.47E-04 1.75E-04 1.77E-04 1.55E-04 
1.00 1.45E-04 1.45E-04 1.45E-04 1.55E-04 1.56E-04 1.43E-04 1.74E-04 1.77E-04 1.47E-04 
2.00 1.39E-04 1.39E-04 1.41E-04 1.48E-04 1.51E-04 1.33E-04 1.67E-04 1.71E-04 1.32E-04 
3.00 1.31E-04 1.31E-04 1.37E-04 1.39E-04 1.42E-04 1.25E-04 1.56E-04 1.62E-04 1.20E-04 
4.00 1.23E-04 1.22E-04 1.33E-04 1.30E-04 1.32E-04 1.19E-04 1.44E-04 1.51E-04 1.10E-04 
5.00 1.15E-04 1.13E-04 1.29E-04 1.20E-04 1.22E-04 1.14E-04 1.32E-04 1.39E-04 1.04E-04 
6.00 1.07E-04 1.04E-04 1.26E-04 1.11E-04 1.12E-04 1.10E-04 1.21E-04 1.28E-04 9.86E-05 
7.00 9.95E-05 9.53E-05 1.24E-04 1.02E-04 1.03E-04 1.08E-04 1.11E-04 1.17E-04 9.49E-05 
8.00 9.29E-05 8.75E-05 1.23E-04 9.46E-05 9.44E-05 1.06E-04 1.02E-04 1.07E-04 9.22E-05 
9.00 8.70E-05 8.03E-05 1.21E-04 8.77E-05 8.65E-05 1.04E-04 9.34E-05 9.83E-05 9.03E-05 
10.00 8.17E-05 7.37E-05 1.20E-04 8.16E-05 7.93E-05 1.03E-04 8.60E-05 8.99E-05 8.89E-05 
11.00 7.70E-05 6.77E-05 1.19E-04 7.61E-05 7.26E-05 1.02E-04 7.94E-05 8.22E-05 8.78E-05 
12.00 7.28E-05 6.23E-05 1.18E-04 7.13E-05 6.66E-05 1.01E-04 7.36E-05 7.52E-05 8.69E-05 
13.00 6.91E-05 5.73E-05 1.18E-04 6.70E-05 6.11E-05 1.00E-04 6.84E-05 6.88E-05 8.62E-05 
14.00 6.58E-05 5.28E-05 1.17E-04 6.33E-05 5.61E-05 9.98E-05 6.39E-05 6.30E-05 8.56E-05 
15.00 6.29E-05 4.86E-05 1.17E-04 5.99E-05 5.16E-05 9.93E-05 5.99E-05 5.78E-05 8.51E-05 
16.00 6.03E-05 4.49E-05 1.16E-04 5.70E-05 4.75E-05 9.88E-05 5.63E-05 5.30E-05 8.47E-05 
17.00 5.80E-05 4.15E-05 1.16E-04 5.43E-05 4.37E-05 9.83E-05 5.32E-05 4.87E-05 8.43E-05 
18.00 5.60E-05 3.85E-05 1.15E-04 5.20E-05 4.04E-05 9.79E-05 5.04E-05 4.47E-05 8.39E-05 
19.00 5.42E-05 3.57E-05 1.15E-04 5.00E-05 3.73E-05 9.74E-05 4.80E-05 4.12E-05 8.35E-05 
20.00 5.26E-05 3.31E-05 1.14E-04 4.81E-05 3.45E-05 9.70E-05 4.58E-05 3.79E-05 8.31E-05 
21.00 5.11E-05 3.08E-05 1.14E-04 4.65E-05 3.20E-05 9.66E-05 4.39E-05 3.50E-05 8.28E-05 
22.00 4.99E-05 2.87E-05 1.13E-04 4.51E-05 2.97E-05 9.62E-05 4.22E-05 3.23E-05 8.24E-05 
23.00 4.87E-05 2.68E-05 1.13E-04 4.38E-05 2.76E-05 9.58E-05 4.06E-05 2.99E-05 8.21E-05 




 05yo 01yo Newborn 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
25.00 4.67E-05 2.35E-05 1.12E-04 4.16E-05 2.40E-05 9.50E-05 3.81E-05 2.57E-05 8.14E-05 
26.00 4.59E-05 2.21E-05 1.11E-04 4.07E-05 2.24E-05 9.46E-05 3.70E-05 2.39E-05 8.10E-05 
27.00 4.51E-05 2.08E-05 1.11E-04 3.99E-05 2.10E-05 9.42E-05 3.61E-05 2.23E-05 8.07E-05 
28.00 4.45E-05 1.96E-05 1.10E-04 3.91E-05 1.97E-05 9.38E-05 3.52E-05 2.08E-05 8.03E-05 
29.00 4.38E-05 1.86E-05 1.10E-04 3.84E-05 1.85E-05 9.34E-05 3.44E-05 1.94E-05 8.00E-05 
30.00 4.33E-05 1.76E-05 1.09E-04 3.78E-05 1.74E-05 9.30E-05 3.37E-05 1.82E-05 7.97E-05 
31.00 4.27E-05 1.67E-05 1.09E-04 3.73E-05 1.64E-05 9.26E-05 3.31E-05 1.70E-05 7.93E-05 
32.00 4.22E-05 1.59E-05 1.08E-04 3.67E-05 1.55E-05 9.22E-05 3.25E-05 1.60E-05 7.90E-05 
33.00 4.18E-05 1.51E-05 1.08E-04 3.63E-05 1.47E-05 9.19E-05 3.20E-05 1.51E-05 7.87E-05 
34.00 4.14E-05 1.44E-05 1.08E-04 3.58E-05 1.40E-05 9.15E-05 3.16E-05 1.42E-05 7.84E-05 
35.00 4.10E-05 1.38E-05 1.07E-04 3.55E-05 1.33E-05 9.11E-05 3.11E-05 1.35E-05 7.80E-05 






EFFECTIVE DOSE RATE 100 CM FOR ADULT PATIENT 
 Adult 15yo 10yo 
Time (hrs) Normal  DTC Hyper  Normal  DTC Hyper  Normal  DTC Hyper  
0.00 2.85E-05 2.85E-05 2.85E-05 2.85E-05 2.85E-05 2.85E-05 3.09E-05 3.09E-05 3.09E-05 
0.25 2.91E-05 2.89E-05 3.08E-05 2.91E-05 2.89E-05 3.07E-05 3.14E-05 3.13E-05 3.26E-05 
0.50 2.92E-05 2.89E-05 3.15E-05 2.92E-05 2.90E-05 3.15E-05 3.16E-05 3.14E-05 3.31E-05 
1.00 2.90E-05 2.87E-05 3.23E-05 2.91E-05 2.87E-05 3.22E-05 3.14E-05 3.12E-05 3.35E-05 
2.00 2.81E-05 2.74E-05 3.26E-05 2.81E-05 2.75E-05 3.25E-05 3.03E-05 2.98E-05 3.33E-05 
3.00 2.67E-05 2.58E-05 3.24E-05 2.67E-05 2.58E-05 3.23E-05 2.87E-05 2.81E-05 3.28E-05 
4.00 2.52E-05 2.40E-05 3.21E-05 2.52E-05 2.41E-05 3.19E-05 2.70E-05 2.61E-05 3.21E-05 
5.00 2.37E-05 2.22E-05 3.17E-05 2.37E-05 2.23E-05 3.15E-05 2.53E-05 2.41E-05 3.16E-05 
6.00 2.23E-05 2.05E-05 3.13E-05 2.23E-05 2.05E-05 3.11E-05 2.37E-05 2.23E-05 3.11E-05 
7.00 2.10E-05 1.89E-05 3.10E-05 2.10E-05 1.89E-05 3.08E-05 2.22E-05 2.05E-05 3.07E-05 
8.00 1.98E-05 1.74E-05 3.07E-05 1.98E-05 1.74E-05 3.05E-05 2.09E-05 1.88E-05 3.04E-05 
9.00 1.88E-05 1.60E-05 3.05E-05 1.87E-05 1.60E-05 3.03E-05 1.97E-05 1.73E-05 3.02E-05 
10.00 1.78E-05 1.47E-05 3.03E-05 1.78E-05 1.47E-05 3.01E-05 1.86E-05 1.59E-05 2.99E-05 
11.00 1.70E-05 1.35E-05 3.01E-05 1.69E-05 1.36E-05 2.99E-05 1.76E-05 1.46E-05 2.97E-05 
12.00 1.62E-05 1.25E-05 3.00E-05 1.62E-05 1.25E-05 2.98E-05 1.68E-05 1.35E-05 2.96E-05 
13.00 1.55E-05 1.15E-05 2.98E-05 1.55E-05 1.15E-05 2.96E-05 1.60E-05 1.24E-05 2.94E-05 
14.00 1.50E-05 1.07E-05 2.97E-05 1.49E-05 1.07E-05 2.95E-05 1.54E-05 1.15E-05 2.93E-05 
15.00 1.44E-05 9.87E-06 2.96E-05 1.44E-05 9.88E-06 2.94E-05 1.48E-05 1.06E-05 2.92E-05 
16.00 1.40E-05 9.15E-06 2.95E-05 1.39E-05 9.16E-06 2.93E-05 1.42E-05 9.81E-06 2.90E-05 
17.00 1.35E-05 8.50E-06 2.93E-05 1.35E-05 8.50E-06 2.91E-05 1.38E-05 9.10E-06 2.89E-05 
18.00 1.32E-05 7.91E-06 2.92E-05 1.31E-05 7.91E-06 2.90E-05 1.34E-05 8.45E-06 2.88E-05 
19.00 1.28E-05 7.37E-06 2.91E-05 1.28E-05 7.37E-06 2.89E-05 1.30E-05 7.86E-06 2.87E-05 
20.00 1.25E-05 6.88E-06 2.90E-05 1.25E-05 6.88E-06 2.88E-05 1.27E-05 7.32E-06 2.86E-05 
21.00 1.23E-05 6.43E-06 2.89E-05 1.22E-05 6.44E-06 2.87E-05 1.24E-05 6.83E-06 2.85E-05 
22.00 1.20E-05 6.03E-06 2.88E-05 1.20E-05 6.03E-06 2.86E-05 1.21E-05 6.39E-06 2.83E-05 
23.00 1.18E-05 5.66E-06 2.86E-05 1.18E-05 5.66E-06 2.85E-05 1.19E-05 5.99E-06 2.82E-05 
24.00 1.16E-05 5.33E-06 2.85E-05 1.16E-05 5.33E-06 2.83E-05 1.16E-05 5.63E-06 2.81E-05 
25.00 1.15E-05 5.03E-06 2.84E-05 1.14E-05 5.02E-06 2.82E-05 1.14E-05 5.29E-06 2.80E-05 
26.00 1.13E-05 4.75E-06 2.83E-05 1.12E-05 4.75E-06 2.81E-05 1.13E-05 4.99E-06 2.79E-05 
27.00 1.11E-05 4.50E-06 2.82E-05 1.11E-05 4.50E-06 2.80E-05 1.11E-05 4.72E-06 2.78E-05 
28.00 1.10E-05 4.27E-06 2.81E-05 1.10E-05 4.27E-06 2.79E-05 1.10E-05 4.47E-06 2.77E-05 
29.00 1.09E-05 4.06E-06 2.80E-05 1.08E-05 4.06E-06 2.78E-05 1.08E-05 4.24E-06 2.76E-05 




 Adult 15yo 10yo 
Time (hrs) Normal  DTC Hyper  Normal  DTC Hyper  Normal  DTC Hyper  
31.00 1.07E-05 3.70E-06 2.77E-05 1.06E-05 3.69E-06 2.76E-05 1.06E-05 3.84E-06 2.74E-05 
32.00 1.06E-05 3.54E-06 2.76E-05 1.05E-05 3.53E-06 2.75E-05 1.05E-05 3.67E-06 2.72E-05 
33.00 1.05E-05 3.40E-06 2.75E-05 1.04E-05 3.39E-06 2.74E-05 1.04E-05 3.51E-06 2.71E-05 
34.00 1.04E-05 3.27E-06 2.74E-05 1.03E-05 3.26E-06 2.72E-05 1.03E-05 3.37E-06 2.70E-05 
35.00 1.03E-05 3.14E-06 2.73E-05 1.03E-05 3.13E-06 2.71E-05 1.02E-05 3.23E-06 2.69E-05 
36.00 1.03E-05 3.03E-06 2.72E-05 1.02E-05 3.02E-06 2.70E-05 1.02E-05 3.11E-06 2.68E-05 
 
 05yo 01yo Newborn 
Time (hrs) Normal  DTC Hyper  Normal  DTC Hyper  Normal  DTC Hyper  
0.00 3.11E-05 3.11E-05 3.11E-05 3.19E-05 3.19E-05 3.19E-05 3.35E-05 3.35E-05 3.35E-05 
0.25 3.16E-05 3.15E-05 3.20E-05 3.24E-05 3.24E-05 3.24E-05 3.40E-05 3.41E-05 3.35E-05 
0.50 3.17E-05 3.16E-05 3.23E-05 3.25E-05 3.25E-05 3.25E-05 3.41E-05 3.42E-05 3.33E-05 
1.00 3.14E-05 3.13E-05 3.23E-05 3.22E-05 3.22E-05 3.22E-05 3.39E-05 3.40E-05 3.27E-05 
2.00 3.02E-05 3.00E-05 3.17E-05 3.09E-05 3.09E-05 3.12E-05 3.25E-05 3.26E-05 3.12E-05 
3.00 2.86E-05 2.82E-05 3.09E-05 2.92E-05 2.91E-05 3.01E-05 3.05E-05 3.07E-05 2.98E-05 
4.00 2.68E-05 2.62E-05 3.01E-05 2.73E-05 2.70E-05 2.92E-05 2.85E-05 2.86E-05 2.87E-05 
5.00 2.50E-05 2.43E-05 2.94E-05 2.54E-05 2.50E-05 2.84E-05 2.64E-05 2.64E-05 2.77E-05 
6.00 2.33E-05 2.23E-05 2.89E-05 2.36E-05 2.30E-05 2.78E-05 2.45E-05 2.43E-05 2.70E-05 
7.00 2.18E-05 2.05E-05 2.85E-05 2.20E-05 2.11E-05 2.73E-05 2.28E-05 2.23E-05 2.65E-05 
8.00 2.04E-05 1.89E-05 2.81E-05 2.06E-05 1.94E-05 2.70E-05 2.12E-05 2.05E-05 2.61E-05 
9.00 1.92E-05 1.73E-05 2.79E-05 1.92E-05 1.78E-05 2.67E-05 1.97E-05 1.88E-05 2.58E-05 
10.00 1.81E-05 1.59E-05 2.76E-05 1.81E-05 1.63E-05 2.65E-05 1.85E-05 1.72E-05 2.55E-05 
11.00 1.71E-05 1.46E-05 2.74E-05 1.70E-05 1.50E-05 2.63E-05 1.73E-05 1.58E-05 2.53E-05 
12.00 1.62E-05 1.35E-05 2.73E-05 1.61E-05 1.38E-05 2.61E-05 1.63E-05 1.45E-05 2.51E-05 
13.00 1.54E-05 1.24E-05 2.71E-05 1.53E-05 1.27E-05 2.60E-05 1.54E-05 1.33E-05 2.50E-05 
14.00 1.47E-05 1.14E-05 2.70E-05 1.46E-05 1.17E-05 2.58E-05 1.47E-05 1.23E-05 2.49E-05 
15.00 1.41E-05 1.06E-05 2.69E-05 1.39E-05 1.08E-05 2.57E-05 1.40E-05 1.13E-05 2.47E-05 
16.00 1.36E-05 9.75E-06 2.68E-05 1.33E-05 9.95E-06 2.56E-05 1.33E-05 1.04E-05 2.46E-05 
17.00 1.31E-05 9.03E-06 2.67E-05 1.28E-05 9.20E-06 2.55E-05 1.28E-05 9.61E-06 2.45E-05 
18.00 1.26E-05 8.37E-06 2.65E-05 1.24E-05 8.52E-06 2.54E-05 1.23E-05 8.88E-06 2.44E-05 
19.00 1.23E-05 7.77E-06 2.64E-05 1.20E-05 7.90E-06 2.53E-05 1.19E-05 8.23E-06 2.43E-05 
20.00 1.19E-05 7.23E-06 2.63E-05 1.16E-05 7.34E-06 2.52E-05 1.15E-05 7.63E-06 2.42E-05 
21.00 1.16E-05 6.74E-06 2.62E-05 1.13E-05 6.83E-06 2.51E-05 1.12E-05 7.09E-06 2.41E-05 
22.00 1.14E-05 6.29E-06 2.61E-05 1.10E-05 6.37E-06 2.50E-05 1.09E-05 6.60E-06 2.40E-05 
23.00 1.11E-05 5.88E-06 2.60E-05 1.08E-05 5.95E-06 2.49E-05 1.06E-05 6.15E-06 2.39E-05 




 05yo 01yo Newborn 
Time (hrs) Normal  DTC Hyper  Normal  DTC Hyper  Normal  DTC Hyper  
25.00 1.07E-05 5.18E-06 2.58E-05 1.03E-05 5.22E-06 2.47E-05 1.01E-05 5.37E-06 2.37E-05 
26.00 1.05E-05 4.87E-06 2.57E-05 1.02E-05 4.90E-06 2.46E-05 9.93E-06 5.04E-06 2.36E-05 
27.00 1.04E-05 4.60E-06 2.56E-05 1.00E-05 4.62E-06 2.45E-05 9.75E-06 4.73E-06 2.36E-05 
28.00 1.02E-05 4.34E-06 2.55E-05 9.85E-06 4.35E-06 2.44E-05 9.59E-06 4.46E-06 2.35E-05 
29.00 1.01E-05 4.11E-06 2.54E-05 9.71E-06 4.12E-06 2.43E-05 9.45E-06 4.20E-06 2.34E-05 
30.00 9.96E-06 3.90E-06 2.53E-05 9.58E-06 3.90E-06 2.42E-05 9.31E-06 3.97E-06 2.33E-05 
31.00 9.84E-06 3.71E-06 2.52E-05 9.47E-06 3.70E-06 2.41E-05 9.19E-06 3.76E-06 2.32E-05 
32.00 9.74E-06 3.54E-06 2.51E-05 9.36E-06 3.52E-06 2.40E-05 9.08E-06 3.57E-06 2.31E-05 
33.00 9.65E-06 3.38E-06 2.50E-05 9.27E-06 3.36E-06 2.39E-05 8.98E-06 3.40E-06 2.30E-05 
34.00 9.56E-06 3.23E-06 2.49E-05 9.18E-06 3.21E-06 2.38E-05 8.89E-06 3.24E-06 2.29E-05 
35.00 9.48E-06 3.10E-06 2.48E-05 9.10E-06 3.07E-06 2.37E-05 8.80E-06 3.09E-06 2.28E-05 






EFFECTIVE DOSE RATE 100 CM FOR 15YO PATIENT 
 Adult 15yo 10yo 
Time (hrs) Normal  DTC Hyper  Normal  DTC Hyper  Normal  DTC Hyper  
0.00 2.80E-05 2.80E-05 2.80E-05 2.91E-05 2.91E-05 2.91E-05 3.13E-05 3.13E-05 3.13E-05 
0.25 2.85E-05 2.83E-05 3.05E-05 2.97E-05 2.95E-05 3.14E-05 3.19E-05 3.17E-05 3.30E-05 
0.50 2.87E-05 2.84E-05 3.14E-05 2.98E-05 2.96E-05 3.22E-05 3.20E-05 3.18E-05 3.36E-05 
1.00 2.86E-05 2.81E-05 3.24E-05 2.97E-05 2.93E-05 3.29E-05 3.18E-05 3.15E-05 3.40E-05 
2.00 2.77E-05 2.70E-05 3.30E-05 2.87E-05 2.80E-05 3.33E-05 3.06E-05 3.02E-05 3.39E-05 
3.00 2.64E-05 2.53E-05 3.29E-05 2.73E-05 2.64E-05 3.31E-05 2.90E-05 2.84E-05 3.33E-05 
4.00 2.49E-05 2.36E-05 3.26E-05 2.57E-05 2.45E-05 3.27E-05 2.73E-05 2.64E-05 3.27E-05 
5.00 2.35E-05 2.18E-05 3.23E-05 2.42E-05 2.27E-05 3.23E-05 2.56E-05 2.44E-05 3.22E-05 
6.00 2.22E-05 2.02E-05 3.20E-05 2.28E-05 2.09E-05 3.19E-05 2.40E-05 2.25E-05 3.17E-05 
7.00 2.09E-05 1.86E-05 3.17E-05 2.14E-05 1.93E-05 3.16E-05 2.25E-05 2.07E-05 3.13E-05 
8.00 1.98E-05 1.71E-05 3.15E-05 2.02E-05 1.77E-05 3.13E-05 2.11E-05 1.90E-05 3.10E-05 
9.00 1.87E-05 1.57E-05 3.12E-05 1.91E-05 1.63E-05 3.11E-05 1.99E-05 1.75E-05 3.07E-05 
10.00 1.78E-05 1.45E-05 3.10E-05 1.82E-05 1.50E-05 3.09E-05 1.89E-05 1.61E-05 3.05E-05 
11.00 1.70E-05 1.34E-05 3.09E-05 1.73E-05 1.38E-05 3.07E-05 1.79E-05 1.48E-05 3.03E-05 
12.00 1.63E-05 1.23E-05 3.07E-05 1.65E-05 1.28E-05 3.05E-05 1.70E-05 1.36E-05 3.02E-05 
13.00 1.56E-05 1.14E-05 3.06E-05 1.59E-05 1.18E-05 3.04E-05 1.63E-05 1.26E-05 3.00E-05 
14.00 1.51E-05 1.05E-05 3.04E-05 1.52E-05 1.09E-05 3.03E-05 1.56E-05 1.16E-05 2.99E-05 
15.00 1.45E-05 9.76E-06 3.03E-05 1.47E-05 1.01E-05 3.01E-05 1.50E-05 1.07E-05 2.97E-05 
16.00 1.41E-05 9.05E-06 3.02E-05 1.42E-05 9.35E-06 3.00E-05 1.45E-05 9.93E-06 2.96E-05 
17.00 1.37E-05 8.41E-06 3.00E-05 1.38E-05 8.68E-06 2.99E-05 1.40E-05 9.21E-06 2.95E-05 
18.00 1.33E-05 7.83E-06 2.99E-05 1.34E-05 8.07E-06 2.97E-05 1.36E-05 8.55E-06 2.93E-05 
19.00 1.30E-05 7.30E-06 2.98E-05 1.31E-05 7.52E-06 2.96E-05 1.32E-05 7.95E-06 2.92E-05 
20.00 1.27E-05 6.83E-06 2.97E-05 1.28E-05 7.02E-06 2.95E-05 1.29E-05 7.41E-06 2.91E-05 
21.00 1.25E-05 6.39E-06 2.95E-05 1.25E-05 6.57E-06 2.94E-05 1.26E-05 6.92E-06 2.90E-05 
22.00 1.22E-05 5.99E-06 2.94E-05 1.23E-05 6.16E-06 2.93E-05 1.23E-05 6.47E-06 2.89E-05 
23.00 1.20E-05 5.63E-06 2.93E-05 1.20E-05 5.78E-06 2.91E-05 1.20E-05 6.07E-06 2.87E-05 
24.00 1.18E-05 5.31E-06 2.92E-05 1.18E-05 5.44E-06 2.90E-05 1.18E-05 5.70E-06 2.86E-05 
25.00 1.16E-05 5.01E-06 2.91E-05 1.16E-05 5.13E-06 2.89E-05 1.16E-05 5.36E-06 2.85E-05 
26.00 1.15E-05 4.74E-06 2.89E-05 1.15E-05 4.85E-06 2.88E-05 1.15E-05 5.05E-06 2.84E-05 
27.00 1.13E-05 4.49E-06 2.88E-05 1.13E-05 4.59E-06 2.87E-05 1.13E-05 4.78E-06 2.83E-05 
28.00 1.12E-05 4.27E-06 2.87E-05 1.12E-05 4.35E-06 2.85E-05 1.11E-05 4.52E-06 2.82E-05 
29.00 1.11E-05 4.06E-06 2.86E-05 1.11E-05 4.14E-06 2.84E-05 1.10E-05 4.29E-06 2.81E-05 




 Adult 15yo 10yo 
Time (hrs) Normal  DTC Hyper  Normal  DTC Hyper  Normal  DTC Hyper  
31.00 1.09E-05 3.70E-06 2.84E-05 1.08E-05 3.77E-06 2.82E-05 1.08E-05 3.89E-06 2.78E-05 
32.00 1.08E-05 3.55E-06 2.82E-05 1.07E-05 3.60E-06 2.81E-05 1.07E-05 3.71E-06 2.77E-05 
33.00 1.07E-05 3.41E-06 2.81E-05 1.07E-05 3.46E-06 2.80E-05 1.06E-05 3.55E-06 2.76E-05 
34.00 1.06E-05 3.28E-06 2.80E-05 1.06E-05 3.32E-06 2.79E-05 1.05E-05 3.41E-06 2.75E-05 
35.00 1.05E-05 3.16E-06 2.79E-05 1.05E-05 3.20E-06 2.78E-05 1.04E-05 3.27E-06 2.74E-05 
36.00 1.04E-05 3.05E-06 2.78E-05 1.04E-05 3.08E-06 2.76E-05 1.03E-05 3.15E-06 2.73E-05 
 
 05yo 01yo Newborn 
Time (hrs) Normal  DTC Hyper  Normal  DTC Hyper  Normal  DTC Hyper  
0.00 3.16E-05 3.16E-05 3.16E-05 3.18E-05 3.18E-05 3.18E-05 3.41E-05 3.41E-05 3.41E-05 
0.25 3.20E-05 3.20E-05 3.25E-05 3.22E-05 3.22E-05 3.22E-05 3.46E-05 3.47E-05 3.40E-05 
0.50 3.21E-05 3.20E-05 3.28E-05 3.23E-05 3.23E-05 3.22E-05 3.47E-05 3.48E-05 3.38E-05 
1.00 3.19E-05 3.18E-05 3.28E-05 3.21E-05 3.21E-05 3.19E-05 3.44E-05 3.45E-05 3.32E-05 
2.00 3.06E-05 3.04E-05 3.22E-05 3.07E-05 3.07E-05 3.09E-05 3.29E-05 3.31E-05 3.17E-05 
3.00 2.89E-05 2.86E-05 3.13E-05 2.90E-05 2.89E-05 2.98E-05 3.10E-05 3.11E-05 3.02E-05 
4.00 2.71E-05 2.66E-05 3.05E-05 2.71E-05 2.68E-05 2.89E-05 2.89E-05 2.90E-05 2.91E-05 
5.00 2.53E-05 2.46E-05 2.99E-05 2.52E-05 2.48E-05 2.81E-05 2.68E-05 2.67E-05 2.81E-05 
6.00 2.36E-05 2.26E-05 2.93E-05 2.35E-05 2.28E-05 2.75E-05 2.49E-05 2.46E-05 2.74E-05 
7.00 2.21E-05 2.08E-05 2.89E-05 2.18E-05 2.10E-05 2.70E-05 2.31E-05 2.26E-05 2.69E-05 
8.00 2.07E-05 1.91E-05 2.85E-05 2.04E-05 1.93E-05 2.67E-05 2.15E-05 2.07E-05 2.64E-05 
9.00 1.94E-05 1.75E-05 2.83E-05 1.91E-05 1.77E-05 2.64E-05 2.00E-05 1.90E-05 2.61E-05 
10.00 1.83E-05 1.61E-05 2.80E-05 1.79E-05 1.62E-05 2.61E-05 1.87E-05 1.74E-05 2.59E-05 
11.00 1.73E-05 1.48E-05 2.79E-05 1.69E-05 1.49E-05 2.60E-05 1.76E-05 1.60E-05 2.57E-05 
12.00 1.64E-05 1.36E-05 2.77E-05 1.60E-05 1.37E-05 2.58E-05 1.66E-05 1.47E-05 2.55E-05 
13.00 1.56E-05 1.25E-05 2.75E-05 1.51E-05 1.26E-05 2.56E-05 1.56E-05 1.35E-05 2.53E-05 
14.00 1.49E-05 1.16E-05 2.74E-05 1.44E-05 1.16E-05 2.55E-05 1.48E-05 1.24E-05 2.52E-05 
15.00 1.43E-05 1.07E-05 2.73E-05 1.38E-05 1.07E-05 2.54E-05 1.41E-05 1.14E-05 2.51E-05 
16.00 1.37E-05 9.87E-06 2.72E-05 1.32E-05 9.88E-06 2.53E-05 1.35E-05 1.05E-05 2.50E-05 
17.00 1.32E-05 9.14E-06 2.70E-05 1.27E-05 9.13E-06 2.52E-05 1.30E-05 9.74E-06 2.48E-05 
18.00 1.28E-05 8.47E-06 2.69E-05 1.22E-05 8.45E-06 2.51E-05 1.25E-05 9.00E-06 2.47E-05 
19.00 1.24E-05 7.87E-06 2.68E-05 1.18E-05 7.84E-06 2.50E-05 1.20E-05 8.34E-06 2.46E-05 
20.00 1.21E-05 7.32E-06 2.67E-05 1.15E-05 7.28E-06 2.49E-05 1.16E-05 7.73E-06 2.45E-05 
21.00 1.18E-05 6.82E-06 2.66E-05 1.12E-05 6.77E-06 2.47E-05 1.13E-05 7.18E-06 2.44E-05 
22.00 1.15E-05 6.37E-06 2.65E-05 1.09E-05 6.31E-06 2.46E-05 1.10E-05 6.68E-06 2.43E-05 
23.00 1.12E-05 5.95E-06 2.64E-05 1.06E-05 5.90E-06 2.45E-05 1.07E-05 6.23E-06 2.42E-05 




 05yo 01yo Newborn 
Time (hrs) Normal  DTC Hyper  Normal  DTC Hyper  Normal  DTC Hyper  
25.00 1.08E-05 5.24E-06 2.62E-05 1.02E-05 5.17E-06 2.43E-05 1.02E-05 5.44E-06 2.40E-05 
26.00 1.06E-05 4.93E-06 2.61E-05 1.00E-05 4.86E-06 2.42E-05 1.00E-05 5.10E-06 2.39E-05 
27.00 1.05E-05 4.65E-06 2.60E-05 9.86E-06 4.57E-06 2.42E-05 9.86E-06 4.79E-06 2.38E-05 
28.00 1.03E-05 4.39E-06 2.58E-05 9.71E-06 4.31E-06 2.41E-05 9.70E-06 4.51E-06 2.37E-05 
29.00 1.02E-05 4.16E-06 2.57E-05 9.58E-06 4.07E-06 2.40E-05 9.55E-06 4.25E-06 2.36E-05 
30.00 1.01E-05 3.95E-06 2.56E-05 9.45E-06 3.86E-06 2.39E-05 9.42E-06 4.02E-06 2.35E-05 
31.00 9.96E-06 3.75E-06 2.55E-05 9.34E-06 3.66E-06 2.38E-05 9.29E-06 3.81E-06 2.35E-05 
32.00 9.85E-06 3.58E-06 2.54E-05 9.23E-06 3.48E-06 2.37E-05 9.18E-06 3.61E-06 2.34E-05 
33.00 9.76E-06 3.41E-06 2.53E-05 9.13E-06 3.32E-06 2.36E-05 9.08E-06 3.43E-06 2.33E-05 
34.00 9.67E-06 3.27E-06 2.52E-05 9.04E-06 3.17E-06 2.35E-05 8.98E-06 3.27E-06 2.32E-05 
35.00 9.58E-06 3.13E-06 2.51E-05 8.96E-06 3.03E-06 2.34E-05 8.89E-06 3.12E-06 2.31E-05 






EFFECTIVE DOSE RATE 100 CM FOR 10YO PATIENT 
 Adult 15yo 10yo 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
0.00 3.03E-05 3.03E-05 3.03E-05 3.09E-05 3.09E-05 3.09E-05 3.31E-05 3.31E-05 3.31E-05 
0.25 3.08E-05 3.06E-05 3.30E-05 3.14E-05 3.12E-05 3.34E-05 3.37E-05 3.35E-05 3.55E-05 
0.50 3.10E-05 3.07E-05 3.39E-05 3.15E-05 3.12E-05 3.43E-05 3.38E-05 3.35E-05 3.63E-05 
1.00 3.08E-05 3.03E-05 3.48E-05 3.13E-05 3.09E-05 3.51E-05 3.36E-05 3.32E-05 3.70E-05 
2.00 2.98E-05 2.90E-05 3.54E-05 3.02E-05 2.95E-05 3.56E-05 3.24E-05 3.17E-05 3.73E-05 
3.00 2.83E-05 2.72E-05 3.53E-05 2.87E-05 2.77E-05 3.55E-05 3.07E-05 2.98E-05 3.70E-05 
4.00 2.68E-05 2.53E-05 3.50E-05 2.71E-05 2.58E-05 3.51E-05 2.90E-05 2.77E-05 3.65E-05 
5.00 2.52E-05 2.35E-05 3.47E-05 2.56E-05 2.38E-05 3.47E-05 2.72E-05 2.56E-05 3.60E-05 
6.00 2.38E-05 2.16E-05 3.43E-05 2.41E-05 2.20E-05 3.44E-05 2.56E-05 2.36E-05 3.56E-05 
7.00 2.24E-05 1.99E-05 3.40E-05 2.27E-05 2.02E-05 3.41E-05 2.41E-05 2.17E-05 3.52E-05 
8.00 2.12E-05 1.83E-05 3.37E-05 2.14E-05 1.86E-05 3.38E-05 2.27E-05 2.00E-05 3.49E-05 
9.00 2.01E-05 1.69E-05 3.35E-05 2.03E-05 1.71E-05 3.35E-05 2.15E-05 1.84E-05 3.46E-05 
10.00 1.91E-05 1.56E-05 3.33E-05 1.93E-05 1.58E-05 3.33E-05 2.04E-05 1.69E-05 3.44E-05 
11.00 1.82E-05 1.43E-05 3.31E-05 1.84E-05 1.45E-05 3.31E-05 1.94E-05 1.56E-05 3.42E-05 
12.00 1.75E-05 1.32E-05 3.29E-05 1.76E-05 1.34E-05 3.30E-05 1.85E-05 1.44E-05 3.40E-05 
13.00 1.68E-05 1.22E-05 3.28E-05 1.69E-05 1.24E-05 3.28E-05 1.77E-05 1.33E-05 3.38E-05 
14.00 1.61E-05 1.13E-05 3.26E-05 1.63E-05 1.15E-05 3.26E-05 1.71E-05 1.23E-05 3.37E-05 
15.00 1.56E-05 1.05E-05 3.25E-05 1.57E-05 1.06E-05 3.25E-05 1.64E-05 1.14E-05 3.35E-05 
16.00 1.51E-05 9.72E-06 3.23E-05 1.52E-05 9.85E-06 3.24E-05 1.59E-05 1.05E-05 3.34E-05 
17.00 1.47E-05 9.03E-06 3.22E-05 1.48E-05 9.15E-06 3.22E-05 1.54E-05 9.77E-06 3.32E-05 
18.00 1.43E-05 8.41E-06 3.20E-05 1.44E-05 8.51E-06 3.21E-05 1.50E-05 9.08E-06 3.31E-05 
19.00 1.39E-05 7.84E-06 3.19E-05 1.40E-05 7.94E-06 3.19E-05 1.46E-05 8.46E-06 3.29E-05 
20.00 1.36E-05 7.33E-06 3.18E-05 1.37E-05 7.42E-06 3.18E-05 1.42E-05 7.90E-06 3.28E-05 
21.00 1.33E-05 6.86E-06 3.16E-05 1.34E-05 6.94E-06 3.17E-05 1.39E-05 7.39E-06 3.27E-05 
22.00 1.31E-05 6.43E-06 3.15E-05 1.31E-05 6.51E-06 3.15E-05 1.37E-05 6.92E-06 3.25E-05 
23.00 1.29E-05 6.05E-06 3.14E-05 1.29E-05 6.12E-06 3.14E-05 1.34E-05 6.50E-06 3.24E-05 
24.00 1.27E-05 5.70E-06 3.12E-05 1.27E-05 5.76E-06 3.13E-05 1.32E-05 6.11E-06 3.23E-05 
25.00 1.25E-05 5.38E-06 3.11E-05 1.25E-05 5.43E-06 3.11E-05 1.30E-05 5.76E-06 3.21E-05 
26.00 1.23E-05 5.09E-06 3.10E-05 1.23E-05 5.14E-06 3.10E-05 1.28E-05 5.44E-06 3.20E-05 
27.00 1.21E-05 4.82E-06 3.09E-05 1.22E-05 4.87E-06 3.09E-05 1.26E-05 5.15E-06 3.19E-05 
28.00 1.20E-05 4.58E-06 3.07E-05 1.20E-05 4.62E-06 3.08E-05 1.25E-05 4.89E-06 3.17E-05 
29.00 1.19E-05 4.36E-06 3.06E-05 1.19E-05 4.40E-06 3.06E-05 1.23E-05 4.64E-06 3.16E-05 




 Adult 15yo 10yo 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
31.00 1.16E-05 3.97E-06 3.03E-05 1.17E-05 4.01E-06 3.04E-05 1.21E-05 4.22E-06 3.13E-05 
32.00 1.15E-05 3.81E-06 3.02E-05 1.16E-05 3.84E-06 3.03E-05 1.19E-05 4.04E-06 3.12E-05 
33.00 1.14E-05 3.65E-06 3.01E-05 1.15E-05 3.68E-06 3.01E-05 1.18E-05 3.87E-06 3.11E-05 
34.00 1.13E-05 3.51E-06 3.00E-05 1.14E-05 3.54E-06 3.00E-05 1.17E-05 3.72E-06 3.09E-05 
35.00 1.13E-05 3.39E-06 2.98E-05 1.13E-05 3.41E-06 2.99E-05 1.16E-05 3.58E-06 3.08E-05 
36.00 1.12E-05 3.27E-06 2.97E-05 1.12E-05 3.29E-06 2.98E-05 1.16E-05 3.45E-06 3.07E-05 
 
 05yo 01yo Newborn 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
0.00 3.36E-05 3.36E-05 3.36E-05 3.49E-05 3.49E-05 3.49E-05 3.72E-05 3.72E-05 3.72E-05 
0.25 3.41E-05 3.39E-05 3.54E-05 3.53E-05 3.53E-05 3.61E-05 3.77E-05 3.77E-05 3.79E-05 
0.50 3.41E-05 3.40E-05 3.59E-05 3.54E-05 3.53E-05 3.64E-05 3.78E-05 3.78E-05 3.81E-05 
1.00 3.39E-05 3.36E-05 3.64E-05 3.51E-05 3.49E-05 3.65E-05 3.75E-05 3.74E-05 3.79E-05 
2.00 3.26E-05 3.21E-05 3.62E-05 3.37E-05 3.34E-05 3.59E-05 3.59E-05 3.58E-05 3.69E-05 
3.00 3.09E-05 3.02E-05 3.57E-05 3.18E-05 3.14E-05 3.51E-05 3.38E-05 3.36E-05 3.57E-05 
4.00 2.91E-05 2.81E-05 3.51E-05 2.98E-05 2.91E-05 3.43E-05 3.17E-05 3.12E-05 3.47E-05 
5.00 2.72E-05 2.59E-05 3.45E-05 2.79E-05 2.69E-05 3.36E-05 2.95E-05 2.89E-05 3.38E-05 
6.00 2.55E-05 2.39E-05 3.40E-05 2.61E-05 2.48E-05 3.30E-05 2.75E-05 2.66E-05 3.32E-05 
7.00 2.40E-05 2.20E-05 3.36E-05 2.44E-05 2.28E-05 3.26E-05 2.57E-05 2.44E-05 3.26E-05 
8.00 2.25E-05 2.02E-05 3.33E-05 2.29E-05 2.10E-05 3.22E-05 2.40E-05 2.24E-05 3.22E-05 
9.00 2.12E-05 1.86E-05 3.30E-05 2.15E-05 1.93E-05 3.19E-05 2.25E-05 2.06E-05 3.19E-05 
10.00 2.01E-05 1.71E-05 3.28E-05 2.03E-05 1.77E-05 3.17E-05 2.11E-05 1.89E-05 3.16E-05 
11.00 1.91E-05 1.57E-05 3.26E-05 1.92E-05 1.63E-05 3.14E-05 1.99E-05 1.74E-05 3.14E-05 
12.00 1.82E-05 1.45E-05 3.24E-05 1.82E-05 1.50E-05 3.13E-05 1.89E-05 1.60E-05 3.12E-05 
13.00 1.74E-05 1.34E-05 3.22E-05 1.74E-05 1.38E-05 3.11E-05 1.79E-05 1.47E-05 3.10E-05 
14.00 1.67E-05 1.23E-05 3.20E-05 1.66E-05 1.27E-05 3.09E-05 1.71E-05 1.35E-05 3.09E-05 
15.00 1.60E-05 1.14E-05 3.19E-05 1.59E-05 1.17E-05 3.08E-05 1.64E-05 1.25E-05 3.07E-05 
16.00 1.55E-05 1.06E-05 3.18E-05 1.53E-05 1.09E-05 3.06E-05 1.57E-05 1.15E-05 3.06E-05 
17.00 1.50E-05 9.79E-06 3.16E-05 1.48E-05 1.01E-05 3.05E-05 1.51E-05 1.07E-05 3.04E-05 
18.00 1.45E-05 9.10E-06 3.15E-05 1.43E-05 9.33E-06 3.04E-05 1.46E-05 9.89E-06 3.03E-05 
19.00 1.41E-05 8.47E-06 3.13E-05 1.39E-05 8.67E-06 3.02E-05 1.42E-05 9.18E-06 3.02E-05 
20.00 1.38E-05 7.89E-06 3.12E-05 1.35E-05 8.07E-06 3.01E-05 1.37E-05 8.53E-06 3.01E-05 
21.00 1.34E-05 7.37E-06 3.11E-05 1.32E-05 7.53E-06 3.00E-05 1.34E-05 7.94E-06 2.99E-05 
22.00 1.31E-05 6.89E-06 3.09E-05 1.29E-05 7.03E-06 2.99E-05 1.31E-05 7.41E-06 2.98E-05 
23.00 1.29E-05 6.46E-06 3.08E-05 1.26E-05 6.58E-06 2.97E-05 1.28E-05 6.92E-06 2.97E-05 




 05yo 01yo Newborn 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
25.00 1.25E-05 5.71E-06 3.06E-05 1.21E-05 5.80E-06 2.95E-05 1.23E-05 6.08E-06 2.94E-05 
26.00 1.23E-05 5.39E-06 3.04E-05 1.20E-05 5.46E-06 2.94E-05 1.20E-05 5.72E-06 2.93E-05 
27.00 1.21E-05 5.09E-06 3.03E-05 1.18E-05 5.15E-06 2.92E-05 1.19E-05 5.39E-06 2.92E-05 
28.00 1.19E-05 4.82E-06 3.02E-05 1.16E-05 4.87E-06 2.91E-05 1.17E-05 5.08E-06 2.91E-05 
29.00 1.18E-05 4.58E-06 3.01E-05 1.15E-05 4.62E-06 2.90E-05 1.15E-05 4.81E-06 2.89E-05 
30.00 1.17E-05 4.36E-06 2.99E-05 1.13E-05 4.38E-06 2.89E-05 1.14E-05 4.56E-06 2.88E-05 
31.00 1.15E-05 4.15E-06 2.98E-05 1.12E-05 4.17E-06 2.88E-05 1.12E-05 4.33E-06 2.87E-05 
32.00 1.14E-05 3.97E-06 2.97E-05 1.11E-05 3.98E-06 2.86E-05 1.11E-05 4.12E-06 2.86E-05 
33.00 1.13E-05 3.80E-06 2.96E-05 1.10E-05 3.80E-06 2.85E-05 1.10E-05 3.93E-06 2.85E-05 
34.00 1.12E-05 3.64E-06 2.94E-05 1.09E-05 3.64E-06 2.84E-05 1.09E-05 3.76E-06 2.83E-05 
35.00 1.11E-05 3.50E-06 2.93E-05 1.08E-05 3.49E-06 2.83E-05 1.08E-05 3.60E-06 2.82E-05 







EFFECTIVE DOSE RATE 300 CM FOR ADULT PATIENT 
 Adult 15yo 10yo 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
0.00 4.84E-06 4.84E-06 4.84E-06 4.79E-06 4.79E-06 4.79E-06 5.05E-06 5.05E-06 5.05E-06 
0.25 4.91E-06 4.88E-06 5.24E-06 4.87E-06 4.84E-06 5.19E-06 5.13E-06 5.10E-06 5.44E-06 
0.50 4.93E-06 4.88E-06 5.38E-06 4.88E-06 4.84E-06 5.32E-06 5.14E-06 5.10E-06 5.57E-06 
1.00 4.90E-06 4.83E-06 5.52E-06 4.86E-06 4.79E-06 5.46E-06 5.11E-06 5.04E-06 5.69E-06 
2.00 4.73E-06 4.61E-06 5.61E-06 4.69E-06 4.57E-06 5.55E-06 4.93E-06 4.81E-06 5.76E-06 
3.00 4.50E-06 4.33E-06 5.59E-06 4.46E-06 4.29E-06 5.53E-06 4.68E-06 4.52E-06 5.73E-06 
4.00 4.25E-06 4.03E-06 5.54E-06 4.21E-06 3.99E-06 5.48E-06 4.42E-06 4.20E-06 5.67E-06 
5.00 4.01E-06 3.73E-06 5.49E-06 3.97E-06 3.69E-06 5.42E-06 4.16E-06 3.88E-06 5.60E-06 
6.00 3.77E-06 3.44E-06 5.43E-06 3.74E-06 3.41E-06 5.37E-06 3.91E-06 3.58E-06 5.54E-06 
7.00 3.56E-06 3.16E-06 5.38E-06 3.52E-06 3.14E-06 5.32E-06 3.68E-06 3.30E-06 5.49E-06 
8.00 3.36E-06 2.91E-06 5.34E-06 3.33E-06 2.89E-06 5.28E-06 3.48E-06 3.03E-06 5.45E-06 
9.00 3.19E-06 2.68E-06 5.31E-06 3.16E-06 2.66E-06 5.24E-06 3.30E-06 2.79E-06 5.41E-06 
10.00 3.03E-06 2.47E-06 5.27E-06 3.00E-06 2.45E-06 5.21E-06 3.13E-06 2.57E-06 5.38E-06 
11.00 2.89E-06 2.28E-06 5.25E-06 2.86E-06 2.26E-06 5.18E-06 2.98E-06 2.37E-06 5.35E-06 
12.00 2.77E-06 2.10E-06 5.22E-06 2.74E-06 2.08E-06 5.16E-06 2.85E-06 2.18E-06 5.32E-06 
13.00 2.66E-06 1.94E-06 5.20E-06 2.63E-06 1.92E-06 5.13E-06 2.74E-06 2.02E-06 5.29E-06 
14.00 2.56E-06 1.79E-06 5.17E-06 2.54E-06 1.78E-06 5.11E-06 2.64E-06 1.87E-06 5.27E-06 
15.00 2.48E-06 1.66E-06 5.15E-06 2.45E-06 1.65E-06 5.09E-06 2.54E-06 1.73E-06 5.25E-06 
16.00 2.40E-06 1.54E-06 5.13E-06 2.37E-06 1.53E-06 5.07E-06 2.46E-06 1.60E-06 5.23E-06 
17.00 2.33E-06 1.43E-06 5.11E-06 2.30E-06 1.42E-06 5.04E-06 2.39E-06 1.49E-06 5.20E-06 
18.00 2.27E-06 1.33E-06 5.09E-06 2.24E-06 1.32E-06 5.02E-06 2.33E-06 1.38E-06 5.18E-06 
19.00 2.21E-06 1.24E-06 5.07E-06 2.19E-06 1.23E-06 5.00E-06 2.27E-06 1.29E-06 5.16E-06 
20.00 2.17E-06 1.16E-06 5.05E-06 2.14E-06 1.15E-06 4.98E-06 2.22E-06 1.21E-06 5.14E-06 
21.00 2.12E-06 1.09E-06 5.03E-06 2.10E-06 1.08E-06 4.96E-06 2.17E-06 1.13E-06 5.12E-06 
22.00 2.08E-06 1.02E-06 5.01E-06 2.06E-06 1.01E-06 4.94E-06 2.13E-06 1.06E-06 5.10E-06 
23.00 2.05E-06 9.60E-07 4.99E-06 2.02E-06 9.51E-07 4.93E-06 2.09E-06 9.94E-07 5.08E-06 
24.00 2.01E-06 9.05E-07 4.97E-06 1.99E-06 8.96E-07 4.91E-06 2.06E-06 9.36E-07 5.06E-06 
25.00 1.98E-06 8.54E-07 4.95E-06 1.96E-06 8.46E-07 4.89E-06 2.03E-06 8.83E-07 5.04E-06 
26.00 1.96E-06 8.08E-07 4.93E-06 1.93E-06 8.00E-07 4.87E-06 2.00E-06 8.35E-07 5.02E-06 
27.00 1.93E-06 7.66E-07 4.91E-06 1.91E-06 7.58E-07 4.85E-06 1.97E-06 7.91E-07 5.00E-06 
28.00 1.91E-06 7.28E-07 4.89E-06 1.89E-06 7.20E-07 4.83E-06 1.95E-06 7.51E-07 4.98E-06 
29.00 1.89E-06 6.93E-07 4.87E-06 1.87E-06 6.86E-07 4.81E-06 1.93E-06 7.15E-07 4.96E-06 




 Adult 15yo 10yo 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
31.00 1.85E-06 6.32E-07 4.83E-06 1.83E-06 6.26E-07 4.77E-06 1.89E-06 6.52E-07 4.92E-06 
32.00 1.84E-06 6.06E-07 4.81E-06 1.82E-06 5.99E-07 4.75E-06 1.88E-06 6.24E-07 4.90E-06 
33.00 1.82E-06 5.81E-07 4.79E-06 1.80E-06 5.75E-07 4.74E-06 1.86E-06 5.99E-07 4.88E-06 
34.00 1.81E-06 5.59E-07 4.78E-06 1.79E-06 5.53E-07 4.72E-06 1.85E-06 5.76E-07 4.87E-06 
35.00 1.80E-06 5.39E-07 4.76E-06 1.77E-06 5.33E-07 4.70E-06 1.83E-06 5.55E-07 4.85E-06 
36.00 1.78E-06 5.21E-07 4.74E-06 1.76E-06 5.15E-07 4.68E-06 1.82E-06 5.35E-07 4.83E-06 
 
 05yo 01yo Newborn 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
0.00 5.02E-06 5.02E-06 5.02E-06 5.17E-06 5.17E-06 5.17E-06 5.31E-06 5.31E-06 5.31E-06 
0.25 5.09E-06 5.07E-06 5.37E-06 5.24E-06 5.21E-06 5.49E-06 5.38E-06 5.36E-06 5.59E-06 
0.50 5.10E-06 5.06E-06 5.49E-06 5.25E-06 5.21E-06 5.60E-06 5.39E-06 5.36E-06 5.67E-06 
1.00 5.07E-06 5.01E-06 5.61E-06 5.20E-06 5.15E-06 5.69E-06 5.35E-06 5.30E-06 5.74E-06 
2.00 4.89E-06 4.78E-06 5.66E-06 5.01E-06 4.91E-06 5.72E-06 5.14E-06 5.06E-06 5.72E-06 
3.00 4.64E-06 4.49E-06 5.61E-06 4.75E-06 4.61E-06 5.66E-06 4.87E-06 4.75E-06 5.63E-06 
4.00 4.37E-06 4.17E-06 5.55E-06 4.47E-06 4.28E-06 5.58E-06 4.58E-06 4.42E-06 5.54E-06 
5.00 4.11E-06 3.86E-06 5.48E-06 4.20E-06 3.96E-06 5.51E-06 4.29E-06 4.08E-06 5.45E-06 
6.00 3.87E-06 3.56E-06 5.42E-06 3.95E-06 3.65E-06 5.44E-06 4.02E-06 3.76E-06 5.37E-06 
7.00 3.64E-06 3.27E-06 5.37E-06 3.71E-06 3.36E-06 5.39E-06 3.77E-06 3.46E-06 5.31E-06 
8.00 3.44E-06 3.01E-06 5.32E-06 3.50E-06 3.09E-06 5.34E-06 3.55E-06 3.18E-06 5.26E-06 
9.00 3.25E-06 2.77E-06 5.28E-06 3.31E-06 2.84E-06 5.30E-06 3.35E-06 2.92E-06 5.22E-06 
10.00 3.09E-06 2.55E-06 5.25E-06 3.14E-06 2.62E-06 5.26E-06 3.17E-06 2.69E-06 5.18E-06 
11.00 2.94E-06 2.35E-06 5.22E-06 2.98E-06 2.41E-06 5.23E-06 3.01E-06 2.48E-06 5.15E-06 
12.00 2.81E-06 2.17E-06 5.19E-06 2.85E-06 2.22E-06 5.21E-06 2.87E-06 2.28E-06 5.12E-06 
13.00 2.69E-06 2.00E-06 5.17E-06 2.73E-06 2.05E-06 5.18E-06 2.74E-06 2.10E-06 5.10E-06 
14.00 2.59E-06 1.85E-06 5.14E-06 2.62E-06 1.89E-06 5.16E-06 2.63E-06 1.94E-06 5.08E-06 
15.00 2.50E-06 1.71E-06 5.12E-06 2.53E-06 1.75E-06 5.14E-06 2.53E-06 1.80E-06 5.05E-06 
16.00 2.42E-06 1.59E-06 5.10E-06 2.44E-06 1.62E-06 5.11E-06 2.44E-06 1.66E-06 5.03E-06 
17.00 2.35E-06 1.47E-06 5.08E-06 2.37E-06 1.51E-06 5.09E-06 2.37E-06 1.54E-06 5.01E-06 
18.00 2.28E-06 1.37E-06 5.06E-06 2.30E-06 1.40E-06 5.07E-06 2.30E-06 1.43E-06 4.99E-06 
19.00 2.22E-06 1.28E-06 5.04E-06 2.24E-06 1.31E-06 5.05E-06 2.23E-06 1.33E-06 4.97E-06 
20.00 2.17E-06 1.19E-06 5.02E-06 2.19E-06 1.22E-06 5.03E-06 2.18E-06 1.24E-06 4.95E-06 
21.00 2.13E-06 1.12E-06 5.00E-06 2.14E-06 1.14E-06 5.01E-06 2.13E-06 1.16E-06 4.93E-06 
22.00 2.09E-06 1.05E-06 4.98E-06 2.10E-06 1.07E-06 4.99E-06 2.09E-06 1.09E-06 4.91E-06 
23.00 2.05E-06 9.83E-07 4.96E-06 2.06E-06 1.00E-06 4.97E-06 2.05E-06 1.02E-06 4.89E-06 




 05yo 01yo Newborn 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
25.00 1.98E-06 8.72E-07 4.92E-06 2.00E-06 8.88E-07 4.93E-06 1.98E-06 9.02E-07 4.85E-06 
26.00 1.96E-06 8.24E-07 4.90E-06 1.97E-06 8.39E-07 4.91E-06 1.95E-06 8.51E-07 4.83E-06 
27.00 1.93E-06 7.81E-07 4.88E-06 1.94E-06 7.94E-07 4.89E-06 1.92E-06 8.05E-07 4.82E-06 
28.00 1.91E-06 7.41E-07 4.86E-06 1.92E-06 7.54E-07 4.88E-06 1.90E-06 7.62E-07 4.80E-06 
29.00 1.89E-06 7.05E-07 4.84E-06 1.90E-06 7.16E-07 4.86E-06 1.87E-06 7.24E-07 4.78E-06 
30.00 1.87E-06 6.72E-07 4.82E-06 1.88E-06 6.82E-07 4.84E-06 1.85E-06 6.89E-07 4.76E-06 
31.00 1.85E-06 6.42E-07 4.81E-06 1.86E-06 6.52E-07 4.82E-06 1.83E-06 6.57E-07 4.74E-06 
32.00 1.83E-06 6.14E-07 4.79E-06 1.84E-06 6.23E-07 4.80E-06 1.82E-06 6.28E-07 4.72E-06 
33.00 1.82E-06 5.89E-07 4.77E-06 1.82E-06 5.97E-07 4.78E-06 1.80E-06 6.01E-07 4.70E-06 
34.00 1.80E-06 5.66E-07 4.75E-06 1.81E-06 5.74E-07 4.76E-06 1.79E-06 5.77E-07 4.68E-06 
35.00 1.79E-06 5.45E-07 4.73E-06 1.80E-06 5.52E-07 4.74E-06 1.77E-06 5.54E-07 4.67E-06 






EFFECTIVE DOSE RATE 300 CM FOR 15YO PATIENT 
 Adult 15yo 10yo 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
0.00 4.79E-06 4.79E-06 4.79E-06 4.86E-06 4.86E-06 4.86E-06 5.07E-06 5.07E-06 5.07E-06 
0.25 4.86E-06 4.83E-06 5.19E-06 4.93E-06 4.90E-06 5.25E-06 5.14E-06 5.12E-06 5.45E-06 
0.50 4.88E-06 4.83E-06 5.33E-06 4.95E-06 4.90E-06 5.38E-06 5.16E-06 5.11E-06 5.58E-06 
1.00 4.85E-06 4.78E-06 5.47E-06 4.92E-06 4.85E-06 5.52E-06 5.12E-06 5.05E-06 5.70E-06 
2.00 4.69E-06 4.57E-06 5.56E-06 4.74E-06 4.63E-06 5.60E-06 4.94E-06 4.82E-06 5.77E-06 
3.00 4.46E-06 4.29E-06 5.55E-06 4.51E-06 4.34E-06 5.57E-06 4.69E-06 4.53E-06 5.74E-06 
4.00 4.21E-06 3.99E-06 5.50E-06 4.26E-06 4.04E-06 5.52E-06 4.42E-06 4.21E-06 5.67E-06 
5.00 3.97E-06 3.69E-06 5.44E-06 4.01E-06 3.74E-06 5.46E-06 4.16E-06 3.89E-06 5.61E-06 
6.00 3.74E-06 3.41E-06 5.39E-06 3.78E-06 3.45E-06 5.41E-06 3.92E-06 3.59E-06 5.55E-06 
7.00 3.53E-06 3.14E-06 5.34E-06 3.56E-06 3.17E-06 5.36E-06 3.69E-06 3.31E-06 5.50E-06 
8.00 3.33E-06 2.89E-06 5.30E-06 3.36E-06 2.92E-06 5.31E-06 3.48E-06 3.04E-06 5.45E-06 
9.00 3.16E-06 2.66E-06 5.26E-06 3.19E-06 2.69E-06 5.28E-06 3.30E-06 2.80E-06 5.41E-06 
10.00 3.01E-06 2.45E-06 5.23E-06 3.03E-06 2.48E-06 5.24E-06 3.13E-06 2.58E-06 5.38E-06 
11.00 2.87E-06 2.26E-06 5.20E-06 2.89E-06 2.28E-06 5.21E-06 2.99E-06 2.37E-06 5.35E-06 
12.00 2.75E-06 2.08E-06 5.17E-06 2.77E-06 2.10E-06 5.19E-06 2.86E-06 2.19E-06 5.32E-06 
13.00 2.64E-06 1.92E-06 5.15E-06 2.65E-06 1.94E-06 5.16E-06 2.74E-06 2.02E-06 5.29E-06 
14.00 2.54E-06 1.78E-06 5.12E-06 2.56E-06 1.80E-06 5.14E-06 2.64E-06 1.87E-06 5.27E-06 
15.00 2.45E-06 1.65E-06 5.10E-06 2.47E-06 1.67E-06 5.12E-06 2.55E-06 1.73E-06 5.25E-06 
16.00 2.38E-06 1.53E-06 5.08E-06 2.39E-06 1.54E-06 5.09E-06 2.46E-06 1.61E-06 5.22E-06 
17.00 2.31E-06 1.42E-06 5.06E-06 2.32E-06 1.44E-06 5.07E-06 2.39E-06 1.49E-06 5.20E-06 
18.00 2.25E-06 1.32E-06 5.04E-06 2.26E-06 1.34E-06 5.05E-06 2.33E-06 1.39E-06 5.18E-06 
19.00 2.19E-06 1.23E-06 5.02E-06 2.20E-06 1.25E-06 5.03E-06 2.27E-06 1.29E-06 5.16E-06 
20.00 2.14E-06 1.15E-06 5.00E-06 2.15E-06 1.16E-06 5.01E-06 2.22E-06 1.21E-06 5.14E-06 
21.00 2.10E-06 1.08E-06 4.98E-06 2.11E-06 1.09E-06 4.99E-06 2.17E-06 1.13E-06 5.12E-06 
22.00 2.06E-06 1.01E-06 4.96E-06 2.07E-06 1.02E-06 4.97E-06 2.13E-06 1.06E-06 5.10E-06 
23.00 2.02E-06 9.51E-07 4.94E-06 2.03E-06 9.60E-07 4.95E-06 2.09E-06 9.95E-07 5.07E-06 
24.00 1.99E-06 8.96E-07 4.92E-06 2.00E-06 9.04E-07 4.93E-06 2.06E-06 9.37E-07 5.05E-06 
25.00 1.96E-06 8.46E-07 4.90E-06 1.97E-06 8.53E-07 4.91E-06 2.02E-06 8.84E-07 5.03E-06 
26.00 1.94E-06 8.00E-07 4.88E-06 1.94E-06 8.07E-07 4.89E-06 2.00E-06 8.35E-07 5.01E-06 
27.00 1.91E-06 7.58E-07 4.86E-06 1.92E-06 7.65E-07 4.87E-06 1.97E-06 7.91E-07 4.99E-06 
28.00 1.89E-06 7.20E-07 4.84E-06 1.90E-06 7.26E-07 4.85E-06 1.95E-06 7.51E-07 4.97E-06 
29.00 1.87E-06 6.85E-07 4.82E-06 1.88E-06 6.91E-07 4.83E-06 1.93E-06 7.15E-07 4.95E-06 




 Adult 15yo 10yo 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
31.00 1.83E-06 6.25E-07 4.78E-06 1.84E-06 6.30E-07 4.79E-06 1.89E-06 6.51E-07 4.91E-06 
32.00 1.82E-06 5.99E-07 4.76E-06 1.82E-06 6.03E-07 4.77E-06 1.87E-06 6.23E-07 4.89E-06 
33.00 1.80E-06 5.75E-07 4.74E-06 1.81E-06 5.79E-07 4.75E-06 1.85E-06 5.98E-07 4.87E-06 
34.00 1.79E-06 5.53E-07 4.72E-06 1.79E-06 5.57E-07 4.73E-06 1.84E-06 5.75E-07 4.85E-06 
35.00 1.77E-06 5.33E-07 4.70E-06 1.78E-06 5.36E-07 4.71E-06 1.83E-06 5.53E-07 4.83E-06 
36.00 1.76E-06 5.14E-07 4.68E-06 1.77E-06 5.17E-07 4.70E-06 1.81E-06 5.34E-07 4.81E-06 
 
 05yo 01yo Newborn 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
0.00 5.02E-06 5.02E-06 5.02E-06 5.18E-06 5.18E-06 5.18E-06 5.35E-06 5.35E-06 5.35E-06 
0.25 5.09E-06 5.06E-06 5.38E-06 5.24E-06 5.22E-06 5.46E-06 5.42E-06 5.39E-06 5.67E-06 
0.50 5.10E-06 5.06E-06 5.50E-06 5.25E-06 5.22E-06 5.54E-06 5.42E-06 5.39E-06 5.78E-06 
1.00 5.07E-06 5.00E-06 5.61E-06 5.20E-06 5.15E-06 5.61E-06 5.38E-06 5.32E-06 5.87E-06 
2.00 4.89E-06 4.78E-06 5.66E-06 5.00E-06 4.91E-06 5.60E-06 5.17E-06 5.07E-06 5.89E-06 
3.00 4.64E-06 4.48E-06 5.62E-06 4.73E-06 4.61E-06 5.52E-06 4.90E-06 4.76E-06 5.83E-06 
4.00 4.37E-06 4.17E-06 5.55E-06 4.45E-06 4.28E-06 5.43E-06 4.61E-06 4.42E-06 5.74E-06 
5.00 4.11E-06 3.86E-06 5.49E-06 4.17E-06 3.96E-06 5.35E-06 4.33E-06 4.09E-06 5.67E-06 
6.00 3.87E-06 3.56E-06 5.42E-06 3.91E-06 3.64E-06 5.28E-06 4.07E-06 3.77E-06 5.60E-06 
7.00 3.64E-06 3.27E-06 5.37E-06 3.67E-06 3.35E-06 5.22E-06 3.82E-06 3.47E-06 5.54E-06 
8.00 3.44E-06 3.01E-06 5.32E-06 3.46E-06 3.08E-06 5.17E-06 3.60E-06 3.19E-06 5.49E-06 
9.00 3.25E-06 2.77E-06 5.29E-06 3.26E-06 2.83E-06 5.13E-06 3.41E-06 2.93E-06 5.45E-06 
10.00 3.09E-06 2.55E-06 5.25E-06 3.09E-06 2.61E-06 5.09E-06 3.23E-06 2.70E-06 5.41E-06 
11.00 2.94E-06 2.35E-06 5.22E-06 2.93E-06 2.40E-06 5.06E-06 3.07E-06 2.48E-06 5.38E-06 
12.00 2.81E-06 2.17E-06 5.19E-06 2.80E-06 2.21E-06 5.04E-06 2.93E-06 2.29E-06 5.35E-06 
13.00 2.69E-06 2.00E-06 5.17E-06 2.68E-06 2.04E-06 5.01E-06 2.81E-06 2.11E-06 5.32E-06 
14.00 2.59E-06 1.85E-06 5.14E-06 2.57E-06 1.88E-06 4.99E-06 2.70E-06 1.95E-06 5.30E-06 
15.00 2.50E-06 1.71E-06 5.12E-06 2.47E-06 1.74E-06 4.96E-06 2.60E-06 1.81E-06 5.28E-06 
16.00 2.42E-06 1.59E-06 5.10E-06 2.39E-06 1.61E-06 4.94E-06 2.51E-06 1.67E-06 5.25E-06 
17.00 2.34E-06 1.47E-06 5.08E-06 2.31E-06 1.50E-06 4.92E-06 2.44E-06 1.55E-06 5.23E-06 
18.00 2.28E-06 1.37E-06 5.06E-06 2.25E-06 1.39E-06 4.90E-06 2.37E-06 1.45E-06 5.21E-06 
19.00 2.22E-06 1.28E-06 5.04E-06 2.19E-06 1.30E-06 4.88E-06 2.31E-06 1.35E-06 5.19E-06 
20.00 2.17E-06 1.19E-06 5.02E-06 2.13E-06 1.21E-06 4.86E-06 2.25E-06 1.26E-06 5.17E-06 
21.00 2.12E-06 1.12E-06 5.00E-06 2.08E-06 1.13E-06 4.84E-06 2.20E-06 1.17E-06 5.14E-06 
22.00 2.08E-06 1.05E-06 4.98E-06 2.04E-06 1.06E-06 4.82E-06 2.16E-06 1.10E-06 5.12E-06 
23.00 2.05E-06 9.82E-07 4.95E-06 2.00E-06 9.91E-07 4.80E-06 2.12E-06 1.03E-06 5.10E-06 




 05yo 01yo Newborn 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
25.00 1.98E-06 8.71E-07 4.91E-06 1.93E-06 8.77E-07 4.76E-06 2.05E-06 9.15E-07 5.06E-06 
26.00 1.95E-06 8.23E-07 4.89E-06 1.91E-06 8.27E-07 4.74E-06 2.02E-06 8.64E-07 5.04E-06 
27.00 1.93E-06 7.80E-07 4.88E-06 1.88E-06 7.83E-07 4.72E-06 1.99E-06 8.17E-07 5.02E-06 
28.00 1.90E-06 7.40E-07 4.86E-06 1.86E-06 7.42E-07 4.70E-06 1.97E-06 7.75E-07 5.00E-06 
29.00 1.88E-06 7.04E-07 4.84E-06 1.83E-06 7.04E-07 4.69E-06 1.94E-06 7.37E-07 4.98E-06 
30.00 1.86E-06 6.71E-07 4.82E-06 1.81E-06 6.70E-07 4.67E-06 1.92E-06 7.01E-07 4.96E-06 
31.00 1.84E-06 6.40E-07 4.80E-06 1.80E-06 6.39E-07 4.65E-06 1.90E-06 6.69E-07 4.94E-06 
32.00 1.83E-06 6.13E-07 4.78E-06 1.78E-06 6.11E-07 4.63E-06 1.89E-06 6.40E-07 4.92E-06 
33.00 1.81E-06 5.88E-07 4.76E-06 1.76E-06 5.85E-07 4.61E-06 1.87E-06 6.13E-07 4.90E-06 
34.00 1.80E-06 5.65E-07 4.74E-06 1.75E-06 5.61E-07 4.59E-06 1.85E-06 5.89E-07 4.88E-06 
35.00 1.78E-06 5.44E-07 4.72E-06 1.73E-06 5.40E-07 4.57E-06 1.84E-06 5.67E-07 4.86E-06 






EFFECTIVE DOSE RATE 300 CM FOR 10YO PATIENT 
 Adult 15yo 10yo 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
0.00 5.04E-06 5.04E-06 5.04E-06 5.08E-06 5.08E-06 5.08E-06 5.28E-06 5.28E-06 5.28E-06 
0.25 5.11E-06 5.08E-06 5.41E-06 5.15E-06 5.12E-06 5.45E-06 5.35E-06 5.31E-06 5.68E-06 
0.50 5.11E-06 5.07E-06 5.54E-06 5.15E-06 5.11E-06 5.58E-06 5.35E-06 5.31E-06 5.82E-06 
1.00 5.08E-06 5.01E-06 5.67E-06 5.11E-06 5.04E-06 5.70E-06 5.31E-06 5.24E-06 5.95E-06 
2.00 4.89E-06 4.78E-06 5.73E-06 4.92E-06 4.81E-06 5.76E-06 5.12E-06 4.99E-06 6.03E-06 
3.00 4.65E-06 4.48E-06 5.70E-06 4.67E-06 4.51E-06 5.73E-06 4.86E-06 4.68E-06 6.00E-06 
4.00 4.38E-06 4.17E-06 5.64E-06 4.41E-06 4.19E-06 5.67E-06 4.59E-06 4.35E-06 5.95E-06 
5.00 4.12E-06 3.85E-06 5.58E-06 4.15E-06 3.87E-06 5.61E-06 4.32E-06 4.03E-06 5.88E-06 
6.00 3.88E-06 3.55E-06 5.52E-06 3.90E-06 3.57E-06 5.55E-06 4.07E-06 3.71E-06 5.82E-06 
7.00 3.66E-06 3.27E-06 5.47E-06 3.68E-06 3.29E-06 5.50E-06 3.83E-06 3.42E-06 5.77E-06 
8.00 3.45E-06 3.01E-06 5.42E-06 3.47E-06 3.03E-06 5.45E-06 3.62E-06 3.15E-06 5.72E-06 
9.00 3.27E-06 2.77E-06 5.38E-06 3.29E-06 2.78E-06 5.41E-06 3.43E-06 2.90E-06 5.68E-06 
10.00 3.11E-06 2.55E-06 5.35E-06 3.12E-06 2.56E-06 5.38E-06 3.26E-06 2.67E-06 5.65E-06 
11.00 2.96E-06 2.35E-06 5.32E-06 2.98E-06 2.36E-06 5.35E-06 3.11E-06 2.46E-06 5.61E-06 
12.00 2.83E-06 2.17E-06 5.29E-06 2.85E-06 2.18E-06 5.32E-06 2.98E-06 2.27E-06 5.58E-06 
13.00 2.72E-06 2.00E-06 5.26E-06 2.73E-06 2.01E-06 5.29E-06 2.86E-06 2.09E-06 5.56E-06 
14.00 2.62E-06 1.85E-06 5.24E-06 2.63E-06 1.86E-06 5.27E-06 2.75E-06 1.94E-06 5.53E-06 
15.00 2.52E-06 1.71E-06 5.22E-06 2.54E-06 1.72E-06 5.24E-06 2.66E-06 1.79E-06 5.51E-06 
16.00 2.44E-06 1.59E-06 5.19E-06 2.46E-06 1.60E-06 5.22E-06 2.57E-06 1.66E-06 5.48E-06 
17.00 2.37E-06 1.48E-06 5.17E-06 2.38E-06 1.48E-06 5.20E-06 2.50E-06 1.55E-06 5.46E-06 
18.00 2.31E-06 1.37E-06 5.15E-06 2.32E-06 1.38E-06 5.18E-06 2.43E-06 1.44E-06 5.43E-06 
19.00 2.25E-06 1.28E-06 5.13E-06 2.26E-06 1.29E-06 5.15E-06 2.37E-06 1.34E-06 5.41E-06 
20.00 2.20E-06 1.20E-06 5.10E-06 2.21E-06 1.20E-06 5.13E-06 2.32E-06 1.25E-06 5.39E-06 
21.00 2.15E-06 1.12E-06 5.08E-06 2.16E-06 1.13E-06 5.11E-06 2.27E-06 1.17E-06 5.37E-06 
22.00 2.11E-06 1.05E-06 5.06E-06 2.12E-06 1.06E-06 5.09E-06 2.22E-06 1.10E-06 5.34E-06 
23.00 2.07E-06 9.87E-07 5.04E-06 2.08E-06 9.92E-07 5.07E-06 2.19E-06 1.03E-06 5.32E-06 
24.00 2.04E-06 9.29E-07 5.02E-06 2.05E-06 9.34E-07 5.05E-06 2.15E-06 9.74E-07 5.30E-06 
25.00 2.01E-06 8.76E-07 5.00E-06 2.02E-06 8.81E-07 5.03E-06 2.12E-06 9.19E-07 5.28E-06 
26.00 1.98E-06 8.28E-07 4.98E-06 1.99E-06 8.33E-07 5.00E-06 2.09E-06 8.69E-07 5.26E-06 
27.00 1.96E-06 7.85E-07 4.96E-06 1.97E-06 7.89E-07 4.98E-06 2.06E-06 8.23E-07 5.23E-06 
28.00 1.93E-06 7.45E-07 4.94E-06 1.94E-06 7.49E-07 4.96E-06 2.04E-06 7.82E-07 5.21E-06 
29.00 1.91E-06 7.09E-07 4.92E-06 1.92E-06 7.13E-07 4.94E-06 2.02E-06 7.44E-07 5.19E-06 




 Adult 15yo 10yo 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
31.00 1.87E-06 6.46E-07 4.88E-06 1.88E-06 6.49E-07 4.90E-06 1.97E-06 6.78E-07 5.15E-06 
32.00 1.85E-06 6.18E-07 4.86E-06 1.86E-06 6.22E-07 4.88E-06 1.96E-06 6.50E-07 5.13E-06 
33.00 1.84E-06 5.93E-07 4.84E-06 1.85E-06 5.96E-07 4.86E-06 1.94E-06 6.23E-07 5.10E-06 
34.00 1.82E-06 5.70E-07 4.82E-06 1.83E-06 5.73E-07 4.84E-06 1.92E-06 5.99E-07 5.08E-06 
35.00 1.81E-06 5.49E-07 4.80E-06 1.82E-06 5.52E-07 4.82E-06 1.91E-06 5.77E-07 5.06E-06 
36.00 1.80E-06 5.30E-07 4.78E-06 1.81E-06 5.33E-07 4.80E-06 1.90E-06 5.57E-07 5.04E-06 
 
 05yo 01yo Newborn 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
0.00 5.22E-06 5.22E-06 5.22E-06 5.29E-06 5.29E-06 5.29E-06 5.35E-06 5.35E-06 5.35E-06 
0.25 5.29E-06 5.26E-06 5.60E-06 5.36E-06 5.34E-06 5.64E-06 5.43E-06 5.41E-06 5.75E-06 
0.50 5.30E-06 5.25E-06 5.72E-06 5.37E-06 5.33E-06 5.75E-06 5.45E-06 5.40E-06 5.88E-06 
1.00 5.25E-06 5.19E-06 5.85E-06 5.33E-06 5.27E-06 5.86E-06 5.41E-06 5.34E-06 6.01E-06 
2.00 5.06E-06 4.94E-06 5.91E-06 5.13E-06 5.02E-06 5.90E-06 5.22E-06 5.10E-06 6.07E-06 
3.00 4.80E-06 4.64E-06 5.87E-06 4.86E-06 4.71E-06 5.84E-06 4.96E-06 4.79E-06 6.03E-06 
4.00 4.53E-06 4.31E-06 5.81E-06 4.58E-06 4.38E-06 5.77E-06 4.67E-06 4.45E-06 5.96E-06 
5.00 4.26E-06 3.98E-06 5.74E-06 4.30E-06 4.05E-06 5.69E-06 4.40E-06 4.12E-06 5.89E-06 
6.00 4.01E-06 3.67E-06 5.68E-06 4.04E-06 3.73E-06 5.63E-06 4.13E-06 3.80E-06 5.82E-06 
7.00 3.78E-06 3.38E-06 5.62E-06 3.81E-06 3.44E-06 5.57E-06 3.89E-06 3.50E-06 5.76E-06 
8.00 3.56E-06 3.11E-06 5.58E-06 3.59E-06 3.16E-06 5.52E-06 3.67E-06 3.22E-06 5.71E-06 
9.00 3.38E-06 2.86E-06 5.54E-06 3.39E-06 2.91E-06 5.48E-06 3.48E-06 2.96E-06 5.67E-06 
10.00 3.21E-06 2.64E-06 5.50E-06 3.22E-06 2.68E-06 5.44E-06 3.30E-06 2.73E-06 5.63E-06 
11.00 3.06E-06 2.43E-06 5.47E-06 3.06E-06 2.46E-06 5.41E-06 3.15E-06 2.51E-06 5.60E-06 
12.00 2.92E-06 2.24E-06 5.44E-06 2.93E-06 2.27E-06 5.38E-06 3.01E-06 2.32E-06 5.57E-06 
13.00 2.80E-06 2.07E-06 5.41E-06 2.80E-06 2.10E-06 5.35E-06 2.88E-06 2.14E-06 5.54E-06 
14.00 2.70E-06 1.91E-06 5.39E-06 2.70E-06 1.94E-06 5.33E-06 2.77E-06 1.98E-06 5.52E-06 
15.00 2.60E-06 1.77E-06 5.36E-06 2.60E-06 1.79E-06 5.30E-06 2.67E-06 1.83E-06 5.49E-06 
16.00 2.52E-06 1.64E-06 5.34E-06 2.51E-06 1.66E-06 5.28E-06 2.59E-06 1.70E-06 5.47E-06 
17.00 2.44E-06 1.53E-06 5.32E-06 2.44E-06 1.54E-06 5.26E-06 2.51E-06 1.58E-06 5.44E-06 
18.00 2.38E-06 1.42E-06 5.29E-06 2.37E-06 1.44E-06 5.24E-06 2.44E-06 1.47E-06 5.42E-06 
19.00 2.32E-06 1.32E-06 5.27E-06 2.31E-06 1.34E-06 5.21E-06 2.38E-06 1.37E-06 5.40E-06 
20.00 2.26E-06 1.24E-06 5.25E-06 2.25E-06 1.25E-06 5.19E-06 2.32E-06 1.28E-06 5.38E-06 
21.00 2.22E-06 1.16E-06 5.23E-06 2.20E-06 1.17E-06 5.17E-06 2.27E-06 1.19E-06 5.35E-06 
22.00 2.17E-06 1.08E-06 5.21E-06 2.16E-06 1.09E-06 5.15E-06 2.23E-06 1.12E-06 5.33E-06 
23.00 2.13E-06 1.02E-06 5.18E-06 2.12E-06 1.03E-06 5.13E-06 2.19E-06 1.05E-06 5.31E-06 




 05yo 01yo Newborn 
Time (hrs) Normal  DTC Hyper Normal  DTC Hyper Normal  DTC Hyper 
25.00 2.07E-06 9.05E-07 5.14E-06 2.05E-06 9.11E-07 5.08E-06 2.12E-06 9.32E-07 5.26E-06 
26.00 2.04E-06 8.55E-07 5.12E-06 2.02E-06 8.60E-07 5.06E-06 2.09E-06 8.81E-07 5.24E-06 
27.00 2.01E-06 8.10E-07 5.10E-06 2.00E-06 8.14E-07 5.04E-06 2.06E-06 8.34E-07 5.22E-06 
28.00 1.99E-06 7.69E-07 5.08E-06 1.97E-06 7.73E-07 5.02E-06 2.04E-06 7.92E-07 5.20E-06 
29.00 1.97E-06 7.31E-07 5.06E-06 1.95E-06 7.34E-07 5.00E-06 2.01E-06 7.53E-07 5.18E-06 
30.00 1.95E-06 6.97E-07 5.04E-06 1.93E-06 7.00E-07 4.98E-06 1.99E-06 7.18E-07 5.16E-06 
31.00 1.93E-06 6.66E-07 5.01E-06 1.91E-06 6.68E-07 4.96E-06 1.97E-06 6.85E-07 5.13E-06 
32.00 1.91E-06 6.38E-07 4.99E-06 1.89E-06 6.39E-07 4.94E-06 1.96E-06 6.56E-07 5.11E-06 
33.00 1.89E-06 6.12E-07 4.97E-06 1.87E-06 6.13E-07 4.92E-06 1.94E-06 6.29E-07 5.09E-06 
34.00 1.88E-06 5.88E-07 4.95E-06 1.86E-06 5.88E-07 4.90E-06 1.92E-06 6.04E-07 5.07E-06 
35.00 1.86E-06 5.66E-07 4.93E-06 1.84E-06 5.66E-07 4.88E-06 1.91E-06 5.82E-07 5.05E-06 
36.00 1.85E-06 5.46E-07 4.91E-06 1.83E-06 5.46E-07 4.86E-06 1.89E-06 5.61E-07 5.03E-06 
 
